{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Science vs Pseudoscience\n",
    "\n",
    "Science: knowledge or a system of knowledge covering general truths or the operation of general laws especially as obtained and tested through scientific method\n",
    "\n",
    "Pseudoscience: knowledge or a system of knowledge covering general truths or the operation of general laws especially as obtained and tested through scientific method\n",
    "\n",
    "Medicine: The science or practice of the diagnosis, treatment, and prevention of disease\n",
    "\n",
    "Alternative Medicine: Any of a range of medical therapies that are not regarded as orthodox by the medical profession, such as herbalism, naturopathy, and crystal healing.\n",
    "\n",
    "Alternative Medicine: Treatments that are used instead of standard treatments. Standard treatments are based on the results of scientific research and are currently accepted and widely used. Less research has been done for most types of alternative medicine. Alternative medicine may include special diets, megadose vitamins, herbal preparations, special teas, and magnet therapy. For example, a special diet may be used instead of anticancer drugs as a treatment for cancer.\n",
    "\n",
    "\"Science.\" Merriam-Webster.com. 2020. https://www.merriam-webster.com/dictionary/science (27 Mar 2020).\n",
    "\n",
    "\"Pseudocience.\" Merriam-Webster.com. 2020. https://www.merriam-webster.com/dictionary/pseudoscience (27 Mar 2020).\n",
    "\n",
    "\"Medicine.\" Lexico.com 2020 https://www.lexico.com/definition/medicine (27 Mar 2020)\n",
    "\n",
    "\"Alterantive Medicine.\" cancer.gov 2020 https://www.cancer.gov/publications/dictionaries/cancer-terms/def/alternative-medicine (27 Mar 2020)\n",
    "\n",
    "\"Alterantive Medicine.\" 2020 https://www.lexico.com/definition/alternative_medicine (27 Mar 2020)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Medicine vs Alternative Medicine: Data Collection\n",
    "\n",
    "Utilized web-scraping to collect titles and abstracts from 4 different medical science journals and 6 different alternative medicine journals.\n",
    "\n",
    "Decided on medicine vs alternative medicine as it is a more precise comparison than the broader science vs pseudoscience comparison."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Hypothesis\n",
    "\n",
    "Medical vs alternative medical research papers can be accurately distinguished based on titles and abstracts by various classification algorithms. "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fit Data to Naive Bayes Classifier"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fit to Titles"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                                                 Titles  Class\n",
      "0     Rivaroxaban or Enoxaparin in Nonmajor Orthoped...      1\n",
      "1     Apixaban for the Treatment of Venous Thromboem...      1\n",
      "2     Anticoagulation with or without Clopidogrel af...      1\n",
      "3     Vericiguat in Patients with Heart Failure and ...      1\n",
      "4     Rivaroxaban in Peripheral Artery Disease after...      1\n",
      "...                                                 ...    ...\n",
      "3367  \"Toward General Experimentation and Discovery ...      0\n",
      "3368  \"Single-Needle Acupuncture Alleviates Gag Refl...      0\n",
      "3369  Military Report More Complementary and Alterna...      0\n",
      "3370  Explanatory Attributions of Anxiety and Recove...      0\n",
      "3371  \"The Efficacy of Echinacea Compound Herbal Tea...      0\n",
      "\n",
      "[3372 rows x 2 columns]\n",
      "[[286  26]\n",
      " [ 41 322]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       0.87      0.92      0.90       312\n",
      "           1       0.93      0.89      0.91       363\n",
      "\n",
      "    accuracy                           0.90       675\n",
      "   macro avg       0.90      0.90      0.90       675\n",
      "weighted avg       0.90      0.90      0.90       675\n",
      "\n",
      "Predictions of 5 medical and 5 alternative medical titles, respectively are [1 0 1 1 0 0 0 0 0 0]\n",
      "--- 0.17224693298339844 seconds ---\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "from sklearn.feature_extraction import text \n",
    "from sklearn.naive_bayes import MultinomialNB\n",
    "from sklearn.metrics import classification_report,confusion_matrix\n",
    "from sklearn.model_selection import train_test_split\n",
    "import time\n",
    "start_time = time.time()\n",
    "\n",
    "# Load Data and assign global values\n",
    "\n",
    "# create a list of titles\n",
    "with open('sci_titles_scraped_dropdu', 'r') as f:\n",
    "    realtitles = [line.strip() for line in f]\n",
    "# create an array of ones the same length as the title list\n",
    "k = np.ones(len(realtitles), dtype = int)\n",
    "# create a dataframe of titles in one column and corresponding class in the next\n",
    "titles_real = pd.DataFrame({'Titles': realtitles, \"Class\":k })\n",
    "with open('pseudo_titles_scraped', 'r') as f:\n",
    "    pseudotitles = [line.strip() for line in f]\n",
    "l = np.zeros(len(pseudotitles), dtype = int)\n",
    "titles_fake = pd.DataFrame({\"Titles\": pseudotitles, 'Class': l})\n",
    "# concatenate \n",
    "titles_all = pd.concat([titles_real, titles_fake], ignore_index=True)\n",
    "print(titles_all)\n",
    "\n",
    "stop_wordz = text.ENGLISH_STOP_WORDS.union([\"accupuncture\", 'acupuncture', 'chiropractic', 'homeopathy', 'abstract', 'background', 'abstractobjectives', 'abstractbackground'])   \n",
    "   \n",
    "\n",
    "word_bagger = text.CountVectorizer(stop_words=stop_wordz)\n",
    "word_bagger.fit(titles_all['Titles'])\n",
    "\n",
    "y = titles_all['Class']\n",
    "X = word_bagger.transform(titles_all['Titles'])\n",
    "\n",
    "def multNB(X,y): \n",
    "\n",
    "    X_Train, X_Test, y_Train, y_Test = train_test_split(X, y, test_size = 0.20, random_state = 101)\n",
    "    \n",
    "    model = MultinomialNB()\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "    history = model.fit(X_Train, y_Train)\n",
    "\n",
    "    preds = model.predict(X_Test)\n",
    "\n",
    "\n",
    "    #trainedsvm = svm.LinearSVC(dual=False, C=0.2, max_iter=10000).fit(train_X, train_y)\n",
    "    #predictionsvm = trainedsvm.predict(test_X)\n",
    "    print(confusion_matrix(y_Test,preds))\n",
    "    print(classification_report(y_Test,preds))\n",
    "    \n",
    "    # Make a predicition on unseen, randomly chosen titles.\n",
    "    \n",
    "    med = \"Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study\"\n",
    "    med2 = \"Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial\"\n",
    "    med3 = \"Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer\"\n",
    "    med4 = \"PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma\"\n",
    "    med5 = \"Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone\"\n",
    "    altm = \"Prevalence, Patterns, and Predictors of T'ai Chi and Qigong Use in the United States: Results of a Nationally Representative Survey\"\n",
    "    altm2 = 'Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin'\n",
    "    altm3 = \"The American Coneflower: A Prophylactic Role Involving Nonspecific Immunity\"\n",
    "    altm4 = \"Effect of BEMER Magnetic Field Therapy on the Level of Fatigue in Patients with Multiple Sclerosis: A Randomized, Double-Blind Controlled Trial\"\n",
    "    altm5 = \"Improving Access to Integrative Oncology Through Group Medical Visits: A Pilot Implementation Project\"\n",
    "    \n",
    "    bagged = word_bagger.transform([med, med2, med3, med4, med5, altm, altm2, altm3, altm4, altm5])\n",
    "    print(\"Predictions of 5 medical and 5 alternative medical titles, respectively are {}\".format(model.predict(bagged)))\n",
    "\n",
    "multNB(X,y)\n",
    "\n",
    "print(\"--- %s seconds ---\" % (time.time() - start_time))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fit to Abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                                              Abstracts  Class\n",
      "0     \"Abstract Background Nonmajor orthopedic surge...      1\n",
      "1     \"Abstract Background Recent guidelines recomme...      1\n",
      "2     \"Abstract Background The roles of anticoagulat...      1\n",
      "3     \"Abstract Background The effect of vericiguat,...      1\n",
      "4     \"Abstract Background Patients with peripheral ...      1\n",
      "...                                                 ...    ...\n",
      "3373  \"AbstractObjectives: (1) To demonstrate inform...      0\n",
      "3374  \"AbstractObjectives: To study the effect of si...      0\n",
      "3375  \"AbstractObjectives: The study objective was t...      0\n",
      "3376  \"AbstractObjective: A need exists to understan...      0\n",
      "3377  \"AbstractObjectives: The aim of this study was...      0\n",
      "\n",
      "[3378 rows x 2 columns]\n",
      "[[301  17]\n",
      " [ 26 332]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       0.92      0.95      0.93       318\n",
      "           1       0.95      0.93      0.94       358\n",
      "\n",
      "    accuracy                           0.94       676\n",
      "   macro avg       0.94      0.94      0.94       676\n",
      "weighted avg       0.94      0.94      0.94       676\n",
      "\n",
      "Predictions of 5 medical and 5 alternative medical abstracts, respectively are [1 1 1 1 1 0 1 0 0 0]\n",
      "--- 1.0190870761871338 seconds ---\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "from sklearn.feature_extraction import text \n",
    "from sklearn.naive_bayes import MultinomialNB\n",
    "from sklearn.metrics import classification_report,confusion_matrix\n",
    "from sklearn.model_selection import train_test_split\n",
    "import time\n",
    "start_time = time.time()\n",
    "\n",
    "# Load Data and assign global values\n",
    "\n",
    "with open('sci_abstracts_scraped_dropdu', 'r') as f:\n",
    "    realabstracts = [line.strip() for line in f]\n",
    "# create an array of ones the same length as the title list\n",
    "k = np.ones(len(realabstracts), dtype = int)\n",
    "# create a dataframe of abstracts in one column and corresponding class in the next\n",
    "abstracts_real = pd.DataFrame({'Abstracts': realabstracts, \"Class\":k })\n",
    "with open('pseudo_abstracts_scraped', 'r') as f:\n",
    "    pseudoabstracts = [line.strip() for line in f]\n",
    "l = np.zeros(len(pseudoabstracts), dtype = int)\n",
    "abstracts_fake = pd.DataFrame({\"Abstracts\": pseudoabstracts, 'Class': l})\n",
    "# concatenate \n",
    "abstracts_all = pd.concat([abstracts_real, abstracts_fake], ignore_index=True)\n",
    "print(abstracts_all)\n",
    "\n",
    "word_bagger = text.CountVectorizer(stop_words=stop_wordz)\n",
    "word_bagger.fit(abstracts_all['Abstracts'])\n",
    "\n",
    "y_abstracts = abstracts_all['Class']\n",
    "X_abstracts = word_bagger.transform(abstracts_all['Abstracts'])\n",
    "\n",
    "\n",
    "def multnb_abstracts(X_abstratcs, y_abstracts):\n",
    "    \n",
    "\n",
    "\n",
    "    X_Train, X_Test, y_Train, y_Test = train_test_split(X_abstracts, y_abstracts, test_size = 0.20, random_state = 101)\n",
    "\n",
    "    model = MultinomialNB()\n",
    "    #pseudokill.fit(X, y)\n",
    "\n",
    "\n",
    "    #pseudokill.score(X,y)\n",
    "\n",
    "    history = model.fit(X_Train, y_Train)\n",
    "\n",
    "    preds = model.predict(X_Test)\n",
    "\n",
    "\n",
    "    #trainedsvm = svm.LinearSVC(dual=False, C=0.2, max_iter=10000).fit(train_X, train_y)\n",
    "    #predictionsvm = trainedsvm.predict(test_X)\n",
    "    print(confusion_matrix(y_Test,preds))\n",
    "    print(classification_report(y_Test,preds))\n",
    "    \n",
    "    \n",
    "    # Make a Prediction on unseen, randomly chosen abstracts:\n",
    "\n",
    "    medab = \"The National Institute of Mental Health (NIMH) ‘fast-fail’ approach seeks to improve too-often-misleading early-phase drug development methods by incorporating biomarker-based proof-of-mechanism (POM) testing in phase 2a. This first comprehensive application of the fast-fail approach evaluated the potential of κ-opioid receptor (KOR) antagonism for treating anhedonia with a POM study determining whether robust target engagement favorably impacts the brain circuitry hypothesized to mediate clinical effects. Here we report the results from a multicenter, 8-week, double-blind, placebo-controlled, randomized trial in patients with anhedonia and a mood or anxiety disorder (selective KOR antagonist (JNJ-67953964, 10 mg; n = 45) and placebo (n = 44)). JNJ-67953964 significantly increased functional magnetic resonance imaging (fMRI) ventral striatum activation during reward anticipation (primary outcome) as compared to placebo (baseline-adjusted mean: JNJ-67953964, 0.72 (s.d. = 0.67); placebo, 0.33 (s.d. = 0.68); F(1,86) = 5.58, P < 0.01; effect size = 0.58 (95% confidence interval, 0.13–0.99)). JNJ-67953964, generally well tolerated, was not associated with any serious adverse events. This study supports proceeding with assessment of the clinical impact of target engagement and serves as a model for implementing the ‘fast-fail’ approach.\"\n",
    "    medab2 = \"Neoadjuvant checkpoint inhibition, in which the therapy is administered before surgery, is a promising new approach to managing bulky but resectable melanoma, and is also being explored in other cancers. This strategy has a high pathologic response rate, which correlates with survival outcomes. The fact that biopsies are routinely available provides a unique opportunity for understanding the responses to therapy and carrying out reverse translation in which these data are used to select therapies in the clinic or in trials that are more likely to improve patient outcomes. In this Perspective, we discuss the rationale for neoadjuvant immunotherapy in resectable solid tumors based on preclinical and human translational data, summarize the results of recent clinical trials and ongoing research, and focus on future directions for enhancing reverse translation.\"\n",
    "    medab3 = \"Successful drug discovery is ultimately contingent on the availability of workable, relevant, predictive model systems. Conversely, for cardiac muscle, the lack of human preclinical models to inform target validation and compound development has likely contributed to the perennial problem of clinical trial failures, despite encouraging non-human results. By contrast, human cardiomyocytes produced from pluripotent stem cell models have recently been applied to safety pharmacology, phenotypic screening, target validation and high-throughput assays, facilitating cardiac drug discovery. Here, we review the impact of human pluripotent stem cell models in cardiac drug discovery, discussing the range of applications, readouts, and disease models employed, along with the challenges and prospects to advance this fruitful mode of research further.\"\n",
    "    medab4 = \"Epithelial-to-mesenchymal transition (EMT) plays an important role in invasion and metastasis of hepatocellular carcinoma (HCC). Our previous study found that atypical protein kinase C-ι (aPKC-ι) promoted the EMT process in HCC. However, how the aPKC-ι signaling pathway is regulated in HCC has not been elucidated. In this study, vector transfection was utilized to study the invasion of HCC cells, and the mechanism between P300 and aPKC-ι signaling pathways in regulating the EMT process of HCC was further elucidated in vitro and in vivo. We found both P300 and aPKC-ι were highly expressed in HCC and they were correlated with tumor progression and poor survival in HCC patients. P300 knockdown inhibited EMT, invasion and other malignant events of HCC cells but promoted cell apoptosis and cycle arrest. However, the effects mediated by P300 knockdown were abolished by aPKC-ι overexpression. Further studies showed that P300 upregulates aPKC-ι expression through increasing the transcription of Elk1, a transcriptional activator of aPKC-ι, and stabilizing Elk1 protein and its phosphorylation. In conclusion, our work uncovered the molecular mechanism by which oncogenic aPKC-ι is upregulated in HCC and suggests that P300, like aPKC-ι, may be used as a prognostic biomarker and therapeutic target in patients with HCC.\"\n",
    "    medab5 = \"An unmet clinical need remains for an effective tetravalent dengue vaccine suitable for all age groups, regardless of serostatus. We assessed the immunogenicity and safety of three different dose schedules of a tetravalent dengue vaccine (TAK-003) over a 48-month period in children living in dengue-endemic countries. We did a large, phase 2, double-blind, placebo-controlled trial at three sites in the Dominican Republic, Panama, and the Philippines. Healthy participants aged 2–17 years were randomly assigned 1:2:5:1 using an interactive web response system with stratification by age to receive either a two-dose primary series (days 1 and 91), one primary dose (day 1), one primary dose plus booster (days 1 and 365), or placebo. Participants and relevant study personnel were masked to the random assignment until completion of the study at month 48. To maintain masking, TAK-003 recipients were administered placebo doses when appropriate. The primary objective was assessment of neutralising geometric mean titres for each serotype to month 48 assessed in the per-protocol immunogenicity subset. Secondary safety endpoints included proportions of participants with serious adverse events and symptomatic virologically confirmed dengue. This study is registered with ClinicalTrials.gov, NCT02302066. Between Dec 5, 2014, and Feb 13, 2015, 1800 children were randomly assigned to the following groups: two-dose primary series (n=201), one primary dose (n=398), one primary dose plus 1-year booster (n=1002), and placebo (n=199). Of them, 1479 (82%) participants completed the 48-month study. Immunogenicity endpoints were assessed in 562 participants enrolled in the immunogenicity subset, of whom 509 were included in the per-protocol subset. At month 48, antibody titres remained elevated in all TAK-003 groups compared with placebo, irrespective of baseline serostatus. At month 48, geometric mean titres were 378 (95% CI 226–632) in two-dose, 421 (285–622) in one-dose, 719 (538–960) in one-dose plus 1-year booster, and 100 (50–201) in placebo recipients against DENV 1; 1052 (732–1511), 1319 (970–1794), 1200 (927–1553), and 208 (99–437) against DENV 2; 183 (113–298), 201 (135–298), 288 (211–392), and 71 (37–139) against DENV 3; and 152 (97–239), 164 (114–236), 219 (165–290), and 46 (26–82) against DENV 4; and tetravalent seropositivity rate was 89% (79–96), 86% (80–92), 97% (93–99), and 60% (47–72), respectively. Virologically confirmed dengue was recorded in 37 (2%) TAK-003 and 13 (7%) placebo participants, with a relative risk of 0·35 (0·19–0·65). No vaccine-related serious adverse events or severe dengue virus disease were reported. TAK-003 elicited antibody responses against all four serotypes, which persisted to 48 months post-vaccination, regardless of baseline serostatus. No important safety risks were identified. We observed a long-term reduction in risk of symptomatic dengue virus disease in vaccinees. Results from this study provide a long-term safety database and support assessment of the vaccine in the ongoing phase 3 efficacy study.\"\n",
    "    altmab = \"In order to meet the growing needs of the European Union medicinal and aromatic plants, Hungary is still one of the major exporters today, although earlier, until the 1980s, we were considered a great herb-growing nation. Therefore, the development of the national medicinal and aromatic herb growing sector is an essential requirement for maintaining and developing our market position. The natural conditions of Hungary favor the cultivation of medicinal and aromatic plants. There are more than 330 herbs in our country. About seventy percent of the drugs grown and harvested are exported. However, significant changes are needed in domestic sales and further processing in order to become a leading industrial sector. Hungary also possesses modern separation techniques and large instruments for analysis, which allow the proper analytical examination of drugs and the precise determination of their active substances. Our universities and research institutes are also prepared to study the active ingredients of herbs by molecular biological methods, which may allow the exact mechanism of action of bioactive substances to be determined and the herbs to be reassessed. Our accession to the European Union the palette of products made from former herbs has significantly changed. From 2013, the category of medicinal product was discontinued and the preparations were classified as either food or medicine. However, there are significant costs associated with qualifying as a drug, so drugs or extracts are largely added to dietary supplements. As a result, the strange situation is that dietary supplements are prohibited from making any health claims, even though the dietary supplement is actually not for the benefit of a healthy population, but for those who have a health problem or do not have suitable foods, which are rich in bioactive substances. The justification of phytotherapy must be demonstrated, depending on the state of the art. In the context of safe therapy, studies must follow the requirements of medicines and only then can they become herbal medicines. There is still much to be desired in this area in our country. Classification as a drug is based on expensive animal tests and clinical studies. A new problem arises here, as herbal cure is currently part of the arsenal of complementary medicine. With few exceptions, clinical doctors do not use herbal therapies. Patients usually ask the advice of pharmacists, naturalists, and more rarely, dietitians. At the Arteriosclerosis Research Group, at the II. Department of Medicine and Institute of Pharmacognosy several decades of biomedical research have served and serve the purpose of evaluating and reassessing the effects of plants used in folk medicine. Over the years, we have been searching for drugs, extracts, and medicines of natural origin that are useful in liver and intestinal diseases known in folk medicine, and are believed to have lipid lowering, antioxidant and immune stimulating effects. In the article, animal and human studies will be also presented.\"\n",
    "    altmab2 = \"This research was done to explore the role of fresh garlic homogenate (GH) on attenuation of myocardial damage when administered concurrently with atenolol (ATN) in experimental animals. At the end of treatment of male albino rats, hearts were excised from anesthetized animals and mounted on modified Langendorff setup. After initial perfusion with physiological solution, hearts were subjected to 15 min global no flow ischemia reperfusion injury (IRI) and perfused again. Significant recovery in developed tension and heart rate was exhibited by hearts of animals pretreated with ATN, GH-125 and GH-250. There was significant elevation of LDH and CK-MB in heart tissue homogenate and fall in perfusate of treated groups (ATN, GH-125 and GH-250). Additionally, simultaneous administration of GH-250 with ATN resulted in significant increase in endogenous antioxidant enzymes (SOD and catalase) activities. The augmented antioxidant activities could be due to the possible synergistic potential of ATN in GH mediated scavenging of oxidative free radicals produced during IRI. On the contrary, high dose of GH (500 mg/kg) failed to demonstrate similar potential even in presence of ATN. Hence, only moderate intake of garlic is good for cardioprotection when administered prophylactically and addition of ATN produces synergistic effect.\"\n",
    "    altmab3 = \"NMR proton relaxation is sensitive to the dynamics of the water molecule H2O, through the interaction of the spin of the proton (1H) with external magnetic and electromagnetic fields. We measured dilution and potentization processes through measurements of 1H spin-lattice T1 and spin–spin T2 relaxation times. In order to interpret the recorded fluctuations in T1- or T2-values, experimental data were linearized by investigating how the area under a fluctuating time = f(dilution) curve (dilution integral or DI) changes with dilution. Two kinds of fitting procedures were considered: chi-square fitting with a goodness-of-fit probability, and least absolute deviations criterion with Pearson's linear correlation coefficient. We showed that fluctuations are not attributable to random noise and/or experimental errors, evidencing a memory effect quantifiable by the slope of the DI = f(dilution) straight line. For all experiments, correlation coefficients were found to lie above 0.9999, against 0.999 for random noise. The discrimination between experimental slopes and slopes associated with random noise data was very good at a five-sigma level of confidence (i.e. probability 3 × 10−7). Discrimination between experimental slopes at a five-sigma level was possible in most cases, with three exceptions: gelsemium aqua pura v gelsemium dilution (four-sigma); copper aqua pura v gelsemium aqua pura (four-sigma) and copper simple dilution v gelsemium simple dilution (three-sigma). All potentized samples show very good discrimination (at least nine-sigma level) against aqua pura, lactose or simple dilution. It was possible to transform the associated relaxation times into a molecular rotational correlation time τc and an average spin–spin distance d. Our experiments thus point to a considerable slowing down of molecular movements (τc > 1300 ps or T = 224–225 K) around water molecules up to a distance of 3.7 Å, values. It was also possible to rule out other possible mechanisms of relaxation (diffusive motion, 17O-1H relaxation or coupling with the electronic spin, S = 1, of dissolved dioxygen molecules). There is clear evidence that homeopathic solutions cannot be considered as pure water as commonly assumed. Instead, we have evidenced a clear memory effect upon dilution/potentization of a substance (water, lactose, copper, gelsemium) reflected by different rotational correlation times and average H⋯H distances. A possible explanation for such a memory effect may lie in the formation of mesoscopic water structures around nanoparticles and/or nanobubbles mediated by zero-point fluctuations of the vacuum electromagnetic field as suggested by quantum field theories. The existence of an Avogadro's ‘wall’ for homeopathically-prepared medicines is not supported by our data. Rather it appears that all dilutions have a specific material configuration determined by the potentized substance, also by the chemical nature of the containers, and dissolved gases and the electromagnetic environment. This sensitivity of homeopathically-prepared medicines to electromagnetic fields may be amplified by the highly non-linear processing routinely applied in the preparation of homeopathic medicines. Future work is needed in such directions. The time is now ripe for a demystification of the preparation of homeopathic remedies.\"\n",
    "    altmab4 = \"This article describes the implementation of a group medical visit (GMV) model to increase access to integrative oncology (IO) care. The most challenging and critical time to access high-quality IO care is while patients are receiving conventional cancer therapy. Often demand for individual IO clinic consultations precludes this from occurring. A three-session GMV program was designed to alleviate barriers to receiving integrative care during active cancer treatment. Design: A consolidated framework was used for implementation research and focused ethnography methods to describe the IO GMV implementation process. Data sources included patient evaluations, participant observation, and brief provider and patient interviews. Setting: A pilot program was created to assess the feasibility and acceptability of implementing IO GMVs at a comprehensive cancer center. Intervention: Each three-session GMV consisted of a didactic session, followed by individual visits with the integrative oncologist. Results: The setting, intervention, and implementation process of the IO GMV program were described. Thirty-two patients participated in the first five cohorts of the program. Twenty-two were women; 24 were White. The median age of participants was 52. Patient evaluations demonstrate high levels of satisfaction with the program with all scored aspects rated >4.0 on a five-point Likert scale. For the medical center, group visits are a financially viable alternative to individual IO visits; revenue from group visits exceeded the revenue potential of 6 h of individual visits by an average of 38%. Conclusion: GMVs are a feasible and promising model for increasing access to IO. Patients in active cancer treatment were able to participate in the program. Future research and implementation efforts could examine health outcomes over time after participation in GMVs, as well as the feasibility of using this model with more diverse patient populations.\" \n",
    "    altmab5 = \"As rates of opiate misuse rise in the United States, so do significant associated health and financial consequences to afflicted individuals, their families, and society at large. Methadone maintenance therapy (MMT) is one evidence-based approach to treating opiate addiction, yet supplemental psychosocial treatment to support this approach is lacking. Mindfulness-based relapse prevention (MBRP) has shown to be efficacious in various substance use populations, but has yet to be assessed with MMT clients. Design: The current mixed methods study was designed to inform protocol adaptation for MMT clients and to evaluate the feasibility, acceptability, and preliminary efficacy of MBRP for this population. Subjects: The sample consisted of adults (N = 15) recruited from a methadone clinic to participate in a 6-week MBRP course. Outcome measures: Data from focus groups and course satisfaction surveys supported feasibility and acceptability of the intervention. Self-report outcome measures included depression, anxiety, craving, symptoms of post-traumatic stress, and experiential avoidance, and were assessed at baseline and postcourse. Results: Mean scores on all primary outcomes changed in the expected direction at postcourse, and baseline to postcourse changes in depression, craving, and trauma symptoms reached statistical significance. Conclusions: Results from this initial pilot trial support feasibility and acceptability, and provide preliminary data on outcomes for future trials of mindfulness-based approaches within the MMT community.\"\n",
    "\n",
    "    abs_words = word_bagger.transform([medab, medab2, medab3, medab4, medab5, altmab, altmab2, altmab3, altmab4, altmab5])\n",
    "    \n",
    "    model.predict(abs_words)\n",
    "    \n",
    "    \n",
    "    \n",
    "    print(\"Predictions of 5 medical and 5 alternative medical abstracts, respectively are {}\".format(model.predict(abs_words)))\n",
    "    \n",
    "multnb_abstracts(X_abstracts, y_abstracts)\n",
    "print(\"--- %s seconds ---\" % (time.time() - start_time))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fit Data to Decision Tree Classifier\n",
    "\n",
    "Gini = Measure of how often a randomly chosen element from a set would be incorrectly labeled.\n",
    "\n",
    "Entropy = Measure of the degree of randomness of a system.\n",
    "\n",
    "Entropy is slightly more computationally costly.\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fit to Titles"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['abhyanga', 'abilities', 'ability', 'abiotically', 'abiraterone', 'ablation', 'able', 'abnormal', 'abnormalities', 'abortion', 'abrogates', 'absence', 'absorption', 'abstinence', 'abundances', 'abundant', 'abuse', 'academic', 'acadl', 'accelerated', 'accelerates', 'accelerating', 'accelerometer', 'acceptability', 'acceptance', 'accepted', 'access', 'accessibility', 'accessory', 'accident', 'acclimatisation', 'accompanied', 'accomplish', 'accomplishing', 'according', 'account', 'acculturation', 'accumulation', 'accuracy', 'accurate', 'ace2', 'acetaminophen', 'acetate', 'acetone', 'acetylator', 'acetylcholine', 'acetylcholinesterase', 'achieve', 'achieved', 'acid']\n",
      "\n",
      "Using criterion entropy\n",
      "Evaluating on depth 1\n",
      "Evaluating on depth 5\n",
      "Evaluating on depth 10\n",
      "Evaluating on depth 15\n",
      "Evaluating on depth 20\n",
      "Evaluating on depth 25\n",
      "Evaluating on depth 30\n",
      "Evaluating on depth 50\n",
      "Evaluating on depth 100\n",
      "Depth: 1   Train: 0.5699152542372882    Val: 0.5841584158415841\n",
      "Depth: 5   Train: 0.6406779661016949    Val: 0.6455445544554456\n",
      "Depth: 10   Train: 0.7436440677966102    Val: 0.7207920792079208\n",
      "Depth: 15   Train: 0.7872881355932203    Val: 0.7386138613861386\n",
      "Depth: 20   Train: 0.8211864406779661    Val: 0.7584158415841584\n",
      "Depth: 25   Train: 0.8436440677966102    Val: 0.7584158415841584\n",
      "Depth: 30   Train: 0.863135593220339    Val: 0.7702970297029703\n",
      "Depth: 50   Train: 0.8944915254237288    Val: 0.7960396039603961\n",
      "Depth: 100   Train: 0.9533898305084746    Val: 0.8138613861386138\n",
      "Best depth: 100    Test: 0.8284023668639053\n",
      "[[227  25]\n",
      " [ 62 193]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "         0.0       0.79      0.90      0.84       252\n",
      "         1.0       0.89      0.76      0.82       255\n",
      "\n",
      "    accuracy                           0.83       507\n",
      "   macro avg       0.84      0.83      0.83       507\n",
      "weighted avg       0.84      0.83      0.83       507\n",
      "\n",
      "Predictions of 5 medical and 5 alternative medical titles, respectively are [0. 1. 0. 0. 0. 1. 1. 0. 1. 1.]\n",
      "\n",
      "Using criterion gini\n",
      "Evaluating on depth 1\n",
      "Evaluating on depth 5\n",
      "Evaluating on depth 10\n",
      "Evaluating on depth 15\n",
      "Evaluating on depth 20\n",
      "Evaluating on depth 25\n",
      "Evaluating on depth 30\n",
      "Evaluating on depth 50\n",
      "Evaluating on depth 100\n",
      "Depth: 1   Train: 0.5699152542372882    Val: 0.5841584158415841\n",
      "Depth: 5   Train: 0.6673728813559322    Val: 0.6594059405940594\n",
      "Depth: 10   Train: 0.75    Val: 0.7247524752475247\n",
      "Depth: 15   Train: 0.8050847457627118    Val: 0.7504950495049505\n",
      "Depth: 20   Train: 0.8317796610169491    Val: 0.7643564356435644\n",
      "Depth: 25   Train: 0.8546610169491525    Val: 0.7742574257425743\n",
      "Depth: 30   Train: 0.8711864406779661    Val: 0.7801980198019802\n",
      "Depth: 50   Train: 0.9211864406779661    Val: 0.80990099009901\n",
      "Depth: 100   Train: 0.9673728813559322    Val: 0.805940594059406\n",
      "Best depth: 50    Test: 0.7909270216962525\n",
      "[[225  27]\n",
      " [ 79 176]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "         0.0       0.74      0.89      0.81       252\n",
      "         1.0       0.87      0.69      0.77       255\n",
      "\n",
      "    accuracy                           0.79       507\n",
      "   macro avg       0.80      0.79      0.79       507\n",
      "weighted avg       0.80      0.79      0.79       507\n",
      "\n",
      "Predictions of 5 medical and 5 alternative medical titles, respectively are [0. 1. 0. 0. 0. 1. 1. 0. 1. 1.]\n",
      "--- 92.96546173095703 seconds ---\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1440x1440 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "from sklearn.tree import DecisionTreeClassifier\n",
    "from sklearn.feature_extraction.text import CountVectorizer, TfidfVectorizer, HashingVectorizer\n",
    "from sklearn.model_selection import train_test_split\n",
    "import numpy as np\n",
    "import time\n",
    "start_time = time.time()\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "def load_data(paths):\n",
    "    vec = CountVectorizer(input='content', stop_words = stop_wordz) # vectorize text\n",
    "    # create 2 new lists\n",
    "    lines = [] \n",
    "    counts = []\n",
    "    for p in paths:\n",
    "        with open(p) as f:\n",
    "            file_lines = f.readlines()\n",
    "            # append the size/length of file_lines to counts\n",
    "        counts.append(len(file_lines))\n",
    "        lines.extend([l.strip() for l in file_lines])\n",
    "    vec.fit(lines)\n",
    "    # create a data_matrix array of your vectorized data\n",
    "    data_matrix = vec.transform(lines).toarray()\n",
    "    # set classes to 0 and 1\n",
    "    y = np.concatenate((np.zeros(counts[0]), np.ones(counts[1])))\n",
    "    return split_data(data_matrix, y), vec.get_feature_names()\n",
    "\n",
    "\n",
    "def split_data(X, y, train_size=0.7, val_size=0.15):\n",
    "    total_data = X.shape[0]\n",
    "    train_size = int(train_size * total_data)\n",
    "    val_size = int(val_size * total_data)\n",
    "    test_size = total_data - train_size - val_size\n",
    "\n",
    "    train_test_X, val_X, train_test_y, val_y = train_test_split(X, y, test_size=val_size)\n",
    "    train_X, test_X, train_y, test_y = train_test_split(train_test_X, train_test_y, test_size=test_size)\n",
    "\n",
    "    return {\n",
    "        'train': (train_X, train_y),\n",
    "        'val':  (val_X, val_y),\n",
    "        'test': (test_X, test_y)\n",
    "    }\n",
    "\n",
    "\n",
    "def select_model(depths, data, criterion):\n",
    "    out = {}\n",
    "    for d in depths:\n",
    "        print('Evaluating on depth {}'.format(d))\n",
    "        out[d] = {}\n",
    "        tree = DecisionTreeClassifier(criterion=criterion, max_depth=d)\n",
    "        tree.fit(data['train'][0], data['train'][1])\n",
    "        out[d]['val'] = tree.score(*data['val'])\n",
    "        out[d]['train'] = tree.score(*data['train'])\n",
    "        out[d]['model'] = tree\n",
    "    return out\n",
    "\n",
    "\n",
    "def visualize_tree(model, feature_names, criterion):\n",
    "    from sklearn.tree import export_graphviz\n",
    "    from sklearn import tree\n",
    "    import graphviz\n",
    "    export_graphviz(model, 'tree.dot', feature_names = feature_names, filled=True)\n",
    "    #dot_data = tree.export_graphviz(model, feature_names=feature_names)\n",
    "    ! dot -Tpng tree.dot -o tree.png\n",
    "    import matplotlib.pyplot as plt\n",
    "    import cv2\n",
    "    %matplotlib inline\n",
    "    img = cv2.imread('tree.png')\n",
    "    plt.figure(figsize = (20, 20))\n",
    "    plt.imshow(img)\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "def main():\n",
    "    data, feature_names = load_data(['sci_titles_scraped_dropdu', 'pseudo_titles_scraped'])\n",
    "    print(feature_names[200:250])\n",
    "\n",
    "    for criterion in (\"entropy\", \"gini\"):\n",
    "        print(\"\\nUsing criterion {}\".format(criterion))\n",
    "        res = select_model([1,5,10,15,20,25,30,50,100], data, criterion)\n",
    "        best_d = None\n",
    "        best_acc = 0\n",
    "        for d in res:\n",
    "            val_acc = res[d]['val']\n",
    "            print(\"Depth: {}   Train: {}    Val: {}\".format(d, res[d]['train'], val_acc))\n",
    "            if val_acc  > best_acc:\n",
    "                best_d = d\n",
    "                best_acc = val_acc\n",
    "        print(\"Best depth: {}    Test: {}\".format(best_d, res[best_d]['model'].score(*data['test'])))\n",
    "        visualize_tree(res[best_d]['model'], feature_names, criterion,)\n",
    "        \n",
    "        \n",
    "        hooglin = res[best_d]['model'].predict(data['test'][0])\n",
    "        print(confusion_matrix(data['test'][1], hooglin))\n",
    "        print(classification_report(data['test'][1], hooglin))\n",
    "        \n",
    "        med = \"Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study\"\n",
    "        med2 = \"Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial\"\n",
    "        med3 = \"Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer\"\n",
    "        med4 = \"PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma\"\n",
    "        med5 = \"Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone\"\n",
    "        altm = \"Prevalence, Patterns, and Predictors of T'ai Chi and Qigong Use in the United States: Results of a Nationally Representative Survey\"\n",
    "        altm2 = 'Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin'\n",
    "        altm3 = \"The American Coneflower: A Prophylactic Role Involving Nonspecific Immunity\"\n",
    "        altm4 = \"Effect of BEMER Magnetic Field Therapy on the Level of Fatigue in Patients with Multiple Sclerosis: A Randomized, Double-Blind Controlled Trial\"\n",
    "        altm5 = \"Improving Access to Integrative Oncology Through Group Medical Visits: A Pilot Implementation Project\"\n",
    "\n",
    "        with open('sci_titles_scraped_dropdu', 'r') as f:\n",
    "            realtitles = [line.strip() for line in f]\n",
    "        # create an array of ones the same length as the title list\n",
    "        k = np.ones(len(realtitles), dtype = int)\n",
    "        # create a dataframe of titles in one column and corresponding class in the next\n",
    "        titles_real = pd.DataFrame({'Titles': realtitles, \"Class\":k })\n",
    "        with open('pseudo_titles_scraped', 'r') as f:\n",
    "            pseudotitles = [line.strip() for line in f]\n",
    "        l = np.zeros(len(pseudotitles), dtype = int)\n",
    "        titles_fake = pd.DataFrame({\"Titles\": pseudotitles, 'Class': l})\n",
    "            # concatenate \n",
    "        titles_all = pd.concat([titles_real, titles_fake], ignore_index=True)\n",
    "        \n",
    "        word_bagger = CountVectorizer(stop_words=stop_wordz)\n",
    "        word_bagger.fit(titles_all['Titles'])\n",
    "        #word_bagger.fit([medab, medab2, medab3, medab4, medab5, altmab, altmab2, altmab3, altmab4, altmab5])\n",
    "        \n",
    "        \n",
    "        bagged = word_bagger.transform([med, med2, med3, med4, med5, altm, altm2, altm3, altm4, altm5]).toarray()\n",
    "        \n",
    "        print(\"Predictions of 5 medical and 5 alternative medical titles, respectively are {}\".format(res[best_d]['model'].predict(bagged)))\n",
    "\n",
    "\n",
    "        \n",
    "\n",
    "\n",
    "if __name__ == '__main__':\n",
    "    main()\n",
    "print(\"--- %s seconds ---\" % (time.time() - start_time))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fit to Abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['072', '073', '074', '0747', '075', '077', '078', '079', '08', '080', '081', '082', '084', '0842nrf', '085', '086', '09', '093', '094', '0941', '095', '097', '0978', '098', '099', '0_5', '0r4534', '0t', '10', '100', '1000', '10000', '1000ch', '1003', '10045', '1007', '100mf', '101', '1010', '101056', '1012', '1014', '1015del', '102', '102000', '1025', '1026', '1027', '1029', '103']\n",
      "\n",
      "Using criterion entropy\n",
      "Evaluating on depth 1\n",
      "Evaluating on depth 5\n",
      "Evaluating on depth 10\n",
      "Evaluating on depth 15\n",
      "Evaluating on depth 20\n",
      "Evaluating on depth 25\n",
      "Evaluating on depth 30\n",
      "Evaluating on depth 50\n",
      "Evaluating on depth 100\n",
      "Depth: 1   Train: 0.6611675126903553    Val: 0.691699604743083\n",
      "Depth: 5   Train: 0.8591370558375635    Val: 0.841897233201581\n",
      "Depth: 10   Train: 0.9141285956006768    Val: 0.8715415019762845\n",
      "Depth: 15   Train: 0.9352791878172588    Val: 0.8754940711462451\n",
      "Depth: 20   Train: 0.9450084602368867    Val: 0.8735177865612648\n",
      "Depth: 25   Train: 0.9619289340101523    Val: 0.8675889328063241\n",
      "Depth: 30   Train: 0.9805414551607445    Val: 0.8794466403162056\n",
      "Depth: 50   Train: 0.9983079526226735    Val: 0.8873517786561265\n",
      "Depth: 100   Train: 0.9983079526226735    Val: 0.883399209486166\n",
      "Best depth: 50    Test: 0.8976377952755905\n",
      "[[239  30]\n",
      " [ 22 217]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "         0.0       0.92      0.89      0.90       269\n",
      "         1.0       0.88      0.91      0.89       239\n",
      "\n",
      "    accuracy                           0.90       508\n",
      "   macro avg       0.90      0.90      0.90       508\n",
      "weighted avg       0.90      0.90      0.90       508\n",
      "\n",
      "Predictions of 5 medical and 5 alternative medical abstracts, respectively are [0. 0. 0. 0. 1. 0. 0. 1. 1. 1.]\n",
      "\n",
      "Using criterion gini\n",
      "Evaluating on depth 1\n",
      "Evaluating on depth 5\n",
      "Evaluating on depth 10\n",
      "Evaluating on depth 15\n",
      "Evaluating on depth 20\n",
      "Evaluating on depth 25\n",
      "Evaluating on depth 30\n",
      "Evaluating on depth 50\n",
      "Evaluating on depth 100\n",
      "Depth: 1   Train: 0.6611675126903553    Val: 0.691699604743083\n",
      "Depth: 5   Train: 0.8659052453468697    Val: 0.8458498023715415\n",
      "Depth: 10   Train: 0.9285109983079526    Val: 0.8656126482213439\n",
      "Depth: 15   Train: 0.9450084602368867    Val: 0.8774703557312253\n",
      "Depth: 20   Train: 0.9572758037225042    Val: 0.8873517786561265\n",
      "Depth: 25   Train: 0.9623519458544839    Val: 0.883399209486166\n",
      "Depth: 30   Train: 0.9691201353637902    Val: 0.8794466403162056\n",
      "Depth: 50   Train: 0.9983079526226735    Val: 0.883399209486166\n",
      "Depth: 100   Train: 0.9983079526226735    Val: 0.8893280632411067\n",
      "Best depth: 100    Test: 0.9035433070866141\n",
      "[[242  27]\n",
      " [ 22 217]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "         0.0       0.92      0.90      0.91       269\n",
      "         1.0       0.89      0.91      0.90       239\n",
      "\n",
      "    accuracy                           0.90       508\n",
      "   macro avg       0.90      0.90      0.90       508\n",
      "weighted avg       0.90      0.90      0.90       508\n",
      "\n",
      "Predictions of 5 medical and 5 alternative medical abstracts, respectively are [0. 0. 0. 0. 0. 1. 0. 1. 1. 1.]\n",
      "--- 260.15264987945557 seconds ---\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1440x1440 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "from sklearn.tree import DecisionTreeClassifier\n",
    "from sklearn.feature_extraction.text import CountVectorizer, TfidfVectorizer, HashingVectorizer\n",
    "from sklearn.model_selection import train_test_split\n",
    "import numpy as np\n",
    "import time\n",
    "start_time = time.time()\n",
    "\n",
    "\n",
    "\n",
    "def load_data(paths):\n",
    "    vec = CountVectorizer(input='content', stop_words = stop_wordz) # vectorize text\n",
    "    # create 2 new lists\n",
    "    lines = [] \n",
    "    counts = []\n",
    "    for p in paths:\n",
    "        with open(p) as f:\n",
    "            file_lines = f.readlines()\n",
    "            # append the size/length of file_lines to counts\n",
    "        counts.append(len(file_lines))\n",
    "        lines.extend([l.strip() for l in file_lines])\n",
    "    vec.fit(lines)\n",
    "    # create a data_matrix array of your vectorized data\n",
    "    data_matrix = vec.transform(lines).toarray()\n",
    "    # set classes to 0 and 1\n",
    "    y = np.concatenate((np.zeros(counts[0]), np.ones(counts[1])))\n",
    "    return split_data(data_matrix, y), vec.get_feature_names()\n",
    "\n",
    "\n",
    "def split_data(X, y, train_size=0.7, val_size=0.15):\n",
    "    total_data = X.shape[0]\n",
    "    train_size = int(train_size * total_data)\n",
    "    val_size = int(val_size * total_data)\n",
    "    test_size = total_data - train_size - val_size\n",
    "\n",
    "    train_test_X, val_X, train_test_y, val_y = train_test_split(X, y, test_size=val_size)\n",
    "    train_X, test_X, train_y, test_y = train_test_split(train_test_X, train_test_y, test_size=test_size)\n",
    "\n",
    "    return {\n",
    "        'train': (train_X, train_y),\n",
    "        'val':  (val_X, val_y),\n",
    "        'test': (test_X, test_y)\n",
    "    }\n",
    "\n",
    "\n",
    "def select_model(depths, data, criterion):\n",
    "    out = {}\n",
    "    for d in depths:\n",
    "        print('Evaluating on depth {}'.format(d))\n",
    "        out[d] = {}\n",
    "        tree = DecisionTreeClassifier(criterion=criterion, max_depth=d)\n",
    "        tree.fit(data['train'][0], data['train'][1])\n",
    "        out[d]['val'] = tree.score(*data['val'])\n",
    "        out[d]['train'] = tree.score(*data['train'])\n",
    "        out[d]['model'] = tree\n",
    "    return out\n",
    "\n",
    "\n",
    "def visualize_tree(model, feature_names, criterion):\n",
    "    from sklearn.tree import export_graphviz\n",
    "    from sklearn import tree\n",
    "    import graphviz\n",
    "    export_graphviz(model, 'tree.dot', feature_names = feature_names, filled=True)\n",
    "    #dot_data = tree.export_graphviz(model, feature_names=feature_names)\n",
    "    ! dot -Tpng tree.dot -o tree.png\n",
    "    import matplotlib.pyplot as plt\n",
    "    import cv2\n",
    "    %matplotlib inline\n",
    "    img = cv2.imread('tree.png')\n",
    "    plt.figure(figsize = (20, 20))\n",
    "    plt.imshow(img)\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "def main():\n",
    "    data, feature_names = load_data(['sci_abstracts_scraped_dropdu', 'pseudo_abstracts_scraped'])\n",
    "    print(feature_names[200:250])\n",
    "\n",
    "    for criterion in (\"entropy\", \"gini\"):\n",
    "        print(\"\\nUsing criterion {}\".format(criterion))\n",
    "        res = select_model([1,5,10,15,20,25,30,50,100], data, criterion)\n",
    "        best_d = None\n",
    "        best_acc = 0\n",
    "        for d in res:\n",
    "            val_acc = res[d]['val']\n",
    "            print(\"Depth: {}   Train: {}    Val: {}\".format(d, res[d]['train'], val_acc))\n",
    "            if val_acc  > best_acc:\n",
    "                best_d = d\n",
    "                best_acc = val_acc\n",
    "        print(\"Best depth: {}    Test: {}\".format(best_d, res[best_d]['model'].score(*data['test'])))\n",
    "        visualize_tree(res[best_d]['model'], feature_names, criterion,)\n",
    "        hooglin = res[best_d]['model'].predict(data['test'][0])\n",
    "        print(confusion_matrix(data['test'][1], hooglin))\n",
    "        print(classification_report(data['test'][1], hooglin))\n",
    "        \n",
    "        \n",
    "        medab = \"The National Institute of Mental Health (NIMH) ‘fast-fail’ approach seeks to improve too-often-misleading early-phase drug development methods by incorporating biomarker-based proof-of-mechanism (POM) testing in phase 2a. This first comprehensive application of the fast-fail approach evaluated the potential of κ-opioid receptor (KOR) antagonism for treating anhedonia with a POM study determining whether robust target engagement favorably impacts the brain circuitry hypothesized to mediate clinical effects. Here we report the results from a multicenter, 8-week, double-blind, placebo-controlled, randomized trial in patients with anhedonia and a mood or anxiety disorder (selective KOR antagonist (JNJ-67953964, 10 mg; n = 45) and placebo (n = 44)). JNJ-67953964 significantly increased functional magnetic resonance imaging (fMRI) ventral striatum activation during reward anticipation (primary outcome) as compared to placebo (baseline-adjusted mean: JNJ-67953964, 0.72 (s.d. = 0.67); placebo, 0.33 (s.d. = 0.68); F(1,86) = 5.58, P < 0.01; effect size = 0.58 (95% confidence interval, 0.13–0.99)). JNJ-67953964, generally well tolerated, was not associated with any serious adverse events. This study supports proceeding with assessment of the clinical impact of target engagement and serves as a model for implementing the ‘fast-fail’ approach.\"\n",
    "        medab2 = \"Neoadjuvant checkpoint inhibition, in which the therapy is administered before surgery, is a promising new approach to managing bulky but resectable melanoma, and is also being explored in other cancers. This strategy has a high pathologic response rate, which correlates with survival outcomes. The fact that biopsies are routinely available provides a unique opportunity for understanding the responses to therapy and carrying out reverse translation in which these data are used to select therapies in the clinic or in trials that are more likely to improve patient outcomes. In this Perspective, we discuss the rationale for neoadjuvant immunotherapy in resectable solid tumors based on preclinical and human translational data, summarize the results of recent clinical trials and ongoing research, and focus on future directions for enhancing reverse translation.\"\n",
    "        medab3 = \"Successful drug discovery is ultimately contingent on the availability of workable, relevant, predictive model systems. Conversely, for cardiac muscle, the lack of human preclinical models to inform target validation and compound development has likely contributed to the perennial problem of clinical trial failures, despite encouraging non-human results. By contrast, human cardiomyocytes produced from pluripotent stem cell models have recently been applied to safety pharmacology, phenotypic screening, target validation and high-throughput assays, facilitating cardiac drug discovery. Here, we review the impact of human pluripotent stem cell models in cardiac drug discovery, discussing the range of applications, readouts, and disease models employed, along with the challenges and prospects to advance this fruitful mode of research further.\"\n",
    "        medab4 = \"Epithelial-to-mesenchymal transition (EMT) plays an important role in invasion and metastasis of hepatocellular carcinoma (HCC). Our previous study found that atypical protein kinase C-ι (aPKC-ι) promoted the EMT process in HCC. However, how the aPKC-ι signaling pathway is regulated in HCC has not been elucidated. In this study, vector transfection was utilized to study the invasion of HCC cells, and the mechanism between P300 and aPKC-ι signaling pathways in regulating the EMT process of HCC was further elucidated in vitro and in vivo. We found both P300 and aPKC-ι were highly expressed in HCC and they were correlated with tumor progression and poor survival in HCC patients. P300 knockdown inhibited EMT, invasion and other malignant events of HCC cells but promoted cell apoptosis and cycle arrest. However, the effects mediated by P300 knockdown were abolished by aPKC-ι overexpression. Further studies showed that P300 upregulates aPKC-ι expression through increasing the transcription of Elk1, a transcriptional activator of aPKC-ι, and stabilizing Elk1 protein and its phosphorylation. In conclusion, our work uncovered the molecular mechanism by which oncogenic aPKC-ι is upregulated in HCC and suggests that P300, like aPKC-ι, may be used as a prognostic biomarker and therapeutic target in patients with HCC.\"\n",
    "        medab5 = \"An unmet clinical need remains for an effective tetravalent dengue vaccine suitable for all age groups, regardless of serostatus. We assessed the immunogenicity and safety of three different dose schedules of a tetravalent dengue vaccine (TAK-003) over a 48-month period in children living in dengue-endemic countries. We did a large, phase 2, double-blind, placebo-controlled trial at three sites in the Dominican Republic, Panama, and the Philippines. Healthy participants aged 2–17 years were randomly assigned 1:2:5:1 using an interactive web response system with stratification by age to receive either a two-dose primary series (days 1 and 91), one primary dose (day 1), one primary dose plus booster (days 1 and 365), or placebo. Participants and relevant study personnel were masked to the random assignment until completion of the study at month 48. To maintain masking, TAK-003 recipients were administered placebo doses when appropriate. The primary objective was assessment of neutralising geometric mean titres for each serotype to month 48 assessed in the per-protocol immunogenicity subset. Secondary safety endpoints included proportions of participants with serious adverse events and symptomatic virologically confirmed dengue. This study is registered with ClinicalTrials.gov, NCT02302066. Between Dec 5, 2014, and Feb 13, 2015, 1800 children were randomly assigned to the following groups: two-dose primary series (n=201), one primary dose (n=398), one primary dose plus 1-year booster (n=1002), and placebo (n=199). Of them, 1479 (82%) participants completed the 48-month study. Immunogenicity endpoints were assessed in 562 participants enrolled in the immunogenicity subset, of whom 509 were included in the per-protocol subset. At month 48, antibody titres remained elevated in all TAK-003 groups compared with placebo, irrespective of baseline serostatus. At month 48, geometric mean titres were 378 (95% CI 226–632) in two-dose, 421 (285–622) in one-dose, 719 (538–960) in one-dose plus 1-year booster, and 100 (50–201) in placebo recipients against DENV 1; 1052 (732–1511), 1319 (970–1794), 1200 (927–1553), and 208 (99–437) against DENV 2; 183 (113–298), 201 (135–298), 288 (211–392), and 71 (37–139) against DENV 3; and 152 (97–239), 164 (114–236), 219 (165–290), and 46 (26–82) against DENV 4; and tetravalent seropositivity rate was 89% (79–96), 86% (80–92), 97% (93–99), and 60% (47–72), respectively. Virologically confirmed dengue was recorded in 37 (2%) TAK-003 and 13 (7%) placebo participants, with a relative risk of 0·35 (0·19–0·65). No vaccine-related serious adverse events or severe dengue virus disease were reported. TAK-003 elicited antibody responses against all four serotypes, which persisted to 48 months post-vaccination, regardless of baseline serostatus. No important safety risks were identified. We observed a long-term reduction in risk of symptomatic dengue virus disease in vaccinees. Results from this study provide a long-term safety database and support assessment of the vaccine in the ongoing phase 3 efficacy study.\"\n",
    "        altmab = \"In order to meet the growing needs of the European Union medicinal and aromatic plants, Hungary is still one of the major exporters today, although earlier, until the 1980s, we were considered a great herb-growing nation. Therefore, the development of the national medicinal and aromatic herb growing sector is an essential requirement for maintaining and developing our market position. The natural conditions of Hungary favor the cultivation of medicinal and aromatic plants. There are more than 330 herbs in our country. About seventy percent of the drugs grown and harvested are exported. However, significant changes are needed in domestic sales and further processing in order to become a leading industrial sector. Hungary also possesses modern separation techniques and large instruments for analysis, which allow the proper analytical examination of drugs and the precise determination of their active substances. Our universities and research institutes are also prepared to study the active ingredients of herbs by molecular biological methods, which may allow the exact mechanism of action of bioactive substances to be determined and the herbs to be reassessed. Our accession to the European Union the palette of products made from former herbs has significantly changed. From 2013, the category of medicinal product was discontinued and the preparations were classified as either food or medicine. However, there are significant costs associated with qualifying as a drug, so drugs or extracts are largely added to dietary supplements. As a result, the strange situation is that dietary supplements are prohibited from making any health claims, even though the dietary supplement is actually not for the benefit of a healthy population, but for those who have a health problem or do not have suitable foods, which are rich in bioactive substances. The justification of phytotherapy must be demonstrated, depending on the state of the art. In the context of safe therapy, studies must follow the requirements of medicines and only then can they become herbal medicines. There is still much to be desired in this area in our country. Classification as a drug is based on expensive animal tests and clinical studies. A new problem arises here, as herbal cure is currently part of the arsenal of complementary medicine. With few exceptions, clinical doctors do not use herbal therapies. Patients usually ask the advice of pharmacists, naturalists, and more rarely, dietitians. At the Arteriosclerosis Research Group, at the II. Department of Medicine and Institute of Pharmacognosy several decades of biomedical research have served and serve the purpose of evaluating and reassessing the effects of plants used in folk medicine. Over the years, we have been searching for drugs, extracts, and medicines of natural origin that are useful in liver and intestinal diseases known in folk medicine, and are believed to have lipid lowering, antioxidant and immune stimulating effects. In the article, animal and human studies will be also presented.\"\n",
    "        altmab2 = \"This research was done to explore the role of fresh garlic homogenate (GH) on attenuation of myocardial damage when administered concurrently with atenolol (ATN) in experimental animals. At the end of treatment of male albino rats, hearts were excised from anesthetized animals and mounted on modified Langendorff setup. After initial perfusion with physiological solution, hearts were subjected to 15 min global no flow ischemia reperfusion injury (IRI) and perfused again. Significant recovery in developed tension and heart rate was exhibited by hearts of animals pretreated with ATN, GH-125 and GH-250. There was significant elevation of LDH and CK-MB in heart tissue homogenate and fall in perfusate of treated groups (ATN, GH-125 and GH-250). Additionally, simultaneous administration of GH-250 with ATN resulted in significant increase in endogenous antioxidant enzymes (SOD and catalase) activities. The augmented antioxidant activities could be due to the possible synergistic potential of ATN in GH mediated scavenging of oxidative free radicals produced during IRI. On the contrary, high dose of GH (500 mg/kg) failed to demonstrate similar potential even in presence of ATN. Hence, only moderate intake of garlic is good for cardioprotection when administered prophylactically and addition of ATN produces synergistic effect.\"\n",
    "        altmab3 = \"NMR proton relaxation is sensitive to the dynamics of the water molecule H2O, through the interaction of the spin of the proton (1H) with external magnetic and electromagnetic fields. We measured dilution and potentization processes through measurements of 1H spin-lattice T1 and spin–spin T2 relaxation times. In order to interpret the recorded fluctuations in T1- or T2-values, experimental data were linearized by investigating how the area under a fluctuating time = f(dilution) curve (dilution integral or DI) changes with dilution. Two kinds of fitting procedures were considered: chi-square fitting with a goodness-of-fit probability, and least absolute deviations criterion with Pearson's linear correlation coefficient. We showed that fluctuations are not attributable to random noise and/or experimental errors, evidencing a memory effect quantifiable by the slope of the DI = f(dilution) straight line. For all experiments, correlation coefficients were found to lie above 0.9999, against 0.999 for random noise. The discrimination between experimental slopes and slopes associated with random noise data was very good at a five-sigma level of confidence (i.e. probability 3 × 10−7). Discrimination between experimental slopes at a five-sigma level was possible in most cases, with three exceptions: gelsemium aqua pura v gelsemium dilution (four-sigma); copper aqua pura v gelsemium aqua pura (four-sigma) and copper simple dilution v gelsemium simple dilution (three-sigma). All potentized samples show very good discrimination (at least nine-sigma level) against aqua pura, lactose or simple dilution. It was possible to transform the associated relaxation times into a molecular rotational correlation time τc and an average spin–spin distance d. Our experiments thus point to a considerable slowing down of molecular movements (τc > 1300 ps or T = 224–225 K) around water molecules up to a distance of 3.7 Å, values. It was also possible to rule out other possible mechanisms of relaxation (diffusive motion, 17O-1H relaxation or coupling with the electronic spin, S = 1, of dissolved dioxygen molecules). There is clear evidence that homeopathic solutions cannot be considered as pure water as commonly assumed. Instead, we have evidenced a clear memory effect upon dilution/potentization of a substance (water, lactose, copper, gelsemium) reflected by different rotational correlation times and average H⋯H distances. A possible explanation for such a memory effect may lie in the formation of mesoscopic water structures around nanoparticles and/or nanobubbles mediated by zero-point fluctuations of the vacuum electromagnetic field as suggested by quantum field theories. The existence of an Avogadro's ‘wall’ for homeopathically-prepared medicines is not supported by our data. Rather it appears that all dilutions have a specific material configuration determined by the potentized substance, also by the chemical nature of the containers, and dissolved gases and the electromagnetic environment. This sensitivity of homeopathically-prepared medicines to electromagnetic fields may be amplified by the highly non-linear processing routinely applied in the preparation of homeopathic medicines. Future work is needed in such directions. The time is now ripe for a demystification of the preparation of homeopathic remedies.\"\n",
    "        altmab4 = \"This article describes the implementation of a group medical visit (GMV) model to increase access to integrative oncology (IO) care. The most challenging and critical time to access high-quality IO care is while patients are receiving conventional cancer therapy. Often demand for individual IO clinic consultations precludes this from occurring. A three-session GMV program was designed to alleviate barriers to receiving integrative care during active cancer treatment. Design: A consolidated framework was used for implementation research and focused ethnography methods to describe the IO GMV implementation process. Data sources included patient evaluations, participant observation, and brief provider and patient interviews. Setting: A pilot program was created to assess the feasibility and acceptability of implementing IO GMVs at a comprehensive cancer center. Intervention: Each three-session GMV consisted of a didactic session, followed by individual visits with the integrative oncologist. Results: The setting, intervention, and implementation process of the IO GMV program were described. Thirty-two patients participated in the first five cohorts of the program. Twenty-two were women; 24 were White. The median age of participants was 52. Patient evaluations demonstrate high levels of satisfaction with the program with all scored aspects rated >4.0 on a five-point Likert scale. For the medical center, group visits are a financially viable alternative to individual IO visits; revenue from group visits exceeded the revenue potential of 6 h of individual visits by an average of 38%. Conclusion: GMVs are a feasible and promising model for increasing access to IO. Patients in active cancer treatment were able to participate in the program. Future research and implementation efforts could examine health outcomes over time after participation in GMVs, as well as the feasibility of using this model with more diverse patient populations.\" \n",
    "        altmab5 = \"As rates of opiate misuse rise in the United States, so do significant associated health and financial consequences to afflicted individuals, their families, and society at large. Methadone maintenance therapy (MMT) is one evidence-based approach to treating opiate addiction, yet supplemental psychosocial treatment to support this approach is lacking. Mindfulness-based relapse prevention (MBRP) has shown to be efficacious in various substance use populations, but has yet to be assessed with MMT clients. Design: The current mixed methods study was designed to inform protocol adaptation for MMT clients and to evaluate the feasibility, acceptability, and preliminary efficacy of MBRP for this population. Subjects: The sample consisted of adults (N = 15) recruited from a methadone clinic to participate in a 6-week MBRP course. Outcome measures: Data from focus groups and course satisfaction surveys supported feasibility and acceptability of the intervention. Self-report outcome measures included depression, anxiety, craving, symptoms of post-traumatic stress, and experiential avoidance, and were assessed at baseline and postcourse. Results: Mean scores on all primary outcomes changed in the expected direction at postcourse, and baseline to postcourse changes in depression, craving, and trauma symptoms reached statistical significance. Conclusions: Results from this initial pilot trial support feasibility and acceptability, and provide preliminary data on outcomes for future trials of mindfulness-based approaches within the MMT community.\"\n",
    "\n",
    "        with open('sci_abstracts_scraped_dropdu', 'r') as f:\n",
    "            realabstracts = [line.strip() for line in f]\n",
    "        # create an array of ones the same length as the title list\n",
    "        k = np.ones(len(realabstracts), dtype = int)\n",
    "        # create a dataframe of abstracts in one column and corresponding class in the next\n",
    "        abstracts_real = pd.DataFrame({'Abstracts': realabstracts, \"Class\":k })\n",
    "        with open('pseudo_abstracts_scraped', 'r') as f:\n",
    "            pseudoabstracts = [line.strip() for line in f]\n",
    "        l = np.zeros(len(pseudoabstracts), dtype = int)\n",
    "        abstracts_fake = pd.DataFrame({\"Abstracts\": pseudoabstracts, 'Class': l})\n",
    "        # concatenate \n",
    "        abstracts_all = pd.concat([abstracts_real, abstracts_fake])\n",
    "        \n",
    "        \n",
    "        word_bagger = CountVectorizer(stop_words=stop_wordz)\n",
    "        word_bagger.fit(abstracts_all['Abstracts'])\n",
    "        \n",
    "        abs_words = word_bagger.transform([medab, medab2, medab3, medab4, medab5, altmab, altmab2, altmab3, altmab4, altmab5]).toarray()\n",
    "    \n",
    "        #res[best_d]['model'].predict(abs_words)\n",
    "    \n",
    "    \n",
    "    \n",
    "        print(\"Predictions of 5 medical and 5 alternative medical abstracts, respectively are {}\".format(res[best_d]['model'].predict(abs_words)))\n",
    "        \n",
    "        \n",
    "    #pass\n",
    "\n",
    "\n",
    "if __name__ == '__main__':\n",
    "    main()\n",
    "print(\"--- %s seconds ---\" % (time.time() - start_time))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fit Data to Random Forest Classifier\n",
    "\n",
    "Should lead to decreased variance and increased accuracy."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fit to Titles "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['abhyanga', 'abilities', 'ability', 'abiotically', 'abiraterone', 'ablation', 'able', 'abnormal', 'abnormalities', 'abortion', 'abrogates', 'absence', 'absorption', 'abstinence', 'abundances', 'abundant', 'abuse', 'academic', 'acadl', 'accelerated', 'accelerates', 'accelerating', 'accelerometer', 'acceptability', 'acceptance', 'accepted', 'access', 'accessibility', 'accessory', 'accident', 'acclimatisation', 'accompanied', 'accomplish', 'accomplishing', 'according', 'account', 'acculturation', 'accumulation', 'accuracy', 'accurate', 'ace2', 'acetaminophen', 'acetate', 'acetone', 'acetylator', 'acetylcholine', 'acetylcholinesterase', 'achieve', 'achieved', 'acid']\n",
      "\n",
      "Using criterion entropy\n",
      "Evaluating on estimator 1\n",
      "Evaluating on estimator 5\n",
      "Evaluating on estimator 10\n",
      "Evaluating on estimator 15\n",
      "Evaluating on estimator 20\n",
      "Evaluating on estimator 25\n",
      "Evaluating on estimator 30\n",
      "Evaluating on estimator 50\n",
      "Evaluating on estimator 100\n",
      "n_Estimators: 1   Train: 0.9144067796610169    Val: 0.7465346534653465\n",
      "n_Estimators: 5   Train: 0.9779661016949153    Val: 0.8138613861386138\n",
      "n_Estimators: 10   Train: 0.9932203389830508    Val: 0.8435643564356435\n",
      "n_Estimators: 15   Train: 0.9983050847457627    Val: 0.8554455445544554\n",
      "n_Estimators: 20   Train: 0.9978813559322034    Val: 0.8712871287128713\n",
      "n_Estimators: 25   Train: 0.9991525423728813    Val: 0.8653465346534653\n",
      "n_Estimators: 30   Train: 0.9987288135593221    Val: 0.8732673267326733\n",
      "n_Estimators: 50   Train: 1.0    Val: 0.8653465346534653\n",
      "n_Estimators: 100   Train: 1.0    Val: 0.8653465346534653\n",
      "Best n_Estimators: 30    Test: 0.8323471400394478\n",
      "[[217  42]\n",
      " [ 43 205]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "         0.0       0.83      0.84      0.84       259\n",
      "         1.0       0.83      0.83      0.83       248\n",
      "\n",
      "    accuracy                           0.83       507\n",
      "   macro avg       0.83      0.83      0.83       507\n",
      "weighted avg       0.83      0.83      0.83       507\n",
      "\n",
      "Predictions of 5 medical and 5 alternative medical title, respectively are [0. 1. 0. 0. 0. 1. 1. 1. 1. 1.]\n",
      "\n",
      "Using criterion gini\n",
      "Evaluating on estimator 1\n",
      "Evaluating on estimator 5\n",
      "Evaluating on estimator 10\n",
      "Evaluating on estimator 15\n",
      "Evaluating on estimator 20\n",
      "Evaluating on estimator 25\n",
      "Evaluating on estimator 30\n",
      "Evaluating on estimator 50\n",
      "Evaluating on estimator 100\n",
      "n_Estimators: 1   Train: 0.9110169491525424    Val: 0.7603960396039604\n",
      "n_Estimators: 5   Train: 0.9809322033898306    Val: 0.8356435643564356\n",
      "n_Estimators: 10   Train: 0.989406779661017    Val: 0.8198019801980198\n",
      "n_Estimators: 15   Train: 0.9953389830508474    Val: 0.8514851485148515\n",
      "n_Estimators: 20   Train: 0.9966101694915255    Val: 0.8534653465346534\n",
      "n_Estimators: 25   Train: 1.0    Val: 0.8495049504950495\n",
      "n_Estimators: 30   Train: 0.9995762711864407    Val: 0.8475247524752475\n",
      "n_Estimators: 50   Train: 0.9995762711864407    Val: 0.8613861386138614\n",
      "n_Estimators: 100   Train: 1.0    Val: 0.8594059405940594\n",
      "Best n_Estimators: 50    Test: 0.8500986193293886\n",
      "[[224  35]\n",
      " [ 41 207]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "         0.0       0.85      0.86      0.85       259\n",
      "         1.0       0.86      0.83      0.84       248\n",
      "\n",
      "    accuracy                           0.85       507\n",
      "   macro avg       0.85      0.85      0.85       507\n",
      "weighted avg       0.85      0.85      0.85       507\n",
      "\n",
      "Predictions of 5 medical and 5 alternative medical title, respectively are [0. 1. 0. 0. 0. 1. 1. 1. 1. 1.]\n",
      "--- 87.72410082817078 seconds ---\n"
     ]
    }
   ],
   "source": [
    "from sklearn.ensemble import RandomForestClassifier\n",
    "from sklearn.feature_extraction.text import CountVectorizer, TfidfVectorizer, HashingVectorizer\n",
    "from sklearn.model_selection import train_test_split\n",
    "import numpy as np\n",
    "\n",
    "from sklearn.ensemble import RandomForestClassifier\n",
    "from sklearn.feature_extraction.text import CountVectorizer, TfidfVectorizer, HashingVectorizer\n",
    "from sklearn.model_selection import train_test_split\n",
    "import numpy as np\n",
    "\n",
    "import time\n",
    "start_time = time.time()\n",
    "\n",
    "\n",
    "\n",
    "def load_data(paths):\n",
    "    vec = CountVectorizer(input='content', stop_words = stop_wordz) # vectorize text\n",
    "    # create 2 new lists\n",
    "    lines = [] \n",
    "    counts = []\n",
    "    for p in paths:\n",
    "        with open(p) as f:\n",
    "            file_lines = f.readlines()\n",
    "            # append the size/lenghth of file_lines to counts\n",
    "        counts.append(len(file_lines))\n",
    "        lines.extend([l.strip() for l in file_lines])\n",
    "    vec.fit(lines)\n",
    "    # create a data_matrix array of your vectorized data\n",
    "    data_matrix = vec.transform(lines).toarray()\n",
    "    # set classes to 0 and 1\n",
    "    y = np.concatenate((np.zeros(counts[0]), np.ones(counts[1])))\n",
    "    return split_data(data_matrix, y), vec.get_feature_names()\n",
    "\n",
    "\n",
    "def split_data(X, y, train_size=0.7, val_size=0.15):\n",
    "    total_data = X.shape[0]\n",
    "    train_size = int(train_size * total_data)\n",
    "    val_size = int(val_size * total_data)\n",
    "    test_size = total_data - train_size - val_size\n",
    "\n",
    "    train_test_X, val_X, train_test_y, val_y = train_test_split(X, y, test_size=val_size)\n",
    "    train_X, test_X, train_y, test_y = train_test_split(train_test_X, train_test_y, test_size=test_size)\n",
    "\n",
    "    return {\n",
    "        'train': (train_X, train_y),\n",
    "        'val':  (val_X, val_y),\n",
    "        'test': (test_X, test_y)\n",
    "    }\n",
    "\n",
    "\n",
    "def select_model(estimators, data, criterion):\n",
    "    out = {}\n",
    "    for d in estimators:\n",
    "        print('Evaluating on estimator {}'.format(d))\n",
    "        out[d] = {}\n",
    "        tree = RandomForestClassifier(criterion=criterion, n_estimators=d)\n",
    "        tree.fit(data['train'][0], data['train'][1])\n",
    "        out[d]['val'] = tree.score(*data['val'])\n",
    "        out[d]['train'] = tree.score(*data['train'])\n",
    "        out[d]['model'] = tree\n",
    "    return out\n",
    "\n",
    "\n",
    "def visualize_tree(model, feature_names, criterion):\n",
    "    \n",
    "\n",
    "   \n",
    "    # from sklearn.ensemble import RandomForestClassifier\n",
    "    # model = RandomForestClassifier(n_estimators=10)\n",
    "\n",
    "    # Train\n",
    "    # model.fit(X,y)\n",
    "    # Extract single tree\n",
    "    # estimator = model.estimators_[5]\n",
    "\n",
    "    from sklearn.tree import export_graphviz\n",
    "    # Export as dot file\n",
    "    export_graphviz(model, 'tree.dot', feature_names = feature_names,\n",
    "                rounded = True, proportion = False, \n",
    "                precision = 2, filled = True)\n",
    "\n",
    "    # Convert to png using system command (requires Graphviz)\n",
    "    from subprocess import call\n",
    "    #call(['dot', '-Tpng', 'tree.dot', '-o', 'tree.png', '-Gdpi=600'])\n",
    "    ! dot -Tpng tree.dot -o tree.png -Gdpi=600\n",
    "    # Display in jupyter notebook\n",
    "    from IPython.display import Image\n",
    "    Image(filename = 'tree.png')\n",
    "\n",
    "\n",
    "def main():\n",
    "    data, feature_names = load_data(['sci_titles_scraped_dropdu', 'pseudo_titles_scraped'])\n",
    "    print(feature_names[200:250])\n",
    "\n",
    "    for criterion in (\"entropy\", \"gini\"):\n",
    "        print(\"\\nUsing criterion {}\".format(criterion))\n",
    "        res = select_model([1,5,10,15,20,25,30,50,100], data, criterion)\n",
    "        best_d = None\n",
    "        best_acc = 0\n",
    "        for d in res:\n",
    "            val_acc = res[d]['val']\n",
    "            print(\"n_Estimators: {}   Train: {}    Val: {}\".format(d, res[d]['train'], val_acc))\n",
    "            if val_acc  > best_acc:\n",
    "                best_d = d\n",
    "                best_acc = val_acc\n",
    "        print(\"Best n_Estimators: {}    Test: {}\".format(best_d, res[best_d]['model'].score(*data['test'])))\n",
    "        #visualize_tree(res[best_d]['model'], feature_names, criterion,)\n",
    "        hooglin = res[best_d]['model'].predict(data['test'][0])\n",
    "        print(confusion_matrix(data['test'][1], hooglin))\n",
    "        print(classification_report(data['test'][1], hooglin))\n",
    "        \n",
    "        with open('sci_titles_scraped_dropdu', 'r') as f:\n",
    "            realtitles = [line.strip() for line in f]\n",
    "        # create an array of ones the same length as the title list\n",
    "        k = np.ones(len(realtitles), dtype = int)\n",
    "        # create a dataframe of titles in one column and corresponding class in the next\n",
    "        titles_real = pd.DataFrame({'Titles': realtitles, \"Class\":k })\n",
    "        with open('pseudo_titles_scraped', 'r') as f:\n",
    "            pseudotitles = [line.strip() for line in f]\n",
    "        l = np.zeros(len(pseudotitles), dtype = int)\n",
    "        titles_fake = pd.DataFrame({\"Titles\": pseudotitles, 'Class': l})\n",
    "            # concatenate \n",
    "        titles_all = pd.concat([titles_real, titles_fake])\n",
    "        \n",
    "        word_bagger = CountVectorizer(stop_words=stop_wordz)\n",
    "        word_bagger.fit(titles_all['Titles'])\n",
    "        #word_bagger.fit([medab, medab2, medab3, medab4, medab5, altmab, altmab2, altmab3, altmab4, altmab5])\n",
    "        \n",
    "        \n",
    "        bagged = word_bagger.transform([med, med2, med3, med4, med5, altm, altm2, altm3, altm4, altm5]).toarray()\n",
    "        \n",
    "        print(\"Predictions of 5 medical and 5 alternative medical title, respectively are {}\".format(res[best_d]['model'].predict(bagged)))\n",
    "\n",
    "\n",
    "        \n",
    "    #pass\n",
    "\n",
    "\n",
    "if __name__ == '__main__':\n",
    "    main()\n",
    "print(\"--- %s seconds ---\" % (time.time() - start_time))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fit to Abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['072', '073', '074', '0747', '075', '077', '078', '079', '08', '080', '081', '082', '084', '0842nrf', '085', '086', '09', '093', '094', '0941', '095', '097', '0978', '098', '099', '0_5', '0r4534', '0t', '10', '100', '1000', '10000', '1000ch', '1003', '10045', '1007', '100mf', '101', '1010', '101056', '1012', '1014', '1015del', '102', '102000', '1025', '1026', '1027', '1029', '103']\n",
      "\n",
      "Using criterion entropy\n",
      "Evaluating on estimator 1\n",
      "Evaluating on estimator 5\n",
      "Evaluating on estimator 10\n",
      "Evaluating on estimator 15\n",
      "Evaluating on estimator 20\n",
      "Evaluating on estimator 25\n",
      "Evaluating on estimator 30\n",
      "Evaluating on estimator 50\n",
      "Evaluating on estimator 100\n",
      "Evaluating on estimator 150\n",
      "n_Estimators: 1   Train: 0.9170896785109983    Val: 0.7964426877470355\n",
      "n_Estimators: 5   Train: 0.9847715736040609    Val: 0.8952569169960475\n",
      "n_Estimators: 10   Train: 0.9970389170896785    Val: 0.9189723320158103\n",
      "n_Estimators: 15   Train: 0.9970389170896785    Val: 0.932806324110672\n",
      "n_Estimators: 20   Train: 0.9974619289340102    Val: 0.9268774703557312\n",
      "n_Estimators: 25   Train: 0.9978849407783418    Val: 0.932806324110672\n",
      "n_Estimators: 30   Train: 0.9983079526226735    Val: 0.9446640316205533\n",
      "n_Estimators: 50   Train: 0.9983079526226735    Val: 0.9426877470355731\n",
      "n_Estimators: 100   Train: 0.9983079526226735    Val: 0.950592885375494\n",
      "n_Estimators: 150   Train: 0.9983079526226735    Val: 0.958498023715415\n",
      "Best n_Estimators: 150    Test: 0.9448818897637795\n",
      "[[248  16]\n",
      " [ 12 232]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "         0.0       0.95      0.94      0.95       264\n",
      "         1.0       0.94      0.95      0.94       244\n",
      "\n",
      "    accuracy                           0.94       508\n",
      "   macro avg       0.94      0.95      0.94       508\n",
      "weighted avg       0.95      0.94      0.94       508\n",
      "\n",
      "Predictions of 5 medical and 5 alternative medical abstracts, respectively are [0. 0. 0. 0. 0. 1. 1. 1. 1. 1.]\n",
      "\n",
      "Using criterion gini\n",
      "Evaluating on estimator 1\n",
      "Evaluating on estimator 5\n",
      "Evaluating on estimator 10\n",
      "Evaluating on estimator 15\n",
      "Evaluating on estimator 20\n",
      "Evaluating on estimator 25\n",
      "Evaluating on estimator 30\n",
      "Evaluating on estimator 50\n",
      "Evaluating on estimator 100\n",
      "Evaluating on estimator 150\n",
      "n_Estimators: 1   Train: 0.9137055837563451    Val: 0.8201581027667985\n",
      "n_Estimators: 5   Train: 0.9906937394247038    Val: 0.8636363636363636\n",
      "n_Estimators: 10   Train: 0.9974619289340102    Val: 0.9031620553359684\n",
      "n_Estimators: 15   Train: 0.9983079526226735    Val: 0.9229249011857708\n",
      "n_Estimators: 20   Train: 0.9983079526226735    Val: 0.924901185770751\n",
      "n_Estimators: 25   Train: 0.9983079526226735    Val: 0.9486166007905138\n",
      "n_Estimators: 30   Train: 0.9983079526226735    Val: 0.9387351778656127\n",
      "n_Estimators: 50   Train: 0.9983079526226735    Val: 0.9387351778656127\n",
      "n_Estimators: 100   Train: 0.9983079526226735    Val: 0.9387351778656127\n",
      "n_Estimators: 150   Train: 0.9983079526226735    Val: 0.950592885375494\n",
      "Best n_Estimators: 150    Test: 0.9429133858267716\n",
      "[[248  16]\n",
      " [ 13 231]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "         0.0       0.95      0.94      0.94       264\n",
      "         1.0       0.94      0.95      0.94       244\n",
      "\n",
      "    accuracy                           0.94       508\n",
      "   macro avg       0.94      0.94      0.94       508\n",
      "weighted avg       0.94      0.94      0.94       508\n",
      "\n",
      "Predictions of 5 medical and 5 alternative medical abstracts, respectively are [0. 0. 0. 0. 0. 1. 1. 1. 1. 1.]\n",
      "--- 162.48287296295166 seconds ---\n"
     ]
    }
   ],
   "source": [
    "from sklearn.ensemble import RandomForestClassifier\n",
    "from sklearn.feature_extraction.text import CountVectorizer, TfidfVectorizer, HashingVectorizer\n",
    "from sklearn.model_selection import train_test_split\n",
    "import numpy as np\n",
    "\n",
    "from sklearn.ensemble import RandomForestClassifier\n",
    "from sklearn.feature_extraction.text import CountVectorizer, TfidfVectorizer, HashingVectorizer\n",
    "from sklearn.model_selection import train_test_split\n",
    "import numpy as np\n",
    "\n",
    "import time\n",
    "start_time = time.time()\n",
    "\n",
    "\n",
    "\n",
    "def load_data(paths):\n",
    "    vec = CountVectorizer(input='content', stop_words=stop_wordz) # vectorize text\n",
    "    # create 2 new lists\n",
    "    lines = [] \n",
    "    counts = []\n",
    "    for p in paths:\n",
    "        with open(p) as f:\n",
    "            file_lines = f.readlines()\n",
    "            # append the size/lenghth of file_lines to counts\n",
    "        counts.append(len(file_lines))\n",
    "        lines.extend([l.strip() for l in file_lines])\n",
    "    vec.fit(lines)\n",
    "    # create a data_matrix array of your vectorized data\n",
    "    data_matrix = vec.transform(lines).toarray()\n",
    "    # set classes to 0 and 1\n",
    "    y = np.concatenate((np.zeros(counts[0]), np.ones(counts[1])))\n",
    "    return split_data(data_matrix, y), vec.get_feature_names()\n",
    "\n",
    "\n",
    "def split_data(X, y, train_size=0.7, val_size=0.15):\n",
    "    total_data = X.shape[0]\n",
    "    train_size = int(train_size * total_data)\n",
    "    val_size = int(val_size * total_data)\n",
    "    test_size = total_data - train_size - val_size\n",
    "\n",
    "    train_test_X, val_X, train_test_y, val_y = train_test_split(X, y, test_size=val_size)\n",
    "    train_X, test_X, train_y, test_y = train_test_split(train_test_X, train_test_y, test_size=test_size)\n",
    "\n",
    "    return {\n",
    "        'train': (train_X, train_y),\n",
    "        'val':  (val_X, val_y),\n",
    "        'test': (test_X, test_y)\n",
    "    }\n",
    "\n",
    "\n",
    "def select_model(estimators, data, criterion):\n",
    "    out = {}\n",
    "    for d in estimators:\n",
    "        print('Evaluating on estimator {}'.format(d))\n",
    "        out[d] = {}\n",
    "        tree = RandomForestClassifier(criterion=criterion, n_estimators=d)\n",
    "        tree.fit(data['train'][0], data['train'][1])\n",
    "        out[d]['val'] = tree.score(*data['val'])\n",
    "        out[d]['train'] = tree.score(*data['train'])\n",
    "        out[d]['model'] = tree\n",
    "    return out\n",
    "\n",
    "\n",
    "def visualize_tree(model, feature_names, criterion):\n",
    "    \n",
    "\n",
    "\n",
    "\n",
    "    from sklearn.tree import export_graphviz\n",
    "    # Export as dot file\n",
    "    export_graphviz(model, 'tree.dot', feature_names = feature_names,\n",
    "                rounded = True, proportion = False, \n",
    "                precision = 2, filled = True)\n",
    "\n",
    "    # Convert to png using system command (requires Graphviz)\n",
    "    from subprocess import call\n",
    "    #call(['dot', '-Tpng', 'tree.dot', '-o', 'tree.png', '-Gdpi=600'])\n",
    "    ! dot -Tpng tree.dot -o tree.png -Gdpi=600\n",
    "    # Display in jupyter notebook\n",
    "    from IPython.display import Image\n",
    "    Image(filename = 'tree.png')\n",
    "\n",
    "\n",
    "def main():\n",
    "    data, feature_names = load_data(['sci_abstracts_scraped_dropdu', 'pseudo_abstracts_scraped'])\n",
    "    print(feature_names[200:250])\n",
    "\n",
    "    for criterion in (\"entropy\", \"gini\"):\n",
    "        print(\"\\nUsing criterion {}\".format(criterion))\n",
    "        res = select_model([1,5,10,15,20,25,30,50,100,150], data, criterion)\n",
    "        best_d = None\n",
    "        best_acc = 0\n",
    "        for d in res:\n",
    "            val_acc = res[d]['val']\n",
    "            print(\"n_Estimators: {}   Train: {}    Val: {}\".format(d, res[d]['train'], val_acc))\n",
    "            if val_acc  > best_acc:\n",
    "                best_d = d\n",
    "                best_acc = val_acc\n",
    "        print(\"Best n_Estimators: {}    Test: {}\".format(best_d, res[best_d]['model'].score(*data['test'])))\n",
    "        hooglin = res[best_d]['model'].predict(data['test'][0])\n",
    "        print(confusion_matrix(data['test'][1], hooglin))\n",
    "        print(classification_report(data['test'][1], hooglin))\n",
    "        \n",
    "        medab = \"The National Institute of Mental Health (NIMH) ‘fast-fail’ approach seeks to improve too-often-misleading early-phase drug development methods by incorporating biomarker-based proof-of-mechanism (POM) testing in phase 2a. This first comprehensive application of the fast-fail approach evaluated the potential of κ-opioid receptor (KOR) antagonism for treating anhedonia with a POM study determining whether robust target engagement favorably impacts the brain circuitry hypothesized to mediate clinical effects. Here we report the results from a multicenter, 8-week, double-blind, placebo-controlled, randomized trial in patients with anhedonia and a mood or anxiety disorder (selective KOR antagonist (JNJ-67953964, 10 mg; n = 45) and placebo (n = 44)). JNJ-67953964 significantly increased functional magnetic resonance imaging (fMRI) ventral striatum activation during reward anticipation (primary outcome) as compared to placebo (baseline-adjusted mean: JNJ-67953964, 0.72 (s.d. = 0.67); placebo, 0.33 (s.d. = 0.68); F(1,86) = 5.58, P < 0.01; effect size = 0.58 (95% confidence interval, 0.13–0.99)). JNJ-67953964, generally well tolerated, was not associated with any serious adverse events. This study supports proceeding with assessment of the clinical impact of target engagement and serves as a model for implementing the ‘fast-fail’ approach.\"\n",
    "        medab2 = \"Neoadjuvant checkpoint inhibition, in which the therapy is administered before surgery, is a promising new approach to managing bulky but resectable melanoma, and is also being explored in other cancers. This strategy has a high pathologic response rate, which correlates with survival outcomes. The fact that biopsies are routinely available provides a unique opportunity for understanding the responses to therapy and carrying out reverse translation in which these data are used to select therapies in the clinic or in trials that are more likely to improve patient outcomes. In this Perspective, we discuss the rationale for neoadjuvant immunotherapy in resectable solid tumors based on preclinical and human translational data, summarize the results of recent clinical trials and ongoing research, and focus on future directions for enhancing reverse translation.\"\n",
    "        medab3 = \"Successful drug discovery is ultimately contingent on the availability of workable, relevant, predictive model systems. Conversely, for cardiac muscle, the lack of human preclinical models to inform target validation and compound development has likely contributed to the perennial problem of clinical trial failures, despite encouraging non-human results. By contrast, human cardiomyocytes produced from pluripotent stem cell models have recently been applied to safety pharmacology, phenotypic screening, target validation and high-throughput assays, facilitating cardiac drug discovery. Here, we review the impact of human pluripotent stem cell models in cardiac drug discovery, discussing the range of applications, readouts, and disease models employed, along with the challenges and prospects to advance this fruitful mode of research further.\"\n",
    "        medab4 = \"Epithelial-to-mesenchymal transition (EMT) plays an important role in invasion and metastasis of hepatocellular carcinoma (HCC). Our previous study found that atypical protein kinase C-ι (aPKC-ι) promoted the EMT process in HCC. However, how the aPKC-ι signaling pathway is regulated in HCC has not been elucidated. In this study, vector transfection was utilized to study the invasion of HCC cells, and the mechanism between P300 and aPKC-ι signaling pathways in regulating the EMT process of HCC was further elucidated in vitro and in vivo. We found both P300 and aPKC-ι were highly expressed in HCC and they were correlated with tumor progression and poor survival in HCC patients. P300 knockdown inhibited EMT, invasion and other malignant events of HCC cells but promoted cell apoptosis and cycle arrest. However, the effects mediated by P300 knockdown were abolished by aPKC-ι overexpression. Further studies showed that P300 upregulates aPKC-ι expression through increasing the transcription of Elk1, a transcriptional activator of aPKC-ι, and stabilizing Elk1 protein and its phosphorylation. In conclusion, our work uncovered the molecular mechanism by which oncogenic aPKC-ι is upregulated in HCC and suggests that P300, like aPKC-ι, may be used as a prognostic biomarker and therapeutic target in patients with HCC.\"\n",
    "        medab5 = \"An unmet clinical need remains for an effective tetravalent dengue vaccine suitable for all age groups, regardless of serostatus. We assessed the immunogenicity and safety of three different dose schedules of a tetravalent dengue vaccine (TAK-003) over a 48-month period in children living in dengue-endemic countries. We did a large, phase 2, double-blind, placebo-controlled trial at three sites in the Dominican Republic, Panama, and the Philippines. Healthy participants aged 2–17 years were randomly assigned 1:2:5:1 using an interactive web response system with stratification by age to receive either a two-dose primary series (days 1 and 91), one primary dose (day 1), one primary dose plus booster (days 1 and 365), or placebo. Participants and relevant study personnel were masked to the random assignment until completion of the study at month 48. To maintain masking, TAK-003 recipients were administered placebo doses when appropriate. The primary objective was assessment of neutralising geometric mean titres for each serotype to month 48 assessed in the per-protocol immunogenicity subset. Secondary safety endpoints included proportions of participants with serious adverse events and symptomatic virologically confirmed dengue. This study is registered with ClinicalTrials.gov, NCT02302066. Between Dec 5, 2014, and Feb 13, 2015, 1800 children were randomly assigned to the following groups: two-dose primary series (n=201), one primary dose (n=398), one primary dose plus 1-year booster (n=1002), and placebo (n=199). Of them, 1479 (82%) participants completed the 48-month study. Immunogenicity endpoints were assessed in 562 participants enrolled in the immunogenicity subset, of whom 509 were included in the per-protocol subset. At month 48, antibody titres remained elevated in all TAK-003 groups compared with placebo, irrespective of baseline serostatus. At month 48, geometric mean titres were 378 (95% CI 226–632) in two-dose, 421 (285–622) in one-dose, 719 (538–960) in one-dose plus 1-year booster, and 100 (50–201) in placebo recipients against DENV 1; 1052 (732–1511), 1319 (970–1794), 1200 (927–1553), and 208 (99–437) against DENV 2; 183 (113–298), 201 (135–298), 288 (211–392), and 71 (37–139) against DENV 3; and 152 (97–239), 164 (114–236), 219 (165–290), and 46 (26–82) against DENV 4; and tetravalent seropositivity rate was 89% (79–96), 86% (80–92), 97% (93–99), and 60% (47–72), respectively. Virologically confirmed dengue was recorded in 37 (2%) TAK-003 and 13 (7%) placebo participants, with a relative risk of 0·35 (0·19–0·65). No vaccine-related serious adverse events or severe dengue virus disease were reported. TAK-003 elicited antibody responses against all four serotypes, which persisted to 48 months post-vaccination, regardless of baseline serostatus. No important safety risks were identified. We observed a long-term reduction in risk of symptomatic dengue virus disease in vaccinees. Results from this study provide a long-term safety database and support assessment of the vaccine in the ongoing phase 3 efficacy study.\"\n",
    "        altmab = \"In order to meet the growing needs of the European Union medicinal and aromatic plants, Hungary is still one of the major exporters today, although earlier, until the 1980s, we were considered a great herb-growing nation. Therefore, the development of the national medicinal and aromatic herb growing sector is an essential requirement for maintaining and developing our market position. The natural conditions of Hungary favor the cultivation of medicinal and aromatic plants. There are more than 330 herbs in our country. About seventy percent of the drugs grown and harvested are exported. However, significant changes are needed in domestic sales and further processing in order to become a leading industrial sector. Hungary also possesses modern separation techniques and large instruments for analysis, which allow the proper analytical examination of drugs and the precise determination of their active substances. Our universities and research institutes are also prepared to study the active ingredients of herbs by molecular biological methods, which may allow the exact mechanism of action of bioactive substances to be determined and the herbs to be reassessed. Our accession to the European Union the palette of products made from former herbs has significantly changed. From 2013, the category of medicinal product was discontinued and the preparations were classified as either food or medicine. However, there are significant costs associated with qualifying as a drug, so drugs or extracts are largely added to dietary supplements. As a result, the strange situation is that dietary supplements are prohibited from making any health claims, even though the dietary supplement is actually not for the benefit of a healthy population, but for those who have a health problem or do not have suitable foods, which are rich in bioactive substances. The justification of phytotherapy must be demonstrated, depending on the state of the art. In the context of safe therapy, studies must follow the requirements of medicines and only then can they become herbal medicines. There is still much to be desired in this area in our country. Classification as a drug is based on expensive animal tests and clinical studies. A new problem arises here, as herbal cure is currently part of the arsenal of complementary medicine. With few exceptions, clinical doctors do not use herbal therapies. Patients usually ask the advice of pharmacists, naturalists, and more rarely, dietitians. At the Arteriosclerosis Research Group, at the II. Department of Medicine and Institute of Pharmacognosy several decades of biomedical research have served and serve the purpose of evaluating and reassessing the effects of plants used in folk medicine. Over the years, we have been searching for drugs, extracts, and medicines of natural origin that are useful in liver and intestinal diseases known in folk medicine, and are believed to have lipid lowering, antioxidant and immune stimulating effects. In the article, animal and human studies will be also presented.\"\n",
    "        altmab2 = \"This research was done to explore the role of fresh garlic homogenate (GH) on attenuation of myocardial damage when administered concurrently with atenolol (ATN) in experimental animals. At the end of treatment of male albino rats, hearts were excised from anesthetized animals and mounted on modified Langendorff setup. After initial perfusion with physiological solution, hearts were subjected to 15 min global no flow ischemia reperfusion injury (IRI) and perfused again. Significant recovery in developed tension and heart rate was exhibited by hearts of animals pretreated with ATN, GH-125 and GH-250. There was significant elevation of LDH and CK-MB in heart tissue homogenate and fall in perfusate of treated groups (ATN, GH-125 and GH-250). Additionally, simultaneous administration of GH-250 with ATN resulted in significant increase in endogenous antioxidant enzymes (SOD and catalase) activities. The augmented antioxidant activities could be due to the possible synergistic potential of ATN in GH mediated scavenging of oxidative free radicals produced during IRI. On the contrary, high dose of GH (500 mg/kg) failed to demonstrate similar potential even in presence of ATN. Hence, only moderate intake of garlic is good for cardioprotection when administered prophylactically and addition of ATN produces synergistic effect.\"\n",
    "        altmab3 = \"NMR proton relaxation is sensitive to the dynamics of the water molecule H2O, through the interaction of the spin of the proton (1H) with external magnetic and electromagnetic fields. We measured dilution and potentization processes through measurements of 1H spin-lattice T1 and spin–spin T2 relaxation times. In order to interpret the recorded fluctuations in T1- or T2-values, experimental data were linearized by investigating how the area under a fluctuating time = f(dilution) curve (dilution integral or DI) changes with dilution. Two kinds of fitting procedures were considered: chi-square fitting with a goodness-of-fit probability, and least absolute deviations criterion with Pearson's linear correlation coefficient. We showed that fluctuations are not attributable to random noise and/or experimental errors, evidencing a memory effect quantifiable by the slope of the DI = f(dilution) straight line. For all experiments, correlation coefficients were found to lie above 0.9999, against 0.999 for random noise. The discrimination between experimental slopes and slopes associated with random noise data was very good at a five-sigma level of confidence (i.e. probability 3 × 10−7). Discrimination between experimental slopes at a five-sigma level was possible in most cases, with three exceptions: gelsemium aqua pura v gelsemium dilution (four-sigma); copper aqua pura v gelsemium aqua pura (four-sigma) and copper simple dilution v gelsemium simple dilution (three-sigma). All potentized samples show very good discrimination (at least nine-sigma level) against aqua pura, lactose or simple dilution. It was possible to transform the associated relaxation times into a molecular rotational correlation time τc and an average spin–spin distance d. Our experiments thus point to a considerable slowing down of molecular movements (τc > 1300 ps or T = 224–225 K) around water molecules up to a distance of 3.7 Å, values. It was also possible to rule out other possible mechanisms of relaxation (diffusive motion, 17O-1H relaxation or coupling with the electronic spin, S = 1, of dissolved dioxygen molecules). There is clear evidence that homeopathic solutions cannot be considered as pure water as commonly assumed. Instead, we have evidenced a clear memory effect upon dilution/potentization of a substance (water, lactose, copper, gelsemium) reflected by different rotational correlation times and average H⋯H distances. A possible explanation for such a memory effect may lie in the formation of mesoscopic water structures around nanoparticles and/or nanobubbles mediated by zero-point fluctuations of the vacuum electromagnetic field as suggested by quantum field theories. The existence of an Avogadro's ‘wall’ for homeopathically-prepared medicines is not supported by our data. Rather it appears that all dilutions have a specific material configuration determined by the potentized substance, also by the chemical nature of the containers, and dissolved gases and the electromagnetic environment. This sensitivity of homeopathically-prepared medicines to electromagnetic fields may be amplified by the highly non-linear processing routinely applied in the preparation of homeopathic medicines. Future work is needed in such directions. The time is now ripe for a demystification of the preparation of homeopathic remedies.\"\n",
    "        altmab4 = \"This article describes the implementation of a group medical visit (GMV) model to increase access to integrative oncology (IO) care. The most challenging and critical time to access high-quality IO care is while patients are receiving conventional cancer therapy. Often demand for individual IO clinic consultations precludes this from occurring. A three-session GMV program was designed to alleviate barriers to receiving integrative care during active cancer treatment. Design: A consolidated framework was used for implementation research and focused ethnography methods to describe the IO GMV implementation process. Data sources included patient evaluations, participant observation, and brief provider and patient interviews. Setting: A pilot program was created to assess the feasibility and acceptability of implementing IO GMVs at a comprehensive cancer center. Intervention: Each three-session GMV consisted of a didactic session, followed by individual visits with the integrative oncologist. Results: The setting, intervention, and implementation process of the IO GMV program were described. Thirty-two patients participated in the first five cohorts of the program. Twenty-two were women; 24 were White. The median age of participants was 52. Patient evaluations demonstrate high levels of satisfaction with the program with all scored aspects rated >4.0 on a five-point Likert scale. For the medical center, group visits are a financially viable alternative to individual IO visits; revenue from group visits exceeded the revenue potential of 6 h of individual visits by an average of 38%. Conclusion: GMVs are a feasible and promising model for increasing access to IO. Patients in active cancer treatment were able to participate in the program. Future research and implementation efforts could examine health outcomes over time after participation in GMVs, as well as the feasibility of using this model with more diverse patient populations.\" \n",
    "        altmab5 = \"As rates of opiate misuse rise in the United States, so do significant associated health and financial consequences to afflicted individuals, their families, and society at large. Methadone maintenance therapy (MMT) is one evidence-based approach to treating opiate addiction, yet supplemental psychosocial treatment to support this approach is lacking. Mindfulness-based relapse prevention (MBRP) has shown to be efficacious in various substance use populations, but has yet to be assessed with MMT clients. Design: The current mixed methods study was designed to inform protocol adaptation for MMT clients and to evaluate the feasibility, acceptability, and preliminary efficacy of MBRP for this population. Subjects: The sample consisted of adults (N = 15) recruited from a methadone clinic to participate in a 6-week MBRP course. Outcome measures: Data from focus groups and course satisfaction surveys supported feasibility and acceptability of the intervention. Self-report outcome measures included depression, anxiety, craving, symptoms of post-traumatic stress, and experiential avoidance, and were assessed at baseline and postcourse. Results: Mean scores on all primary outcomes changed in the expected direction at postcourse, and baseline to postcourse changes in depression, craving, and trauma symptoms reached statistical significance. Conclusions: Results from this initial pilot trial support feasibility and acceptability, and provide preliminary data on outcomes for future trials of mindfulness-based approaches within the MMT community.\"\n",
    "\n",
    "        with open('sci_abstracts_scraped_dropdu', 'r') as f:\n",
    "            realabstracts = [line.strip() for line in f]\n",
    "        # create an array of ones the same length as the title list\n",
    "        k = np.ones(len(realabstracts), dtype = int)\n",
    "        # create a dataframe of abstracts in one column and corresponding class in the next\n",
    "        abstracts_real = pd.DataFrame({'Abstracts': realabstracts, \"Class\":k })\n",
    "        with open('pseudo_abstracts_scraped', 'r') as f:\n",
    "            pseudoabstracts = [line.strip() for line in f]\n",
    "        l = np.zeros(len(pseudoabstracts), dtype = int)\n",
    "        abstracts_fake = pd.DataFrame({\"Abstracts\": pseudoabstracts, 'Class': l})\n",
    "        # concatenate \n",
    "        abstracts_all = pd.concat([abstracts_real, abstracts_fake])\n",
    "        \n",
    "        \n",
    "        word_bagger = CountVectorizer(stop_words=stop_wordz)\n",
    "        word_bagger.fit(abstracts_all['Abstracts'])\n",
    "        #word_bagger.fit([medab, medab2, medab3, medab4, medab5, altmab, altmab2, altmab3, altmab4, altmab5])\n",
    "        \n",
    "        abs_words = word_bagger.transform([medab, medab2, medab3, medab4, medab5, altmab, altmab2, altmab3, altmab4, altmab5]).toarray()\n",
    "    \n",
    "        #res[best_d]['model'].predict(abs_words)\n",
    "    \n",
    "    \n",
    "    \n",
    "        print(\"Predictions of 5 medical and 5 alternative medical abstracts, respectively are {}\".format(res[best_d]['model'].predict(abs_words)))\n",
    "        \n",
    "\n",
    "\n",
    "\n",
    "if __name__ == '__main__':\n",
    "    main()\n",
    "\n",
    "print(\"--- %s seconds ---\" % (time.time() - start_time))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fitting Data to Adaboost\n",
    "\n",
    "Reduces bias and increases accuracy by iteratively focusing on previous misclassifications.\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fit to Titles"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['abhyanga', 'abilities', 'ability', 'abiotically', 'abiraterone', 'ablation', 'able', 'abnormal', 'abnormalities', 'abortion', 'abrogates', 'absence', 'absorption', 'abstinence', 'abundances', 'abundant', 'abuse', 'academic', 'acadl', 'accelerated', 'accelerates', 'accelerating', 'accelerometer', 'acceptability', 'acceptance', 'accepted', 'access', 'accessibility', 'accessory', 'accident', 'acclimatisation', 'accompanied', 'accomplish', 'accomplishing', 'according', 'account', 'acculturation', 'accumulation', 'accuracy', 'accurate', 'ace2', 'acetaminophen', 'acetate', 'acetone', 'acetylator', 'acetylcholine', 'acetylcholinesterase', 'achieve', 'achieved', 'acid']\n",
      "Evaluating on estimator 1\n",
      "Evaluating on estimator 5\n",
      "Evaluating on estimator 10\n",
      "Evaluating on estimator 20\n",
      "Evaluating on estimator 30\n",
      "Evaluating on estimator 50\n",
      "Evaluating on estimator 100\n",
      "Evaluating on estimator 150\n",
      "n_Estimators: 1   Train: 0.5673728813559322    Val: 0.5900990099009901\n",
      "n_Estimators: 5   Train: 0.6347457627118644    Val: 0.6455445544554456\n",
      "n_Estimators: 10   Train: 0.7173728813559322    Val: 0.7188118811881188\n",
      "n_Estimators: 20   Train: 0.7652542372881356    Val: 0.7623762376237624\n",
      "n_Estimators: 30   Train: 0.7847457627118644    Val: 0.7742574257425743\n",
      "n_Estimators: 50   Train: 0.8266949152542373    Val: 0.80990099009901\n",
      "n_Estimators: 100   Train: 0.8665254237288136    Val: 0.8336633663366336\n",
      "n_Estimators: 150   Train: 0.9    Val: 0.8376237623762376\n",
      "Best n_Estimators: 150    Test: 0.8027613412228797\n",
      "[[218  42]\n",
      " [ 58 189]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "         0.0       0.79      0.84      0.81       260\n",
      "         1.0       0.82      0.77      0.79       247\n",
      "\n",
      "    accuracy                           0.80       507\n",
      "   macro avg       0.80      0.80      0.80       507\n",
      "weighted avg       0.80      0.80      0.80       507\n",
      "\n",
      "Predictions of 5 medical and 5 alternative medical title, respectively are [0. 1. 0. 0. 0. 1. 1. 1. 1. 1.]\n",
      "--- 241.1643831729889 seconds ---\n"
     ]
    }
   ],
   "source": [
    "from sklearn.ensemble import AdaBoostClassifier\n",
    "from sklearn.feature_extraction.text import CountVectorizer, TfidfVectorizer, HashingVectorizer\n",
    "from sklearn.model_selection import train_test_split\n",
    "import numpy as np\n",
    "from sklearn.metrics import classification_report,confusion_matrix\n",
    "import numpy as np\n",
    "import time\n",
    "start_time = time.time()\n",
    "\n",
    "\n",
    "def load_data(paths):\n",
    "    vec = CountVectorizer(input='content', stop_words=stop_wordz) # vectorize text\n",
    "    # create 2 new lists\n",
    "    lines = [] \n",
    "    counts = []\n",
    "    for p in paths:\n",
    "        with open(p) as f:\n",
    "            file_lines = f.readlines()\n",
    "            # append the size/lenghth of file_lines to counts\n",
    "        counts.append(len(file_lines))\n",
    "        lines.extend([l.strip() for l in file_lines])\n",
    "    vec.fit(lines)\n",
    "    # create a data_matrix array of your vectorized data\n",
    "    data_matrix = vec.transform(lines).toarray()\n",
    "    # set classes to 0 and 1\n",
    "    y = np.concatenate((np.zeros(counts[0]), np.ones(counts[1])))\n",
    "    return split_data(data_matrix, y), vec.get_feature_names()\n",
    "\n",
    "\n",
    "def split_data(X, y, train_size=0.7, val_size=0.15):\n",
    "    total_data = X.shape[0]\n",
    "    train_size = int(train_size * total_data)\n",
    "    val_size = int(val_size * total_data)\n",
    "    test_size = total_data - train_size - val_size\n",
    "\n",
    "    train_test_X, val_X, train_test_y, val_y = train_test_split(X, y, test_size=val_size)\n",
    "    train_X, test_X, train_y, test_y = train_test_split(train_test_X, train_test_y, test_size=test_size)\n",
    "\n",
    "    return {\n",
    "        'train': (train_X, train_y),\n",
    "        'val':  (val_X, val_y),\n",
    "        'test': (test_X, test_y)\n",
    "    }\n",
    "\n",
    "\n",
    "def select_model(estimators, data):\n",
    "    out = {}\n",
    "    for d in estimators:\n",
    "        print('Evaluating on estimator {}'.format(d))\n",
    "        out[d] = {}\n",
    "        tree = AdaBoostClassifier(n_estimators=d, random_state = 42)\n",
    "        tree.fit(data['train'][0], data['train'][1])\n",
    "        out[d]['val'] = tree.score(*data['val'])\n",
    "        out[d]['train'] = tree.score(*data['train'])\n",
    "        out[d]['model'] = tree\n",
    "    return out\n",
    "\n",
    "\n",
    "def main():\n",
    "    data, feature_names = load_data(['sci_titles_scraped_dropdu', 'pseudo_titles_scraped'])\n",
    "    print(feature_names[200:250])\n",
    "    res = select_model([1,5,10,20,30,50,100,150], data)\n",
    "    best_d = None\n",
    "    best_acc = 0\n",
    "    for d in res:\n",
    "        val_acc = res[d]['val']\n",
    "        print(\"n_Estimators: {}   Train: {}    Val: {}\".format(d, res[d]['train'], val_acc))\n",
    "        if val_acc  > best_acc:\n",
    "            best_d = d\n",
    "            best_acc = val_acc\n",
    "    print(\"Best n_Estimators: {}    Test: {}\".format(best_d, res[best_d]['model'].score(*data['test'])))\n",
    "    #visualize_tree(res[best_d]['model'], feature_names)\n",
    "    hooglin = res[best_d]['model'].predict(data['test'][0])\n",
    "    print(confusion_matrix(data['test'][1], hooglin))\n",
    "    print(classification_report(data['test'][1], hooglin))    \n",
    "    \n",
    "    with open('sci_titles_scraped_dropdu', 'r') as f:\n",
    "        realtitles = [line.strip() for line in f]\n",
    "        # create an array of ones the same length as the title list\n",
    "    k = np.ones(len(realtitles), dtype = int)\n",
    "        # create a dataframe of titles in one column and corresponding class in the next\n",
    "    titles_real = pd.DataFrame({'Titles': realtitles, \"Class\":k })\n",
    "    with open('pseudo_titles_scraped', 'r') as f:\n",
    "        pseudotitles = [line.strip() for line in f]\n",
    "    l = np.zeros(len(pseudotitles), dtype = int)\n",
    "    titles_fake = pd.DataFrame({\"Titles\": pseudotitles, 'Class': l})\n",
    "    # concatenate \n",
    "    titles_all = pd.concat([titles_real, titles_fake])\n",
    "        \n",
    "    word_bagger = CountVectorizer(stop_words=stop_wordz)\n",
    "    word_bagger.fit(titles_all['Titles'])\n",
    "    #word_bagger.fit([medab, medab2, medab3, medab4, medab5, altmab, altmab2, altmab3, altmab4, altmab5])\n",
    "        \n",
    "        \n",
    "    bagged = word_bagger.transform([med, med2, med3, med4, med5, altm, altm2, altm3, altm4, altm5]).toarray()\n",
    "        \n",
    "    print(\"Predictions of 5 medical and 5 alternative medical title, respectively are {}\".format(res[best_d]['model'].predict(bagged)))\n",
    "\n",
    "\n",
    "        \n",
    "    \n",
    "    #pass\n",
    "\n",
    "\n",
    "if __name__ == '__main__':\n",
    "    main()\n",
    "print(\"--- %s seconds ---\" % (time.time() - start_time))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fit to Abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['072', '073', '074', '0747', '075', '077', '078', '079', '08', '080', '081', '082', '084', '0842nrf', '085', '086', '09', '093', '094', '0941', '095', '097', '0978', '098', '099', '0_5', '0r4534', '0t', '10', '100', '1000', '10000', '1000ch', '1003', '10045', '1007', '100mf', '101', '1010', '101056', '1012', '1014', '1015del', '102', '102000', '1025', '1026', '1027', '1029', '103']\n",
      "Evaluating on estimator 1\n",
      "Evaluating on estimator 5\n",
      "Evaluating on estimator 10\n",
      "Evaluating on estimator 20\n",
      "Evaluating on estimator 30\n",
      "Evaluating on estimator 50\n",
      "Evaluating on estimator 100\n",
      "Evaluating on estimator 150\n",
      "n_Estimators: 1   Train: 0.6560913705583756    Val: 0.6719367588932806\n",
      "n_Estimators: 5   Train: 0.8142978003384095    Val: 0.83399209486166\n",
      "n_Estimators: 10   Train: 0.8532148900169205    Val: 0.8517786561264822\n",
      "n_Estimators: 20   Train: 0.8955160744500846    Val: 0.8913043478260869\n",
      "n_Estimators: 30   Train: 0.9124365482233503    Val: 0.8972332015810277\n",
      "n_Estimators: 50   Train: 0.9335871404399323    Val: 0.8952569169960475\n",
      "n_Estimators: 100   Train: 0.9805414551607445    Val: 0.9466403162055336\n",
      "n_Estimators: 150   Train: 0.9966159052453468    Val: 0.9367588932806324\n",
      "Best n_Estimators: 100    Test: 0.9488188976377953\n",
      "[[258  12]\n",
      " [ 14 224]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "         0.0       0.95      0.96      0.95       270\n",
      "         1.0       0.95      0.94      0.95       238\n",
      "\n",
      "    accuracy                           0.95       508\n",
      "   macro avg       0.95      0.95      0.95       508\n",
      "weighted avg       0.95      0.95      0.95       508\n",
      "\n",
      "Predictions of 5 medical and 5 alternative medical abstracts, respectively are [0. 0. 0. 0. 0. 0. 1. 1. 1. 1.]\n",
      "--- 1154.428768157959 seconds ---\n"
     ]
    }
   ],
   "source": [
    "from sklearn.ensemble import AdaBoostClassifier\n",
    "from sklearn.feature_extraction.text import CountVectorizer, TfidfVectorizer, HashingVectorizer\n",
    "from sklearn.model_selection import train_test_split\n",
    "import numpy as np\n",
    "import time\n",
    "start_time = time.time()\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "def load_data(paths):\n",
    "    vec = CountVectorizer(input='content', stop_words=stop_wordz) # vectorize text\n",
    "    # create 2 new lists\n",
    "    lines = [] \n",
    "    counts = []\n",
    "    for p in paths:\n",
    "        with open(p) as f:\n",
    "            file_lines = f.readlines()\n",
    "            # append the size/lenghth of file_lines to counts\n",
    "        counts.append(len(file_lines))\n",
    "        lines.extend([l.strip() for l in file_lines])\n",
    "    vec.fit(lines)\n",
    "    # create a data_matrix array of your vectorized data\n",
    "    data_matrix = vec.transform(lines).toarray()\n",
    "    # set classes to 0 and 1\n",
    "    y = np.concatenate((np.zeros(counts[0]), np.ones(counts[1])))\n",
    "    return split_data(data_matrix, y), vec.get_feature_names()\n",
    "\n",
    "\n",
    "def split_data(X, y, train_size=0.7, val_size=0.15):\n",
    "    total_data = X.shape[0]\n",
    "    train_size = int(train_size * total_data)\n",
    "    val_size = int(val_size * total_data)\n",
    "    test_size = total_data - train_size - val_size\n",
    "\n",
    "    train_test_X, val_X, train_test_y, val_y = train_test_split(X, y, test_size=val_size)\n",
    "    train_X, test_X, train_y, test_y = train_test_split(train_test_X, train_test_y, test_size=test_size)\n",
    "\n",
    "    return {\n",
    "        'train': (train_X, train_y),\n",
    "        'val':  (val_X, val_y),\n",
    "        'test': (test_X, test_y)\n",
    "    }\n",
    "\n",
    "\n",
    "def select_model(estimators, data):\n",
    "    out = {}\n",
    "    for d in estimators:\n",
    "        print('Evaluating on estimator {}'.format(d))\n",
    "        out[d] = {}\n",
    "        tree = AdaBoostClassifier(n_estimators=d, random_state = 42)\n",
    "        tree.fit(data['train'][0], data['train'][1])\n",
    "        out[d]['val'] = tree.score(*data['val'])\n",
    "        out[d]['train'] = tree.score(*data['train'])\n",
    "        out[d]['model'] = tree\n",
    "    return out\n",
    "\n",
    "\n",
    "def visualize_tree(model, feature_names):\n",
    "\n",
    "    from sklearn.tree import export_graphviz\n",
    "    # Export as dot file\n",
    "    export_graphviz(model, 'tree.dot', feature_names = feature_names,\n",
    "                rounded = True, proportion = False, \n",
    "                precision = 2, filled = True)\n",
    "\n",
    "    \n",
    "    from subprocess import call\n",
    "    \n",
    "    ! dot -Tpng tree.dot -o tree.png -Gdpi=600\n",
    "\n",
    "    from IPython.display import Image\n",
    "    Image(filename = 'tree.png')\n",
    "\n",
    "\n",
    "def main():\n",
    "    data, feature_names = load_data(['sci_abstracts_scraped_dropdu', 'pseudo_abstracts_scraped'])\n",
    "    print(feature_names[200:250])\n",
    "\n",
    "\n",
    "    res = select_model([1,5,10,20,30,50,100,150], data)\n",
    "    best_d = None\n",
    "    best_acc = 0\n",
    "    for d in res:\n",
    "        val_acc = res[d]['val']\n",
    "        print(\"n_Estimators: {}   Train: {}    Val: {}\".format(d, res[d]['train'], val_acc))\n",
    "        if val_acc  > best_acc:\n",
    "            best_d = d\n",
    "            best_acc = val_acc\n",
    "    print(\"Best n_Estimators: {}    Test: {}\".format(best_d, res[best_d]['model'].score(*data['test'])))\n",
    "    hooglin = res[best_d]['model'].predict(data['test'][0])\n",
    "    print(confusion_matrix(data['test'][1], hooglin))\n",
    "    print(classification_report(data['test'][1], hooglin))\n",
    "    \n",
    "    medab = \"The National Institute of Mental Health (NIMH) ‘fast-fail’ approach seeks to improve too-often-misleading early-phase drug development methods by incorporating biomarker-based proof-of-mechanism (POM) testing in phase 2a. This first comprehensive application of the fast-fail approach evaluated the potential of κ-opioid receptor (KOR) antagonism for treating anhedonia with a POM study determining whether robust target engagement favorably impacts the brain circuitry hypothesized to mediate clinical effects. Here we report the results from a multicenter, 8-week, double-blind, placebo-controlled, randomized trial in patients with anhedonia and a mood or anxiety disorder (selective KOR antagonist (JNJ-67953964, 10 mg; n = 45) and placebo (n = 44)). JNJ-67953964 significantly increased functional magnetic resonance imaging (fMRI) ventral striatum activation during reward anticipation (primary outcome) as compared to placebo (baseline-adjusted mean: JNJ-67953964, 0.72 (s.d. = 0.67); placebo, 0.33 (s.d. = 0.68); F(1,86) = 5.58, P < 0.01; effect size = 0.58 (95% confidence interval, 0.13–0.99)). JNJ-67953964, generally well tolerated, was not associated with any serious adverse events. This study supports proceeding with assessment of the clinical impact of target engagement and serves as a model for implementing the ‘fast-fail’ approach.\"\n",
    "    medab2 = \"Neoadjuvant checkpoint inhibition, in which the therapy is administered before surgery, is a promising new approach to managing bulky but resectable melanoma, and is also being explored in other cancers. This strategy has a high pathologic response rate, which correlates with survival outcomes. The fact that biopsies are routinely available provides a unique opportunity for understanding the responses to therapy and carrying out reverse translation in which these data are used to select therapies in the clinic or in trials that are more likely to improve patient outcomes. In this Perspective, we discuss the rationale for neoadjuvant immunotherapy in resectable solid tumors based on preclinical and human translational data, summarize the results of recent clinical trials and ongoing research, and focus on future directions for enhancing reverse translation.\"\n",
    "    medab3 = \"Successful drug discovery is ultimately contingent on the availability of workable, relevant, predictive model systems. Conversely, for cardiac muscle, the lack of human preclinical models to inform target validation and compound development has likely contributed to the perennial problem of clinical trial failures, despite encouraging non-human results. By contrast, human cardiomyocytes produced from pluripotent stem cell models have recently been applied to safety pharmacology, phenotypic screening, target validation and high-throughput assays, facilitating cardiac drug discovery. Here, we review the impact of human pluripotent stem cell models in cardiac drug discovery, discussing the range of applications, readouts, and disease models employed, along with the challenges and prospects to advance this fruitful mode of research further.\"\n",
    "    medab4 = \"Epithelial-to-mesenchymal transition (EMT) plays an important role in invasion and metastasis of hepatocellular carcinoma (HCC). Our previous study found that atypical protein kinase C-ι (aPKC-ι) promoted the EMT process in HCC. However, how the aPKC-ι signaling pathway is regulated in HCC has not been elucidated. In this study, vector transfection was utilized to study the invasion of HCC cells, and the mechanism between P300 and aPKC-ι signaling pathways in regulating the EMT process of HCC was further elucidated in vitro and in vivo. We found both P300 and aPKC-ι were highly expressed in HCC and they were correlated with tumor progression and poor survival in HCC patients. P300 knockdown inhibited EMT, invasion and other malignant events of HCC cells but promoted cell apoptosis and cycle arrest. However, the effects mediated by P300 knockdown were abolished by aPKC-ι overexpression. Further studies showed that P300 upregulates aPKC-ι expression through increasing the transcription of Elk1, a transcriptional activator of aPKC-ι, and stabilizing Elk1 protein and its phosphorylation. In conclusion, our work uncovered the molecular mechanism by which oncogenic aPKC-ι is upregulated in HCC and suggests that P300, like aPKC-ι, may be used as a prognostic biomarker and therapeutic target in patients with HCC.\"\n",
    "    medab5 = \"An unmet clinical need remains for an effective tetravalent dengue vaccine suitable for all age groups, regardless of serostatus. We assessed the immunogenicity and safety of three different dose schedules of a tetravalent dengue vaccine (TAK-003) over a 48-month period in children living in dengue-endemic countries. We did a large, phase 2, double-blind, placebo-controlled trial at three sites in the Dominican Republic, Panama, and the Philippines. Healthy participants aged 2–17 years were randomly assigned 1:2:5:1 using an interactive web response system with stratification by age to receive either a two-dose primary series (days 1 and 91), one primary dose (day 1), one primary dose plus booster (days 1 and 365), or placebo. Participants and relevant study personnel were masked to the random assignment until completion of the study at month 48. To maintain masking, TAK-003 recipients were administered placebo doses when appropriate. The primary objective was assessment of neutralising geometric mean titres for each serotype to month 48 assessed in the per-protocol immunogenicity subset. Secondary safety endpoints included proportions of participants with serious adverse events and symptomatic virologically confirmed dengue. This study is registered with ClinicalTrials.gov, NCT02302066. Between Dec 5, 2014, and Feb 13, 2015, 1800 children were randomly assigned to the following groups: two-dose primary series (n=201), one primary dose (n=398), one primary dose plus 1-year booster (n=1002), and placebo (n=199). Of them, 1479 (82%) participants completed the 48-month study. Immunogenicity endpoints were assessed in 562 participants enrolled in the immunogenicity subset, of whom 509 were included in the per-protocol subset. At month 48, antibody titres remained elevated in all TAK-003 groups compared with placebo, irrespective of baseline serostatus. At month 48, geometric mean titres were 378 (95% CI 226–632) in two-dose, 421 (285–622) in one-dose, 719 (538–960) in one-dose plus 1-year booster, and 100 (50–201) in placebo recipients against DENV 1; 1052 (732–1511), 1319 (970–1794), 1200 (927–1553), and 208 (99–437) against DENV 2; 183 (113–298), 201 (135–298), 288 (211–392), and 71 (37–139) against DENV 3; and 152 (97–239), 164 (114–236), 219 (165–290), and 46 (26–82) against DENV 4; and tetravalent seropositivity rate was 89% (79–96), 86% (80–92), 97% (93–99), and 60% (47–72), respectively. Virologically confirmed dengue was recorded in 37 (2%) TAK-003 and 13 (7%) placebo participants, with a relative risk of 0·35 (0·19–0·65). No vaccine-related serious adverse events or severe dengue virus disease were reported. TAK-003 elicited antibody responses against all four serotypes, which persisted to 48 months post-vaccination, regardless of baseline serostatus. No important safety risks were identified. We observed a long-term reduction in risk of symptomatic dengue virus disease in vaccinees. Results from this study provide a long-term safety database and support assessment of the vaccine in the ongoing phase 3 efficacy study.\"\n",
    "    altmab = \"In order to meet the growing needs of the European Union medicinal and aromatic plants, Hungary is still one of the major exporters today, although earlier, until the 1980s, we were considered a great herb-growing nation. Therefore, the development of the national medicinal and aromatic herb growing sector is an essential requirement for maintaining and developing our market position. The natural conditions of Hungary favor the cultivation of medicinal and aromatic plants. There are more than 330 herbs in our country. About seventy percent of the drugs grown and harvested are exported. However, significant changes are needed in domestic sales and further processing in order to become a leading industrial sector. Hungary also possesses modern separation techniques and large instruments for analysis, which allow the proper analytical examination of drugs and the precise determination of their active substances. Our universities and research institutes are also prepared to study the active ingredients of herbs by molecular biological methods, which may allow the exact mechanism of action of bioactive substances to be determined and the herbs to be reassessed. Our accession to the European Union the palette of products made from former herbs has significantly changed. From 2013, the category of medicinal product was discontinued and the preparations were classified as either food or medicine. However, there are significant costs associated with qualifying as a drug, so drugs or extracts are largely added to dietary supplements. As a result, the strange situation is that dietary supplements are prohibited from making any health claims, even though the dietary supplement is actually not for the benefit of a healthy population, but for those who have a health problem or do not have suitable foods, which are rich in bioactive substances. The justification of phytotherapy must be demonstrated, depending on the state of the art. In the context of safe therapy, studies must follow the requirements of medicines and only then can they become herbal medicines. There is still much to be desired in this area in our country. Classification as a drug is based on expensive animal tests and clinical studies. A new problem arises here, as herbal cure is currently part of the arsenal of complementary medicine. With few exceptions, clinical doctors do not use herbal therapies. Patients usually ask the advice of pharmacists, naturalists, and more rarely, dietitians. At the Arteriosclerosis Research Group, at the II. Department of Medicine and Institute of Pharmacognosy several decades of biomedical research have served and serve the purpose of evaluating and reassessing the effects of plants used in folk medicine. Over the years, we have been searching for drugs, extracts, and medicines of natural origin that are useful in liver and intestinal diseases known in folk medicine, and are believed to have lipid lowering, antioxidant and immune stimulating effects. In the article, animal and human studies will be also presented.\"\n",
    "    altmab2 = \"This research was done to explore the role of fresh garlic homogenate (GH) on attenuation of myocardial damage when administered concurrently with atenolol (ATN) in experimental animals. At the end of treatment of male albino rats, hearts were excised from anesthetized animals and mounted on modified Langendorff setup. After initial perfusion with physiological solution, hearts were subjected to 15 min global no flow ischemia reperfusion injury (IRI) and perfused again. Significant recovery in developed tension and heart rate was exhibited by hearts of animals pretreated with ATN, GH-125 and GH-250. There was significant elevation of LDH and CK-MB in heart tissue homogenate and fall in perfusate of treated groups (ATN, GH-125 and GH-250). Additionally, simultaneous administration of GH-250 with ATN resulted in significant increase in endogenous antioxidant enzymes (SOD and catalase) activities. The augmented antioxidant activities could be due to the possible synergistic potential of ATN in GH mediated scavenging of oxidative free radicals produced during IRI. On the contrary, high dose of GH (500 mg/kg) failed to demonstrate similar potential even in presence of ATN. Hence, only moderate intake of garlic is good for cardioprotection when administered prophylactically and addition of ATN produces synergistic effect.\"\n",
    "    altmab3 = \"NMR proton relaxation is sensitive to the dynamics of the water molecule H2O, through the interaction of the spin of the proton (1H) with external magnetic and electromagnetic fields. We measured dilution and potentization processes through measurements of 1H spin-lattice T1 and spin–spin T2 relaxation times. In order to interpret the recorded fluctuations in T1- or T2-values, experimental data were linearized by investigating how the area under a fluctuating time = f(dilution) curve (dilution integral or DI) changes with dilution. Two kinds of fitting procedures were considered: chi-square fitting with a goodness-of-fit probability, and least absolute deviations criterion with Pearson's linear correlation coefficient. We showed that fluctuations are not attributable to random noise and/or experimental errors, evidencing a memory effect quantifiable by the slope of the DI = f(dilution) straight line. For all experiments, correlation coefficients were found to lie above 0.9999, against 0.999 for random noise. The discrimination between experimental slopes and slopes associated with random noise data was very good at a five-sigma level of confidence (i.e. probability 3 × 10−7). Discrimination between experimental slopes at a five-sigma level was possible in most cases, with three exceptions: gelsemium aqua pura v gelsemium dilution (four-sigma); copper aqua pura v gelsemium aqua pura (four-sigma) and copper simple dilution v gelsemium simple dilution (three-sigma). All potentized samples show very good discrimination (at least nine-sigma level) against aqua pura, lactose or simple dilution. It was possible to transform the associated relaxation times into a molecular rotational correlation time τc and an average spin–spin distance d. Our experiments thus point to a considerable slowing down of molecular movements (τc > 1300 ps or T = 224–225 K) around water molecules up to a distance of 3.7 Å, values. It was also possible to rule out other possible mechanisms of relaxation (diffusive motion, 17O-1H relaxation or coupling with the electronic spin, S = 1, of dissolved dioxygen molecules). There is clear evidence that homeopathic solutions cannot be considered as pure water as commonly assumed. Instead, we have evidenced a clear memory effect upon dilution/potentization of a substance (water, lactose, copper, gelsemium) reflected by different rotational correlation times and average H⋯H distances. A possible explanation for such a memory effect may lie in the formation of mesoscopic water structures around nanoparticles and/or nanobubbles mediated by zero-point fluctuations of the vacuum electromagnetic field as suggested by quantum field theories. The existence of an Avogadro's ‘wall’ for homeopathically-prepared medicines is not supported by our data. Rather it appears that all dilutions have a specific material configuration determined by the potentized substance, also by the chemical nature of the containers, and dissolved gases and the electromagnetic environment. This sensitivity of homeopathically-prepared medicines to electromagnetic fields may be amplified by the highly non-linear processing routinely applied in the preparation of homeopathic medicines. Future work is needed in such directions. The time is now ripe for a demystification of the preparation of homeopathic remedies.\"\n",
    "    altmab4 = \"This article describes the implementation of a group medical visit (GMV) model to increase access to integrative oncology (IO) care. The most challenging and critical time to access high-quality IO care is while patients are receiving conventional cancer therapy. Often demand for individual IO clinic consultations precludes this from occurring. A three-session GMV program was designed to alleviate barriers to receiving integrative care during active cancer treatment. Design: A consolidated framework was used for implementation research and focused ethnography methods to describe the IO GMV implementation process. Data sources included patient evaluations, participant observation, and brief provider and patient interviews. Setting: A pilot program was created to assess the feasibility and acceptability of implementing IO GMVs at a comprehensive cancer center. Intervention: Each three-session GMV consisted of a didactic session, followed by individual visits with the integrative oncologist. Results: The setting, intervention, and implementation process of the IO GMV program were described. Thirty-two patients participated in the first five cohorts of the program. Twenty-two were women; 24 were White. The median age of participants was 52. Patient evaluations demonstrate high levels of satisfaction with the program with all scored aspects rated >4.0 on a five-point Likert scale. For the medical center, group visits are a financially viable alternative to individual IO visits; revenue from group visits exceeded the revenue potential of 6 h of individual visits by an average of 38%. Conclusion: GMVs are a feasible and promising model for increasing access to IO. Patients in active cancer treatment were able to participate in the program. Future research and implementation efforts could examine health outcomes over time after participation in GMVs, as well as the feasibility of using this model with more diverse patient populations.\" \n",
    "    altmab5 = \"As rates of opiate misuse rise in the United States, so do significant associated health and financial consequences to afflicted individuals, their families, and society at large. Methadone maintenance therapy (MMT) is one evidence-based approach to treating opiate addiction, yet supplemental psychosocial treatment to support this approach is lacking. Mindfulness-based relapse prevention (MBRP) has shown to be efficacious in various substance use populations, but has yet to be assessed with MMT clients. Design: The current mixed methods study was designed to inform protocol adaptation for MMT clients and to evaluate the feasibility, acceptability, and preliminary efficacy of MBRP for this population. Subjects: The sample consisted of adults (N = 15) recruited from a methadone clinic to participate in a 6-week MBRP course. Outcome measures: Data from focus groups and course satisfaction surveys supported feasibility and acceptability of the intervention. Self-report outcome measures included depression, anxiety, craving, symptoms of post-traumatic stress, and experiential avoidance, and were assessed at baseline and postcourse. Results: Mean scores on all primary outcomes changed in the expected direction at postcourse, and baseline to postcourse changes in depression, craving, and trauma symptoms reached statistical significance. Conclusions: Results from this initial pilot trial support feasibility and acceptability, and provide preliminary data on outcomes for future trials of mindfulness-based approaches within the MMT community.\"\n",
    "\n",
    "    with open('sci_abstracts_scraped_dropdu', 'r') as f:\n",
    "        realabstracts = [line.strip() for line in f]\n",
    "    # create an array of ones the same length as the title list\n",
    "    k = np.ones(len(realabstracts), dtype = int)\n",
    "    # create a dataframe of abstracts in one column and corresponding class in the next\n",
    "    abstracts_real = pd.DataFrame({'Abstracts': realabstracts, \"Class\":k })\n",
    "    with open('pseudo_abstracts_scraped', 'r') as f:\n",
    "        pseudoabstracts = [line.strip() for line in f]\n",
    "    l = np.zeros(len(pseudoabstracts), dtype = int)\n",
    "    abstracts_fake = pd.DataFrame({\"Abstracts\": pseudoabstracts, 'Class': l})\n",
    "    # concatenate \n",
    "    abstracts_all = pd.concat([abstracts_real, abstracts_fake])\n",
    "        \n",
    "        \n",
    "    word_bagger = CountVectorizer(stop_words=stop_wordz)\n",
    "    word_bagger.fit(abstracts_all['Abstracts'])\n",
    "     \n",
    "    abs_words = word_bagger.transform([medab, medab2, medab3, medab4, medab5, altmab, altmab2, altmab3, altmab4, altmab5]).toarray()\n",
    "    \n",
    "    \n",
    "    \n",
    "    \n",
    "    \n",
    "    print(\"Predictions of 5 medical and 5 alternative medical abstracts, respectively are {}\".format(res[best_d]['model'].predict(abs_words)))\n",
    "        \n",
    "        \n",
    "        \n",
    "    #pass\n",
    "\n",
    "\n",
    "if __name__ == '__main__':\n",
    "    main()\n",
    "print(\"--- %s seconds ---\" % (time.time() - start_time))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fitting Data to Support Vector Machines (SVM) \n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# SVM Fit to Titles"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[[221  21]\n",
      " [ 31 234]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       0.88      0.91      0.89       242\n",
      "           1       0.92      0.88      0.90       265\n",
      "\n",
      "    accuracy                           0.90       507\n",
      "   macro avg       0.90      0.90      0.90       507\n",
      "weighted avg       0.90      0.90      0.90       507\n",
      "\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1296x504 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Predictions of 5 medical and 5 alternative medical titles, respectively are [1 1 0 1 1 0 0 0 0 0]\n",
      "--- 0.5763862133026123 seconds ---\n"
     ]
    }
   ],
   "source": [
    "from sklearn import svm\n",
    "from sklearn.metrics import classification_report,confusion_matrix\n",
    "import matplotlib.pyplot as plt\n",
    "from sklearn.model_selection import train_test_split\n",
    "import time\n",
    "start_time = time.time()\n",
    "\n",
    "\n",
    "\n",
    "titles_word = text.CountVectorizer(stop_words=stop_wordz)\n",
    "titles_word.fit(titles_all['Titles'])\n",
    "titles_words= titles_word.get_feature_names()\n",
    "trainedsvm = svm.LinearSVC(dual=False, C = 0.2, max_iter=10000).fit(X, y)\n",
    "\n",
    "\n",
    "def SVM_simple(X, y, train_size=0.7, val_size=0.15):\n",
    "    total_data = X.shape[0]\n",
    "    train_size = int(train_size * total_data)\n",
    "    val_size = int(val_size * total_data)\n",
    "    test_size = total_data - train_size - val_size\n",
    "\n",
    "    train_test_X, val_X, train_test_y, val_y = train_test_split(X, y, test_size=val_size)\n",
    "    train_X, test_X, train_y, test_y = train_test_split(train_test_X, train_test_y, test_size=test_size)\n",
    "    \n",
    "    trainedsvm = svm.LinearSVC(dual=False, C=0.2, max_iter=10000).fit(train_X, train_y)\n",
    "    predictionsvm = trainedsvm.predict(test_X)\n",
    "    print(confusion_matrix(test_y,predictionsvm))\n",
    "    print(classification_report(test_y,predictionsvm))\n",
    "    \n",
    "def feature_plot(classifier, feature_names, top_features=10):\n",
    "    coef = classifier.coef_.ravel()\n",
    "    top_positive_coefficients = np.argsort(coef)[-top_features:]\n",
    "    top_negative_coefficients = np.argsort(coef)[:top_features]\n",
    "    top_coefficients = np.hstack([top_negative_coefficients, top_positive_coefficients])\n",
    "    plt.figure(figsize=(18, 7))\n",
    "    colors = ['green' if c < 0 else 'blue' for c in coef[top_coefficients]]\n",
    "    plt.bar(np.arange(2 * top_features), coef[top_coefficients], color=colors)\n",
    "    feature_names = np.array(feature_names)\n",
    "    plt.xticks(np.arange(1 + 2 * top_features), feature_names[top_coefficients], rotation=45, ha='right')\n",
    "    plt.show()\n",
    "\n",
    "\n",
    "SVM_simple(X, y, train_size=0.7, val_size=0.15)\n",
    "feature_plot(trainedsvm, titles_words)\n",
    "\n",
    "med = \"Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study\"\n",
    "med2 = \"Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial\"\n",
    "med3 = \"Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer\"\n",
    "med4 = \"PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma\"\n",
    "med5 = \"Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone\"\n",
    "altm = \"Prevalence, Patterns, and Predictors of T'ai Chi and Qigong Use in the United States: Results of a Nationally Representative Survey\"\n",
    "altm2 = 'Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin'\n",
    "altm3 = \"The American Coneflower: A Prophylactic Role Involving Nonspecific Immunity\"\n",
    "altm4 = \"Effect of BEMER Magnetic Field Therapy on the Level of Fatigue in Patients with Multiple Sclerosis: A Randomized, Double-Blind Controlled Trial\"\n",
    "altm5 = \"Improving Access to Integrative Oncology Through Group Medical Visits: A Pilot Implementation Project\"\n",
    "\n",
    "\n",
    "newtitles = titles_word.transform([med, med2, med3, med4, med5, altm, altm2, altm3, altm4, altm5])\n",
    "trainedsvm.predict(newtitles)\n",
    "print(\"Predictions of 5 medical and 5 alternative medical titles, respectively are {}\".format(trainedsvm.predict(newtitles)))\n",
    "\n",
    "print(\"--- %s seconds ---\" % (time.time() - start_time))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# SVM Fit to Abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[[160  15]\n",
      " [  5 159]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       0.97      0.91      0.94       175\n",
      "           1       0.91      0.97      0.94       164\n",
      "\n",
      "    accuracy                           0.94       339\n",
      "   macro avg       0.94      0.94      0.94       339\n",
      "weighted avg       0.94      0.94      0.94       339\n",
      "\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1296x504 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Predictions of 5 medical and 5 alternative medical abstracts, respectively are [1 1 1 1 1 0 0 0 0 0]\n",
      "--- 2.2006850242614746 seconds ---\n"
     ]
    }
   ],
   "source": [
    "import time\n",
    "start_time = time.time()\n",
    "\n",
    "abstracts_word = text.CountVectorizer(stop_words=stop_wordz)\n",
    "abstracts_word.fit(abstracts_all['Abstracts'])\n",
    "abstracts_words= abstracts_word.get_feature_names()\n",
    "trainedsvmab = svm.LinearSVC(dual=False, max_iter=100000, C=0.2).fit(X_abstracts, y_abstracts)\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "SVM_simple(X_abstracts, y_abstracts, train_size=0.7, val_size=0.20)\n",
    "feature_plot(trainedsvmab, abstracts_words)\n",
    "\n",
    "\n",
    "medab = \"The National Institute of Mental Health (NIMH) ‘fast-fail’ approach seeks to improve too-often-misleading early-phase drug development methods by incorporating biomarker-based proof-of-mechanism (POM) testing in phase 2a. This first comprehensive application of the fast-fail approach evaluated the potential of κ-opioid receptor (KOR) antagonism for treating anhedonia with a POM study determining whether robust target engagement favorably impacts the brain circuitry hypothesized to mediate clinical effects. Here we report the results from a multicenter, 8-week, double-blind, placebo-controlled, randomized trial in patients with anhedonia and a mood or anxiety disorder (selective KOR antagonist (JNJ-67953964, 10 mg; n = 45) and placebo (n = 44)). JNJ-67953964 significantly increased functional magnetic resonance imaging (fMRI) ventral striatum activation during reward anticipation (primary outcome) as compared to placebo (baseline-adjusted mean: JNJ-67953964, 0.72 (s.d. = 0.67); placebo, 0.33 (s.d. = 0.68); F(1,86) = 5.58, P < 0.01; effect size = 0.58 (95% confidence interval, 0.13–0.99)). JNJ-67953964, generally well tolerated, was not associated with any serious adverse events. This study supports proceeding with assessment of the clinical impact of target engagement and serves as a model for implementing the ‘fast-fail’ approach.\"\n",
    "medab2 = \"Neoadjuvant checkpoint inhibition, in which the therapy is administered before surgery, is a promising new approach to managing bulky but resectable melanoma, and is also being explored in other cancers. This strategy has a high pathologic response rate, which correlates with survival outcomes. The fact that biopsies are routinely available provides a unique opportunity for understanding the responses to therapy and carrying out reverse translation in which these data are used to select therapies in the clinic or in trials that are more likely to improve patient outcomes. In this Perspective, we discuss the rationale for neoadjuvant immunotherapy in resectable solid tumors based on preclinical and human translational data, summarize the results of recent clinical trials and ongoing research, and focus on future directions for enhancing reverse translation.\"\n",
    "medab3 = \"Successful drug discovery is ultimately contingent on the availability of workable, relevant, predictive model systems. Conversely, for cardiac muscle, the lack of human preclinical models to inform target validation and compound development has likely contributed to the perennial problem of clinical trial failures, despite encouraging non-human results. By contrast, human cardiomyocytes produced from pluripotent stem cell models have recently been applied to safety pharmacology, phenotypic screening, target validation and high-throughput assays, facilitating cardiac drug discovery. Here, we review the impact of human pluripotent stem cell models in cardiac drug discovery, discussing the range of applications, readouts, and disease models employed, along with the challenges and prospects to advance this fruitful mode of research further.\"\n",
    "medab4 = \"Epithelial-to-mesenchymal transition (EMT) plays an important role in invasion and metastasis of hepatocellular carcinoma (HCC). Our previous study found that atypical protein kinase C-ι (aPKC-ι) promoted the EMT process in HCC. However, how the aPKC-ι signaling pathway is regulated in HCC has not been elucidated. In this study, vector transfection was utilized to study the invasion of HCC cells, and the mechanism between P300 and aPKC-ι signaling pathways in regulating the EMT process of HCC was further elucidated in vitro and in vivo. We found both P300 and aPKC-ι were highly expressed in HCC and they were correlated with tumor progression and poor survival in HCC patients. P300 knockdown inhibited EMT, invasion and other malignant events of HCC cells but promoted cell apoptosis and cycle arrest. However, the effects mediated by P300 knockdown were abolished by aPKC-ι overexpression. Further studies showed that P300 upregulates aPKC-ι expression through increasing the transcription of Elk1, a transcriptional activator of aPKC-ι, and stabilizing Elk1 protein and its phosphorylation. In conclusion, our work uncovered the molecular mechanism by which oncogenic aPKC-ι is upregulated in HCC and suggests that P300, like aPKC-ι, may be used as a prognostic biomarker and therapeutic target in patients with HCC.\"\n",
    "medab5 = \"An unmet clinical need remains for an effective tetravalent dengue vaccine suitable for all age groups, regardless of serostatus. We assessed the immunogenicity and safety of three different dose schedules of a tetravalent dengue vaccine (TAK-003) over a 48-month period in children living in dengue-endemic countries. We did a large, phase 2, double-blind, placebo-controlled trial at three sites in the Dominican Republic, Panama, and the Philippines. Healthy participants aged 2–17 years were randomly assigned 1:2:5:1 using an interactive web response system with stratification by age to receive either a two-dose primary series (days 1 and 91), one primary dose (day 1), one primary dose plus booster (days 1 and 365), or placebo. Participants and relevant study personnel were masked to the random assignment until completion of the study at month 48. To maintain masking, TAK-003 recipients were administered placebo doses when appropriate. The primary objective was assessment of neutralising geometric mean titres for each serotype to month 48 assessed in the per-protocol immunogenicity subset. Secondary safety endpoints included proportions of participants with serious adverse events and symptomatic virologically confirmed dengue. This study is registered with ClinicalTrials.gov, NCT02302066. Between Dec 5, 2014, and Feb 13, 2015, 1800 children were randomly assigned to the following groups: two-dose primary series (n=201), one primary dose (n=398), one primary dose plus 1-year booster (n=1002), and placebo (n=199). Of them, 1479 (82%) participants completed the 48-month study. Immunogenicity endpoints were assessed in 562 participants enrolled in the immunogenicity subset, of whom 509 were included in the per-protocol subset. At month 48, antibody titres remained elevated in all TAK-003 groups compared with placebo, irrespective of baseline serostatus. At month 48, geometric mean titres were 378 (95% CI 226–632) in two-dose, 421 (285–622) in one-dose, 719 (538–960) in one-dose plus 1-year booster, and 100 (50–201) in placebo recipients against DENV 1; 1052 (732–1511), 1319 (970–1794), 1200 (927–1553), and 208 (99–437) against DENV 2; 183 (113–298), 201 (135–298), 288 (211–392), and 71 (37–139) against DENV 3; and 152 (97–239), 164 (114–236), 219 (165–290), and 46 (26–82) against DENV 4; and tetravalent seropositivity rate was 89% (79–96), 86% (80–92), 97% (93–99), and 60% (47–72), respectively. Virologically confirmed dengue was recorded in 37 (2%) TAK-003 and 13 (7%) placebo participants, with a relative risk of 0·35 (0·19–0·65). No vaccine-related serious adverse events or severe dengue virus disease were reported. TAK-003 elicited antibody responses against all four serotypes, which persisted to 48 months post-vaccination, regardless of baseline serostatus. No important safety risks were identified. We observed a long-term reduction in risk of symptomatic dengue virus disease in vaccinees. Results from this study provide a long-term safety database and support assessment of the vaccine in the ongoing phase 3 efficacy study.\"\n",
    "altmab = \"In order to meet the growing needs of the European Union medicinal and aromatic plants, Hungary is still one of the major exporters today, although earlier, until the 1980s, we were considered a great herb-growing nation. Therefore, the development of the national medicinal and aromatic herb growing sector is an essential requirement for maintaining and developing our market position. The natural conditions of Hungary favor the cultivation of medicinal and aromatic plants. There are more than 330 herbs in our country. About seventy percent of the drugs grown and harvested are exported. However, significant changes are needed in domestic sales and further processing in order to become a leading industrial sector. Hungary also possesses modern separation techniques and large instruments for analysis, which allow the proper analytical examination of drugs and the precise determination of their active substances. Our universities and research institutes are also prepared to study the active ingredients of herbs by molecular biological methods, which may allow the exact mechanism of action of bioactive substances to be determined and the herbs to be reassessed. Our accession to the European Union the palette of products made from former herbs has significantly changed. From 2013, the category of medicinal product was discontinued and the preparations were classified as either food or medicine. However, there are significant costs associated with qualifying as a drug, so drugs or extracts are largely added to dietary supplements. As a result, the strange situation is that dietary supplements are prohibited from making any health claims, even though the dietary supplement is actually not for the benefit of a healthy population, but for those who have a health problem or do not have suitable foods, which are rich in bioactive substances. The justification of phytotherapy must be demonstrated, depending on the state of the art. In the context of safe therapy, studies must follow the requirements of medicines and only then can they become herbal medicines. There is still much to be desired in this area in our country. Classification as a drug is based on expensive animal tests and clinical studies. A new problem arises here, as herbal cure is currently part of the arsenal of complementary medicine. With few exceptions, clinical doctors do not use herbal therapies. Patients usually ask the advice of pharmacists, naturalists, and more rarely, dietitians. At the Arteriosclerosis Research Group, at the II. Department of Medicine and Institute of Pharmacognosy several decades of biomedical research have served and serve the purpose of evaluating and reassessing the effects of plants used in folk medicine. Over the years, we have been searching for drugs, extracts, and medicines of natural origin that are useful in liver and intestinal diseases known in folk medicine, and are believed to have lipid lowering, antioxidant and immune stimulating effects. In the article, animal and human studies will be also presented.\"\n",
    "altmab2 = \"This research was done to explore the role of fresh garlic homogenate (GH) on attenuation of myocardial damage when administered concurrently with atenolol (ATN) in experimental animals. At the end of treatment of male albino rats, hearts were excised from anesthetized animals and mounted on modified Langendorff setup. After initial perfusion with physiological solution, hearts were subjected to 15 min global no flow ischemia reperfusion injury (IRI) and perfused again. Significant recovery in developed tension and heart rate was exhibited by hearts of animals pretreated with ATN, GH-125 and GH-250. There was significant elevation of LDH and CK-MB in heart tissue homogenate and fall in perfusate of treated groups (ATN, GH-125 and GH-250). Additionally, simultaneous administration of GH-250 with ATN resulted in significant increase in endogenous antioxidant enzymes (SOD and catalase) activities. The augmented antioxidant activities could be due to the possible synergistic potential of ATN in GH mediated scavenging of oxidative free radicals produced during IRI. On the contrary, high dose of GH (500 mg/kg) failed to demonstrate similar potential even in presence of ATN. Hence, only moderate intake of garlic is good for cardioprotection when administered prophylactically and addition of ATN produces synergistic effect.\"\n",
    "altmab3 = \"NMR proton relaxation is sensitive to the dynamics of the water molecule H2O, through the interaction of the spin of the proton (1H) with external magnetic and electromagnetic fields. We measured dilution and potentization processes through measurements of 1H spin-lattice T1 and spin–spin T2 relaxation times. In order to interpret the recorded fluctuations in T1- or T2-values, experimental data were linearized by investigating how the area under a fluctuating time = f(dilution) curve (dilution integral or DI) changes with dilution. Two kinds of fitting procedures were considered: chi-square fitting with a goodness-of-fit probability, and least absolute deviations criterion with Pearson's linear correlation coefficient. We showed that fluctuations are not attributable to random noise and/or experimental errors, evidencing a memory effect quantifiable by the slope of the DI = f(dilution) straight line. For all experiments, correlation coefficients were found to lie above 0.9999, against 0.999 for random noise. The discrimination between experimental slopes and slopes associated with random noise data was very good at a five-sigma level of confidence (i.e. probability 3 × 10−7). Discrimination between experimental slopes at a five-sigma level was possible in most cases, with three exceptions: gelsemium aqua pura v gelsemium dilution (four-sigma); copper aqua pura v gelsemium aqua pura (four-sigma) and copper simple dilution v gelsemium simple dilution (three-sigma). All potentized samples show very good discrimination (at least nine-sigma level) against aqua pura, lactose or simple dilution. It was possible to transform the associated relaxation times into a molecular rotational correlation time τc and an average spin–spin distance d. Our experiments thus point to a considerable slowing down of molecular movements (τc > 1300 ps or T = 224–225 K) around water molecules up to a distance of 3.7 Å, values. It was also possible to rule out other possible mechanisms of relaxation (diffusive motion, 17O-1H relaxation or coupling with the electronic spin, S = 1, of dissolved dioxygen molecules). There is clear evidence that homeopathic solutions cannot be considered as pure water as commonly assumed. Instead, we have evidenced a clear memory effect upon dilution/potentization of a substance (water, lactose, copper, gelsemium) reflected by different rotational correlation times and average H⋯H distances. A possible explanation for such a memory effect may lie in the formation of mesoscopic water structures around nanoparticles and/or nanobubbles mediated by zero-point fluctuations of the vacuum electromagnetic field as suggested by quantum field theories. The existence of an Avogadro's ‘wall’ for homeopathically-prepared medicines is not supported by our data. Rather it appears that all dilutions have a specific material configuration determined by the potentized substance, also by the chemical nature of the containers, and dissolved gases and the electromagnetic environment. This sensitivity of homeopathically-prepared medicines to electromagnetic fields may be amplified by the highly non-linear processing routinely applied in the preparation of homeopathic medicines. Future work is needed in such directions. The time is now ripe for a demystification of the preparation of homeopathic remedies.\"\n",
    "altmab4 = \"This article describes the implementation of a group medical visit (GMV) model to increase access to integrative oncology (IO) care. The most challenging and critical time to access high-quality IO care is while patients are receiving conventional cancer therapy. Often demand for individual IO clinic consultations precludes this from occurring. A three-session GMV program was designed to alleviate barriers to receiving integrative care during active cancer treatment. Design: A consolidated framework was used for implementation research and focused ethnography methods to describe the IO GMV implementation process. Data sources included patient evaluations, participant observation, and brief provider and patient interviews. Setting: A pilot program was created to assess the feasibility and acceptability of implementing IO GMVs at a comprehensive cancer center. Intervention: Each three-session GMV consisted of a didactic session, followed by individual visits with the integrative oncologist. Results: The setting, intervention, and implementation process of the IO GMV program were described. Thirty-two patients participated in the first five cohorts of the program. Twenty-two were women; 24 were White. The median age of participants was 52. Patient evaluations demonstrate high levels of satisfaction with the program with all scored aspects rated >4.0 on a five-point Likert scale. For the medical center, group visits are a financially viable alternative to individual IO visits; revenue from group visits exceeded the revenue potential of 6 h of individual visits by an average of 38%. Conclusion: GMVs are a feasible and promising model for increasing access to IO. Patients in active cancer treatment were able to participate in the program. Future research and implementation efforts could examine health outcomes over time after participation in GMVs, as well as the feasibility of using this model with more diverse patient populations.\" \n",
    "altmab5 = \"As rates of opiate misuse rise in the United States, so do significant associated health and financial consequences to afflicted individuals, their families, and society at large. Methadone maintenance therapy (MMT) is one evidence-based approach to treating opiate addiction, yet supplemental psychosocial treatment to support this approach is lacking. Mindfulness-based relapse prevention (MBRP) has shown to be efficacious in various substance use populations, but has yet to be assessed with MMT clients. Design: The current mixed methods study was designed to inform protocol adaptation for MMT clients and to evaluate the feasibility, acceptability, and preliminary efficacy of MBRP for this population. Subjects: The sample consisted of adults (N = 15) recruited from a methadone clinic to participate in a 6-week MBRP course. Outcome measures: Data from focus groups and course satisfaction surveys supported feasibility and acceptability of the intervention. Self-report outcome measures included depression, anxiety, craving, symptoms of post-traumatic stress, and experiential avoidance, and were assessed at baseline and postcourse. Results: Mean scores on all primary outcomes changed in the expected direction at postcourse, and baseline to postcourse changes in depression, craving, and trauma symptoms reached statistical significance. Conclusions: Results from this initial pilot trial support feasibility and acceptability, and provide preliminary data on outcomes for future trials of mindfulness-based approaches within the MMT community.\"\n",
    "\n",
    "abs_words = word_bagger.transform([medab, medab2, medab3, medab4, medab5, altmab, altmab2, altmab3, altmab4, altmab5])\n",
    "\n",
    "print(\"Predictions of 5 medical and 5 alternative medical abstracts, respectively are {}\".format(trainedsvmab.predict(abs_words)))\n",
    "print(\"--- %s seconds ---\" % (time.time() - start_time))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fitting Data to Artificial Neural Networks (ANN)\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# ANN Fit to Titles"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Training...\n",
      "Train on 2124 samples, validate on 236 samples\n",
      "Epoch 1/35\n",
      " - 2s - loss: 0.4832 - accuracy: 0.8187 - val_loss: 0.6615 - val_accuracy: 0.6780\n",
      "Epoch 2/35\n",
      " - 1s - loss: 0.3403 - accuracy: 0.9845 - val_loss: 0.6720 - val_accuracy: 0.4703\n",
      "Epoch 3/35\n",
      " - 1s - loss: 0.3093 - accuracy: 0.9986 - val_loss: 0.6849 - val_accuracy: 0.4661\n",
      "Epoch 4/35\n",
      " - 1s - loss: 0.2994 - accuracy: 1.0000 - val_loss: 0.6810 - val_accuracy: 0.4703\n",
      "Epoch 5/35\n",
      " - 2s - loss: 0.2889 - accuracy: 0.9995 - val_loss: 0.6828 - val_accuracy: 0.4703\n",
      "Epoch 6/35\n",
      " - 2s - loss: 0.2779 - accuracy: 1.0000 - val_loss: 0.6739 - val_accuracy: 0.4788\n",
      "Epoch 7/35\n",
      " - 1s - loss: 0.2698 - accuracy: 1.0000 - val_loss: 0.6620 - val_accuracy: 0.5000\n",
      "Epoch 8/35\n",
      " - 1s - loss: 0.2610 - accuracy: 1.0000 - val_loss: 0.6391 - val_accuracy: 0.5466\n",
      "Epoch 9/35\n",
      " - 1s - loss: 0.2507 - accuracy: 1.0000 - val_loss: 0.6203 - val_accuracy: 0.5847\n",
      "Epoch 10/35\n",
      " - 1s - loss: 0.2452 - accuracy: 0.9995 - val_loss: 0.5694 - val_accuracy: 0.6610\n",
      "Epoch 11/35\n",
      " - 1s - loss: 0.2352 - accuracy: 1.0000 - val_loss: 0.5550 - val_accuracy: 0.6695\n",
      "Epoch 12/35\n",
      " - 1s - loss: 0.2289 - accuracy: 1.0000 - val_loss: 0.5454 - val_accuracy: 0.6907\n",
      "Epoch 13/35\n",
      " - 1s - loss: 0.2227 - accuracy: 1.0000 - val_loss: 0.5263 - val_accuracy: 0.6864\n",
      "Epoch 14/35\n",
      " - 2s - loss: 0.2134 - accuracy: 1.0000 - val_loss: 0.4901 - val_accuracy: 0.7712\n",
      "Epoch 15/35\n",
      " - 1s - loss: 0.2082 - accuracy: 1.0000 - val_loss: 0.4602 - val_accuracy: 0.8051\n",
      "Epoch 16/35\n",
      " - 1s - loss: 0.2030 - accuracy: 1.0000 - val_loss: 0.4487 - val_accuracy: 0.7966\n",
      "Epoch 17/35\n",
      " - 2s - loss: 0.1946 - accuracy: 1.0000 - val_loss: 0.4220 - val_accuracy: 0.8390\n",
      "Epoch 18/35\n",
      " - 1s - loss: 0.1896 - accuracy: 1.0000 - val_loss: 0.4087 - val_accuracy: 0.8390\n",
      "Epoch 19/35\n",
      " - 2s - loss: 0.1819 - accuracy: 1.0000 - val_loss: 0.4027 - val_accuracy: 0.8517\n",
      "Epoch 20/35\n",
      " - 2s - loss: 0.1758 - accuracy: 1.0000 - val_loss: 0.3882 - val_accuracy: 0.8602\n",
      "Epoch 21/35\n",
      " - 1s - loss: 0.1727 - accuracy: 1.0000 - val_loss: 0.3761 - val_accuracy: 0.8602\n",
      "Epoch 22/35\n",
      " - 2s - loss: 0.1646 - accuracy: 1.0000 - val_loss: 0.3753 - val_accuracy: 0.8644\n",
      "Epoch 23/35\n",
      " - 1s - loss: 0.1602 - accuracy: 1.0000 - val_loss: 0.3650 - val_accuracy: 0.8602\n",
      "Epoch 24/35\n",
      " - 1s - loss: 0.1556 - accuracy: 1.0000 - val_loss: 0.3736 - val_accuracy: 0.8559\n",
      "Epoch 25/35\n",
      " - 2s - loss: 0.1495 - accuracy: 1.0000 - val_loss: 0.3654 - val_accuracy: 0.8602\n",
      "Epoch 26/35\n",
      " - 2s - loss: 0.1452 - accuracy: 1.0000 - val_loss: 0.3672 - val_accuracy: 0.8475\n",
      "Epoch 27/35\n",
      " - 2s - loss: 0.1389 - accuracy: 1.0000 - val_loss: 0.3590 - val_accuracy: 0.8644\n",
      "Epoch 28/35\n",
      " - 2s - loss: 0.1358 - accuracy: 1.0000 - val_loss: 0.3583 - val_accuracy: 0.8559\n",
      "Epoch 29/35\n",
      " - 2s - loss: 0.1307 - accuracy: 1.0000 - val_loss: 0.3632 - val_accuracy: 0.8602\n",
      "Epoch 30/35\n",
      " - 1s - loss: 0.1266 - accuracy: 1.0000 - val_loss: 0.3553 - val_accuracy: 0.8644\n",
      "Epoch 31/35\n",
      " - 1s - loss: 0.1220 - accuracy: 1.0000 - val_loss: 0.3533 - val_accuracy: 0.8686\n",
      "Epoch 32/35\n",
      " - 2s - loss: 0.1180 - accuracy: 1.0000 - val_loss: 0.3508 - val_accuracy: 0.8686\n",
      "Epoch 33/35\n",
      " - 1s - loss: 0.1143 - accuracy: 1.0000 - val_loss: 0.3513 - val_accuracy: 0.8602\n",
      "Epoch 34/35\n",
      " - 1s - loss: 0.1095 - accuracy: 1.0000 - val_loss: 0.3473 - val_accuracy: 0.8686\n",
      "Epoch 35/35\n",
      " - 1s - loss: 0.1082 - accuracy: 1.0000 - val_loss: 0.3608 - val_accuracy: 0.8432\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYIAAAEWCAYAAABrDZDcAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAgAElEQVR4nO3deXxcdb3/8dcnS5MuabqkCzQtLaVAC5VSCsgiCAICVywKCCiXRbgVBUURvUURUURxvT8VHnrBWwTkgrUIlFIsiyxyEWjBQndauhHolm5p06ZZ5vP745y00zTLJM3kzMx5Px+PeWTmnDNnPnMo5zPf3dwdERGJr7yoAxARkWgpEYiIxJwSgYhIzCkRiIjEnBKBiEjMKRGIiMScEoHEgpkNNzM3s4IUjr3SzF7pirhEMoESgWQcM1tpZrVmVtZk+9zwZj48mshEcpMSgWSqFcCljS/MbCzQPbpwMkMqJRqR9lIikEz1IHB50usrgAeSDzCzUjN7wMw2mNkqM7vFzPLCfflm9gszqzSz5cC/NfPe/zGzNWb2gZn9yMzyUwnMzP5iZmvNbKuZvWxmRyTt625mvwzj2Wpmr5hZ93DfyWb2qpltMbP3zezKcPuLZnZN0jn2qpoKS0HXmdlSYGm47dfhOarM7E0z+1jS8flm9h0ze8/MtoX7h5rZ3Wb2yybf5Ukz+3oq31tylxKBZKrXgN5mNjq8QV8M/KnJMb8FSoGDgVMJEsdV4b7/AD4FHA1MAC5s8t77gXrgkPCYs4BrSM3TwChgIPAW8FDSvl8AxwAnAv2AbwMJMxsWvu+3wABgHDA3xc8DOB84HhgTvp4dnqMf8L/AX8ysONx3I0Fp6lygN/BFYEf4nS9NSpZlwCeAh9sRh+Qid9dDj4x6ACuBM4BbgJ8AZwPPAgWAA8OBfGAXMCbpfV8CXgyf/x24NmnfWeF7C4BB4Xu7J+2/FHghfH4l8EqKsfYJz1tK8MNqJ3BUM8fdDDzWwjleBK5Jer3X54fnP72NODY3fi6wBJjYwnGLgDPD59cDM6P+761H9A/VN0omexB4GRhBk2ohoAzoBqxK2rYKGBI+PxB4v8m+RgcBhcAaM2vcltfk+GaFpZM7gIsIftknkuIpAoqB95p569AWtqdqr9jM7JsEJZgDCRJF7zCGtj7rfuAygsR6GfDr/YhJcoSqhiRjufsqgkbjc4G/NtldCdQR3NQbDQM+CJ+vIbghJu9r9D5BiaDM3fuEj97ufgRt+zwwkaDEUkpQOgGwMKYaYGQz73u/he0A1UCPpNeDmzlm9zTBYXvAfwKfA/q6ex9gaxhDW5/1J2CimR0FjAYeb+E4iRElAsl0VxNUi1Qnb3T3BmAqcIeZlZjZQQR1443tCFOBr5lZuZn1BSYnvXcN8AzwSzPrbWZ5ZjbSzE5NIZ4SgiSykeDm/eOk8yaAKcCvzOzAsNH2BDMrImhHOMPMPmdmBWbW38zGhW+dC3zWzHqY2SHhd24rhnpgA1BgZrcSlAga/QG43cxGWeAjZtY/jLGCoH3hQeBRd9+ZwneWHKdEIBnN3d9z9zkt7P4qwa/p5cArBI2mU8J99wKzgLcJGnSbliguJ6haWkhQvz4NOCCFkB4gqGb6IHzva0323wTMI7jZbgJ+CuS5+2qCks03w+1zgaPC9/wXUAusI6i6eYjWzSJoeH43jKWGvauOfkWQCJ8BqoD/Ye+ut/cDYwmSgQjmroVpROLEzE4hKDkND0sxEnMqEYjEiJkVAjcAf1ASkEZKBCIxYWajgS0EVWD/L+JwJIOoakhEJOZUIhARibmsG1BWVlbmw4cPjzoMEZGs8uabb1a6+4Dm9mVdIhg+fDhz5rTUm1BERJpjZqta2qeqIRGRmFMiEBGJOSUCEZGYy7o2gubU1dVRUVFBTU1N1KF0meLiYsrLyyksLIw6FBHJcjmRCCoqKigpKWH48OEkTSucs9ydjRs3UlFRwYgRI6IOR0SyXNqqhsxsipmtN7P5Lew3M/uNmS0zs3fMbHxHP6umpob+/fvHIgkAmBn9+/ePVQlIRNInnW0EfyRYWaol5xAs9zcKmAT8bn8+LC5JoFHcvq+IpE/aqobc/WUzG97KIROBBzyY4+I1M+tjZgeEc8VnNHenwZ1EwmlIQMKdhkTyNidBsEqIGRgW/t37dXCuYMURdw//ghNsbHzdkqqddfzqmSWd9r3MjMJ8oyA/j4I8ozA/j4J8ozAv+FuQn4e7U9/g1CcS1DU49Q0J6hO++3ldwlsPWkQ67BOjB3HU0D6dft4o2wiGsPcc6hXhtn0SgZlNIig1MGzYsKa7u8yuugbWbK2hqqZur+1bNm9i0iUTAajcsJ68vHz69e8PwENPPk9ht25tnvt7N17H1dd9neEjR6Ucz7aaen77QpurK6ass+7fKqyIpMfA3sU5lwiau100eyty93uAewAmTJjQ5T83GxLO+m01VG6vxYABvYooyM8jP8/INxhR1pO3/vUv8s340e0/pHdJL2666SYalx13gpJCwh2zPBzffdNtLCVMe/jB4ILsU4Jo+a66aFt3Vvzk3zrteyYSTn2iuV/7id2lANhTaijMC0sPyaWGPFO1lUiWiTIRVLD3mrLlwIcRxdIsd2fLjjrWVtVQ15Cgb49uDC4tpjC/5aaV/PBGaGa8t2wZ559/PieffDKvv/46M2bM4Ac/+AFvvfUWO3fu5OKLL+bWW28F4OSTT+auu+7iyCOPpH9ZGddeey1PP/00PXr04IknnmDgwIFp/755eUa3PKObhpeIxEqUiWA6cL2ZPQIcD2ztjPaBHzy5gIUfVu13cAl3dtUnSCScQweV8KPzj6RHUfsv18KFC7nvvvv4/e9/D8Cdd95Jv379qK+v57TTTuPCCy9kzJgxe71n69atnHrqqdx5553ceOONTJkyhcmTJzd3ehGR/ZbO7qMPA/8EDjOzCjO72syuNbNrw0NmEqw1u4xgfdmvpCuW9nBgV32CnbUNuENRYT6l3Qs7lAQARo4cybHHHrv79cMPP8z48eMZP348ixYtYuHChfu8p3v37pxzzjkAHHPMMaxcubJDny0ikop09hq6tI39DlzX2Z/7/fOO6PB7q3fVs7KymoRDWUk3BpYUkZ+3f7myZ8+eu58vXbqUX//617zxxhv06dOHyy67rNmxAN2SGpfz8/Opr6/frxhERFqjyuAkW3bUAjBqUC8OKO2+30mgqaqqKkpKSujduzdr1qxh1qxZnXp+EZGOyIkpJjrLrvoERYX5FBfmp+X848ePZ8yYMRx55JEcfPDBnHTSSWn5HBGR9si6NYsnTJjgTRemWbRoEaNHj97vcy9eU0XPogKG9uux3+fqCp31vUUk95nZm+4+obl9qhoKJRJObUOCbgW6JCISL7rrhWobEgAUKRGISMzorhfaVd8AoBKBiMSO7nqhXfUqEYhIPOmuF6qtS1CQl9fpXUZFRDKd7nqhXfUJlQZEJJZ05wvtauh4Iti4cSPjxo1j3LhxDB48mCFDhux+XVtbm/J5pkyZwtq1azsUg4hIR2lAGcE00/UNCboVdiwR9O/fn7lz5wJw22230atXMA11e02ZMoXx48czePDgDsUhItIRSgRAbdhjqKiV6aU76v777+fuu++mtraWE088kbvuuotEIsFVV13F3LlzcXcmTZrEoEGDmDt3LhdffDHdu3fnjTfe2GvOIRGRdMm9RPD0ZFg7r11vKUwkOLguQfdu+c0vrzV4LJxzZ7tDmT9/Po899hivvvoqBQUFTJo0iUceeYSRI0dSWVnJvHlBnFu2bKFPnz789re/5a677mLcuHHt/iwRkY7KvUTQAYlwlo28Tl5Y67nnnmP27NlMmBCM6t65cydDhw7lk5/8JEuWLOGGG27g3HPP5ayzzurcDxYRaYfcSwQd+OW+btMOtu+qZ/QBvTs1FHfni1/8Irfffvs++9555x2efvppfvOb3/Doo49yzz33dOpni4ikSr2GSF/X0TPOOIOpU6dSWVkJBL2LVq9ezYYNG3B3Lrroot1LVwKUlJSwbdu2To9DRKQ1uVci6IDa+gZ6dy/s9POOHTuW73//+5xxxhkkEgkKCwv5/e9/T35+PldffTXujpnx05/+FICrrrqKa665Ro3FItKlYj8NdX1DgoVrqjigtDsDSoo6I8Quo2moRSRVmoa6FbWaY0hEYi72d7/GyeY066iIxFXO3P06WsW1qz6BkX2JINuq9EQkc2XX3a8FxcXFbNy4sUM3x9r6BIUFeeQ1N5AsQ7k7GzdupLi4OOpQRCQH5ESvofLycioqKtiwYUO737u+qoa8PMM3Z1dDcXFxMeXl5VGHISI5ICcSQWFhISNGjGj3+9ydi257hguPKee2T6v3jYjEU05UDXVU5fZatu+qZ3j/HlGHIiISmVgnghWV1QAML+sZcSQiItGJdSJYGSaCg8t6RRyJiEh0Yp0IVmyspjDfOLCPet+ISHylNRGY2dlmtsTMlpnZ5Gb2H2Rmz5vZO2b2opl1aTeYFRuqGdqvBwVpWJBGRCRbpO0OaGb5wN3AOcAY4FIzG9PksF8AD7j7R4AfAj9JVzzNWbmxmoPVPiAiMZfOn8LHAcvcfbm71wKPABObHDMGeD58/kIz+9MmkXBWbqxmeH8lAhGJt3QmgiHA+0mvK8Jtyd4GLgiffwYoMbP+TU9kZpPMbI6ZzenIoLHmrK2qoaYuoR5DIhJ76UwEzc3Z0HQOiJuAU83sX8CpwAdA/T5vcr/H3Se4+4QBAwZ0SnB7egwpEYhIvKVzZHEFMDTpdTnwYfIB7v4h8FkAM+sFXODuW9MY027LNYZARARIb4lgNjDKzEaYWTfgEmB68gFmVmZmjTHcDExJYzx7WVlZTVFBHoN7q+uoiMRb2hKBu9cD1wOzgEXAVHdfYGY/NLNPh4d9HFhiZu8Cg4A70hVPUys3VjOirCd5edkz66iISDqkddI5d58JzGyy7dak59OAaemMoSXLK6s5dGBJFB8tIpJRYjmSqr4hwfubdqh9QESEmCaCD7fUUNfg6jEkIkJME8Hyyu2AegyJiEBME8HK3V1HtQ6BiEg8E8HGHfQqKmBAr+xanlJEJB1yYqnK9lpeWc3wsh5YFi1YLyJplEjA1tWwfhGsWwDrF8L6xVC7re33HnAUjL0IRp0Fhd3b97mVS2HeNHj3aTjuS3D0FzoW/36KZSJYWVnNUUP7RB2GSHrU74LKd2HHRig7FEoOgGz40bNtLezYBANHpzfeHZv23Ox33/QXQe32PceUDgvi6NGv9XM11MGKl2HRk9CtBEafB2MvhBGnQn4Lt9eqD2H+o0ECWDMXMOh9IDxxHRQUBe/vYrFLBLX1CSo27+D8cQdGHYrI/mn8FbtuIaxfEP5dCBuXQSJpyq7iPjDoCBg4BgaNgYFHwMDDobg0utiTucNbD8Dfboa66iB5jb0IjrwA+o/s+HnrdsKGxXv/yl+3ELav3XNM977B9Rj3+eD6DBwTJIDi3ql/TkM9rHwZ5j0Ki6bD2/8LPQfAEZ8Jvkf5sbBzMyx8IkgAK18BHA48Gj754+C44j7w0IXw10lQ2AMOP7fj37sDzL3pPHCZbcKECT5nzpwOv3/Z+u2c8auX+NXnjuKz47t0HRyR1m1euedGkWho/dja7bBhyd6/YvsMC25qg8IbWs8y2PBukCTWLwpugslVHaVD904Og8ZA/1FQ0K31z3YPftUm/6IuKIaTvw79Dm7fd66uhOlfhSUzg1/Ro8+DBY/DqleC/QeOD5PCZ6FkcPPnSDQE167pr/xNy8ETwTEFxTDgsKTrMzp4XjK4c0sfdTWw9BmYPw2W/A0adkHJgVC9ARJ10P+Q8PtcCGWH7P3emip4YCKsmw+fnwojT+u8uAAze9PdJzS7L26J4LmF67jmgTk89pUTOXpY306MTKQDtq8Pbnzz/gIVbwTbBo2Fbm10bS4oggGH7/0Lv6iNkfLusPX9fUsQle/uKUHkFQS/yAeODpPEEUHJofHX9PrwUZM0N2TvIUF1S6IOjv53OPXbQVVHW96dBU9cH5zrjO/D8V+GvLD/ytYKmP/X4LqsfQcsD4Z/LKg2KS3fO5b1i6F+Z3hSg34j9sTe+LffwZCX33ZMnalmKyx+Knj0HR4kgAOOaj3x7NgEf/wUbF4Bl/0VDjqh08JRIkhy78vLuWPmIubeeiZ9erTxy0ckHWqqYPGM4Ca3/CXwBhh0ZFAVcuQF0Pegro2nvhY2Lt23CmXr6r2PK+qdVIJovNGODqpXtq2Fl38Bb/4xuOEe9x9w8o3N17HXVsMzt8CcKUESu+De4Fwt2fBu8At73l+CX/mNeg7cuzQzcEzwq7+tJJrptq+H+84J/l4xPahC6gRKBEm+89g8Zs5bw9xbz+rEqERSUDEHXv3NniqDPsP2VBMMarqKawaoqQqSw66qoPRRWt52NcrmlfDinfD2I0EJ5cSvwke/vKe08sGbQT34xvfgxOvh9O8FpZtUuAeNqzVVQeLoWbZfXy+jba2AKecEVX9XzQwS7n5SIkjy+XtfY2ddA4995aROjEqkFesWwt9/BEuegu79gpv/2IugfEJ29ObpiPWLgu+8eAb06A8f+2ZQEnjpp9BrMHzmdzDilKijzGwb34P7zgUcrnp6/xrOaT0RxK7X0IrKak44eJ/VMEU636YV8OJP4J2pwS/i026Bj17bdl1+Lhg4Gi55CCrehOd/ALO+E2wfexGc+wvoru7bbeo/Ei5/IqgmemBikAz6DG37fR0Qq0Sws7aBNVtrNMeQpNe2tfDyz+HN+4P68hO/Cid/o+0+6bmo/JignnvFP4ISwWFnRx1Rdhl4OPz7Y3D/eXuSQcmgTv+YWCWCVZuCOYZGKBFIOuzYBP/3a3j9v4MeNOMvh1O+Db0PiDqy6I34WNQRZK8Dx8EXpsGD58PCx+H4L3X6R8QqEazYoEQgHVC5DP5yZTBStzU7N0N9TVD9cdrN7e9TL9KSYcfDV15LW4+yeCWCjVqwXjpg1s2wZRWMmdj6cYXd4ZgrW+8KKdJRaexWHKtEsLKymgElRfQqitXXlv2x9LlgpOhZdwTdHUVyUKymoV5RWc2I/ioNSIoa6oPeLv0OhuMmRR2NSNrELBHs0GI0kro374PKJUFpoK35d0SyWGwSwbaaOiq372JEWa+oQ5FssGMTvHBHMBHaYedEHY1IWsUmEays3AHACJUIJBUv/SyYNOyTP87d0b8iodgkAvUYkpRteBdm3wvjr4DBR0YdjUjaxScRhGMIhquxWNryzC3B4iCnfTfqSES6RGz6UX7ltJF85ughFBd28Zzkkl2WPQdLZ8GZt0OvAVFHI9IlYlMiKMzPY1h/tQ9IKxrqYdZ3oe+ItAzjF8lUsSkRiLTpzfuCNW4vfij1OfJFckBaSwRmdraZLTGzZWY2uZn9w8zsBTP7l5m9Y2Zdu2Kz5Db3YP3fbevaPnbnZnjhx8FyiIf/W/pjE8kgaSsRmFk+cDdwJlABzDaz6e6+MOmwW4Cp7v47MxsDzASGpysmiZm3H4bHvxysdzvi1GAyuNGfCtbgbeqlnwfJ4OyfqLuoxE46SwTHAcvcfbm71wKPAE1n7XKgd/i8FPgwjfFInGx8D2Z+C4adEKyOtXkFPPEV+Pko+PNlsPAJqAsXPK9cBm/8dzBt9OCx0cYtEoF0thEMAd5Pel0BHN/kmNuAZ8zsq0BP4IzmTmRmk4BJAMOGDev0QCXHNNQF6+Lm5cMFfwjW2j3tu8F6ufOmwfxHYdGT0K0ERp8HW1ZDQXc4/ZaoIxeJRDpLBM2Vr5sukHwp8Ed3LwfOBR40s31icvd73H2Cu08YMEBd+qQNL/0UPpgDn/p/QRKAoLqnfAKccyd8czH8++NwxERY/BSsegVOuQl6DYw2bpGIpLNEUAEkL7BZzr5VP1cDZwO4+z/NrBgoA9anMS7JZatehX/8EsZ9AY78bPPH5OXDyNOCx7m/hLXvwJBm1/QWiYV0lghmA6PMbISZdQMuAaY3OWY18AkAMxsNFAMb0hiT5LKdW4IqoT4HwTk/Te09hcUw9DjIi82QGpF9pK1E4O71ZnY9MAvIB6a4+wIz+yEwx92nA98E7jWzbxBUG13p7k2rj0Ta5g5P3QhVH8LVz0BRSdQRiWSNNhNBeDN/yN03t/fk7j6ToEto8rZbk54vBE5q73lF9vHOn4NG4NNvCdoCRCRlqZSHBxOMAZgaDhBTJ2vJLJtWwFM3wbAT4eQbo45GJOu0mQjc/RZgFPA/wJXAUjP7sZmNTHNsIm1rqA/aBSwPPntP0BAsIu2SUgtZWG+/NnzUA32BaWb2szTGJtK2l38OFW/Aef8FfYa2fbyI7COVNoKvAVcAlcAfgG+5e13Y338p8O30hijSgtWvwcs/g6MuhSMviDoakayVSq+hMuCz7r4qeaO7J8zsU+kJS6QN9bvgr/8BfYbBuT+POhqRrJZK1dBMYFPjCzMrMbPjAdx9UboCE2nVqv8LpoY46w51FRXZT6kkgt8B25NeV4fbRKKz9FnIL4KRp0cdiUjWSyURWPIgL3dPoAVtJGpLn4XhJ0E3rTonsr9SSQTLzexrZlYYPm4Alqc7MJEWbV4JG5fCIWdGHYlITkglEVwLnAh8wJ6ppCelMyiRVi19Nvg7SolApDO0WcXj7usJJowTyQzLngsmlut/SNSRiOSEVMYRFBNMF30EweygALj7F9MYl0jz6mpgxcsw7vNaUlKkk6RSNfQgwXxDnwReIlhXYFs6gxJp0epXoW4HjDor6khEckYqieAQd/8eUO3u9wP/BmhhV4nG0ueCbqPDPxZ1JCI5I5VEUBf+3WJmRxIsMj88bRGJtGaZuo2KdLZUEsE9ZtYXuIVghbGFQIrLP4l0os2roPJddRsV6WStNhaHE8tVhYvSvAwc3CVRiTRnmbqNiqRDqyWCcBTx9V0Ui0jrlqrbqEg6pFI19KyZ3WRmQ82sX+Mj7ZGJJKvfFXQbHXWmuo2KdLJU5gxqHC9wXdI2R9VE0pVWvQp11WofEEmDVEYWj+iKQERatew5yO8GI9RtVKSzpTKy+PLmtrv7A50fjkgLlj4LB50E3XpGHYlIzkmlaujYpOfFwCeAtwAlAukaW1ZD5RI45oqoIxHJSalUDX01+bWZlRJMOyHSNRpnG1X7gEhapNJrqKkdwKjODkSkRcueC9YmLtM/O5F0SKWN4EmCXkIQJI4xwNR0BiWyW/0uWP4SHHWJuo2KpEkqbQS/SHpeD6xy94o0xSOyt9X/DLqNajSxSNqkkghWA2vcvQbAzLqb2XB3X5nWyEQgXKS+G4w4JepIRHJWKm0EfwESSa8bwm1tMrOzzWyJmS0zs8nN7P8vM5sbPt41sy2phS2xsew5OOhEdRsVSaNUSgQF7l7b+MLda82sW1tvMrN84G7gTIK1jmeb2XR3X5h0rm8kHf9V4Oj2BC85bsv7sGExHP3vUUciktNSKRFsMLNPN74ws4lAZQrvOw5Y5u7Lw0TyCDCxleMvBR5O4bwSF5ptVKRLpFIiuBZ4yMzuCl9XAM2ONm5iCPB+0usK4PjmDjSzg4ARwN9b2D8JmAQwbNiwFD5acsLS56B0GJQdGnUkIjktlQFl7wEfNbNegLl7qusVN9fXz5vZBnAJMM3dG1qI4R7gHoAJEya0dA7JJfW1sOIl+Mjn1G1UJM3arBoysx+bWR933+7u28ysr5n9KIVzVwBDk16XAx+2cOwlqFpIkq3+J9Ru12hikS6QStXQOe7+ncYX7r7ZzM4lWLqyNbOBUWY2AviA4Gb/+aYHmdlhQF/gnylHLdlr7TyY9sVgoNigI2DgGBg0Jvjb/xDILwyOW6ZuoyJdJZVEkG9mRe6+C4JxBEBRW29y93ozux6YBeQDU9x9gZn9EJjj7tPDQy8FHnF3Vfnkuvf+Dn++HIpKYNjxsG4hvDsLGmsE87sF7QEDx8Cq/4NhJ0BRr2hjFomBVBLBn4Dnzey+8PVVwP2pnNzdZwIzm2y7tcnr21I5l2S5f/0JnrwByg6DL/wFSocE2+t3BQvSr1sI6xcEf1e9ClUfwCnfijZmkZhIpbH4Z2b2DnAGQQPw34CD0h2Y5Ah3ePFOeOlOOPjj8LkHoLh0z/6CIhg8Nngkq6uBwuKujFQktlKdfXQtwejiCwjWI1iUtojSZcv7sORvUUcRLw118MR1QRIY9wX4wrS9k0BrlAREukyLJQIzO5SggfdSYCPwZ4Luo6d1UWyda/6j8Nz3YfL7UNw76mhyX00VTL0clr8Ap06Gj09WN1CRDNVa1dBi4B/Aee6+DMDMvtHK8ZmttDz4W/WBEkG6VX0ID10UTA8x8W44+rKoIxKRVrRWNXQBQZXQC2Z2r5l9guYHiWWHxkSwVTNop9Xa+fCHM2DzKvj8VCUBkSzQYonA3R8DHjOznsD5wDeAQWb2O+Axd3+mi2LsHLsTwfutHyftV7MVFs2AeX8JRgP3GgRffHrfBmARyUip9BqqBh4imG+oH3ARMBnIrkTQazBYPmz9IOpIckNdDSydBfOmBWMBGnZB3+Fw8o1w7DXQ+4CoIxSRFKUyjmA3d98E/Hf4yC75BdD7QFUN7Y+Gelj5cnDzX/Qk7KqCngNhwlUw9iIYcowahEWyULsSQdYrLVci6Ch3uP88WP0qFJXC6E/D2Ath+MeCJCsiWSte/wf3HgIVs6OOIjttWBwkgY99E075tvr5i+SQVAeU5YbS8qBrYyLR9rGyt0UzAIPjJikJiOSY+CWCRB1Ur486kuyz+EkoPxZKBkcdiYh0spglgnB5BLUTtM/mVbDmbRj9qagjEZE0iFki0FiCDln8VPD3cCUCkVwU00SgEkG7LJ4RLhwzMupIRCQN4pUIikuhWy8lgvaorgyWjVRpQCRnxSsRmGksQXstmQmegNHnRR2JiKRJvBIBKBG016IZ0GeY5g0SyWFKBNKymqpgPYHDz9PUESI5LJ6JYEcl1O2MOpLMt+xZaKhVt1GRHBe/RNC7seeQZiFt06IZ0KMMhh4fdSQikkbxSwS7VypT9VCr6nfB0mfh8HMhLz/qaEQkjeKbCNRO0LrlL0HttqB9QERyWvwSQe8DAVMiaMviJ6FbCTiFh3MAAA4OSURBVBx8atSRiEiaxS8RFBQFSylqmomWJRpg8Uw49KzgeolITotfIgAoHaISQWtWvxb0rNJoYpFYiGkiKFevodYsngH5RTDqzKgjEZEuENNEMDQoEbhHHUnmcQ+6jR78cSgqiToaEekCaU0EZna2mS0xs2VmNrmFYz5nZgvNbIGZ/W8649mttBzqd8KOTV3ycVll7TuwdbUGkYnESNrWLDazfOBu4EygAphtZtPdfWHSMaOAm4GT3H2zmQ1MVzx7SV6XoGf/LvnIrLFoBlgeHHZu1JGISBdJZ4ngOGCZuy9391rgEWBik2P+A7jb3TcDuHvXrCGpsQQtWzwDhp0APcuijkREukg6E8EQILmPZkW4LdmhwKFm9n9m9pqZnd3cicxskpnNMbM5GzZs2P/IGqeZqFKD8V42vgfrF6q3kEjMpDMRNDddZdPW2QJgFPBx4FLgD2bWZ583ud/j7hPcfcKAAQP2P7KeZUGvGI0l2NuiJ4O/ah8QiZV0JoIKYGjS63Lgw2aOecLd69x9BbCEIDGklxaoad7iGXDAUcH6AyISG+lMBLOBUWY2wsy6AZcA05sc8zhwGoCZlRFUFS1PY0x7KBHsrWoNVMzW3EIiMZS2RODu9cD1wCxgETDV3ReY2Q/N7NPhYbOAjWa2EHgB+Ja7b0xXTHtpHEsggSVPBX9VLSQSO2nrPgrg7jOBmU223Zr03IEbw0fXKh0C29ZCfS0UdOvyj884Cx6HfiNhwOFRRyIiXSyeI4sh7ELqsG1N1JFEb/FTsPIfMP5yLUkpEkMxTwSoeqimCp66CQYeASdcF3U0IhKBtFYNZbTSsENT3BPB328PSkUXPwj5hVFHIyIRiG+JoHc4ti3OYwnefwPeuBeOmwTlE6KORkQiEt9E0K0HdO8X3xJBfS08eUOwYtsnvhd1NCISofhWDUHQThDXaSZe/U0wncSlj2i6aZGYi2+JAOI7lqByGbz0MxgzEQ47J+poRCRiMU8EMRxd7A4zvg4FxXDOz6KORkQygBLBriqo2Rp1JF1n7kPBmIEzfwAlg6OORkQygBIBxKdUsH0DzPpusN7A+CuijkZEMoQSAcRnIfu/TYa6HXDeryEv3v/pRWSPeN8NkpeszHVLn4X50+Bj34QBh0UdjYhkkHgngl6DIK8g96uGaqthxo1Qdhic/I2ooxGRDBPvcQR5+cGAqlxPBC/8GLauhqv+BgVFUUcjIhkm3iUCyP2xBJtXwev/DUdfBgedEHU0IpKBlAh6D4GqHE4EL/8MLA8+/p2oIxGRDKVEUFoOVR9CoiHqSDpf5TKY+zAce3WwEI+ISDOUCErLIVEP29dFHUnne/HHQZuAGohFpBVKBLm6LsHa+TD/UTj+Wug1MOpoRCSDKRHk6liCF+6AolI46WtRRyIiGU6JIBdHF1e8CUtmwolfhe59o45GRDKcEkFxbyjqnVtVQ3+/HXr0h49eG3UkIpIFlAggt6ajXvkKLH8haCDWgjMikgIlAggTQQ60EbjD87dDyQFw7DVRRyMiWUKJAHKnRLDsOXj/NTjlJijsHnU0IpIllAggSAQ7N0Htjqgj6Tj3oG2gzzA4+vKooxGRLKJEANA77DmUzQvZL3oS1rwNp06Ggm5RRyMiWUSJALJ/LEGiIRg30H8UfOTiqKMRkSyT1kRgZmeb2RIzW2Zmk5vZf6WZbTCzueEjmhbObF+yct402LAYTvsO5Md7ZnERab+03TXMLB+4GzgTqABmm9l0d1/Y5NA/u/v16YojJb0PBCw7E0FDXTCn0KCxMOb8qKMRkSyUzhLBccAyd1/u7rXAI8DENH5ex+UXBl0uszER/OtPsHklnP5drUMsIh2SzjvHECC50r0i3NbUBWb2jplNM7OhzZ3IzCaZ2Rwzm7Nhw4Z0xBpM05xtiWDhE/D0f8LQ4+HQs6OORkSyVDoTgTWzzZu8fhIY7u4fAZ4D7m/uRO5+j7tPcPcJAwYM6OQwQ9k2luCfd8PUK+CAo+CSh8Gau9wiIm1LZyKoAJJ/4ZcDHyYf4O4b3X1X+PJe4Jg0xtO6xkTgTXNVhkk0wNOTYdZ3YPSn4Irp0LN/1FGJSBZLZyKYDYwysxFm1g24BJiefICZHZD08tPAojTG07rSodCwC6orIwuhTXU7Yerl8Prv4KPXwUX3awSxiOy3tPUacvd6M7semAXkA1PcfYGZ/RCY4+7Tga+Z2aeBemATcGW64mlT8liCXmmqftof1ZXw8CVQMQfOvhM++uWoIxKRHJHWTufuPhOY2WTbrUnPbwZuTmcMKStNGl08ZHy0sTS18T340wWwbQ187gEY8+moIxKRHKLRR416Z+igsvffCEoC7nDFkzD0uKgjEpEco0TQqEc/KOieOYlgx6ZgxPCz3wvGOFz2KPQfGXVUIpKDlAgamUW/LkFtNSx5Olh0fumzkKiDYSfAxX+CnmXRxSUiOU2JIFkUYwka6uC9vwe//hc/BXXVUHIgHP8lGHtRME5AYwREJI2UCJKVlgeLvn84FwYc1v6umYkEbF0N6xbC9rWtH+sO6+bDgseDtRCK+8BHLgpu/sNO1HQRItJllAiSDR4L/3oQ7jkVLA/6jYRBY2Bg+Bh0BPQdDnn5UL0R1i8MHusWhM8XQe321D+vsAccdm5w8x95utYREJFIKBEkO25ScENuvLGvWwBr58HC6eyeHaOge7AofPX6Pe/r3hcGHgHjPr8nYZQObbtKp7hUA8JEJHJKBMnMoGxU8DgiaUrn2upgvv91YQmgpgoGHr7npt9rkOrxRSRrKRGkoltPGHJM8BARyTFqkRQRiTklAhGRmFMiEBGJOSUCEZGYUyIQEYk5JQIRkZhTIhARiTklAhGRmDPP9MXamzCzDcCqDr69DMjgRYmbpZi7RrbFnG3xgmLuKi3FfJC7N7sOb9Ylgv1hZnPcfULUcbSHYu4a2RZztsULirmrdCRmVQ2JiMScEoGISMzFLRHcE3UAHaCYu0a2xZxt8YJi7irtjjlWbQQiIrKvuJUIRESkCSUCEZGYi00iMLOzzWyJmS0zs8lRx5MKM1tpZvPMbK6ZzYk6nuaY2RQzW29m85O29TOzZ81safi3b5QxJmsh3tvM7IPwOs81s3OjjLEpMxtqZi+Y2SIzW2BmN4TbM/I6txJvxl5nMys2szfM7O0w5h+E20eY2evhNf6zmWXMwuKtxPxHM1uRdJ3HtXmuOLQRmFk+8C5wJlABzAYudfeFkQbWBjNbCUxw94wd0GJmpwDbgQfc/chw28+ATe5+Z5h0+7r7f0YZZ6MW4r0N2O7uv4gytpaY2QHAAe7+lpmVAG8C5wNXkoHXuZV4P0eGXmczM6Cnu283s0LgFeAG4Ebgr+7+iJn9Hnjb3X8XZayNWon5WmCGu09L9VxxKREcByxz9+XuXgs8AkyMOKac4O4vA5uabJ4I3B8+v5/gJpARWog3o7n7Gnd/K3y+DVgEDCFDr3Mr8WYsD2wPXxaGDwdOBxpvqBlzjaHVmNstLolgCPB+0usKMvwfZsiBZ8zsTTObFHUw7TDI3ddAcFMABkYcTyquN7N3wqqjjKhiaY6ZDQeOBl4nC65zk3ghg6+zmeWb2VxgPfAs8B6wxd3rw0My7r7RNGZ3b7zOd4TX+b/MrKit88QlEVgz27KhTuwkdx8PnANcF1ZrSOf7HTASGAesAX4ZbTjNM7NewKPA1929Kup42tJMvBl9nd29wd3HAeUEtQijmzusa6NqXdOYzexI4GbgcOBYoB/QZnVhXBJBBTA06XU58GFEsaTM3T8M/64HHiP4x5kN1oX1xI31xesjjqdV7r4u/B8qAdxLBl7nsA74UeAhd/9ruDljr3Nz8WbDdQZw9y3Ai8BHgT5mVhDuytj7RlLMZ4dVc+7uu4D7SOE6xyURzAZGhT0AugGXANMjjqlVZtYzbGjDzHoCZwHzW39XxpgOXBE+vwJ4IsJY2tR4Mw19hgy7zmGj4P8Ai9z9V0m7MvI6txRvJl9nMxtgZn3C592BMwjaNl4ALgwPy5hrDC3GvDjpx4ERtGm0eZ1j0WsIIOyq9v+AfGCKu98RcUitMrODCUoBAAXA/2ZizGb2MPBxgqlv1wHfBx4HpgLDgNXARe6eEQ20LcT7cYLqCgdWAl9qrHvPBGZ2MvAPYB6QCDd/h6DePeOucyvxXkqGXmcz+whBY3A+wQ/kqe7+w/D/w0cIqlj+BVwW/tKOXCsx/x0YQFAlPhe4NqlRuflzxSURiIhI8+JSNSQiIi1QIhARiTklAhGRmFMiEBGJOSUCEZGYUyIQacLMGpJmbpxrnThbrZkNt6SZT0UyQUHbh4jEzs5w2L5ILKhEIJIiC9aH+Gk4B/wbZnZIuP0gM3s+nOTreTMbFm4fZGaPhfPFv21mJ4anyjeze8M55J8JR4WKREaJQGRf3ZtUDV2ctK/K3Y8D7iIYqU74/AF3/wjwEPCbcPtvgJfc/ShgPLAg3D4KuNvdjwC2ABek+fuItEoji0WaMLPt7t6rme0rgdPdfXk4qdpad+9vZpUEC7HUhdvXuHuZmW0AypOnJAinZX7W3UeFr/8TKHT3H6X/m4k0TyUCkfbxFp63dExzkueqaUBtdRIxJQKR9rk46e8/w+evEsxoC/AFgiUDAZ4Hvgy7FxDp3VVBirSHfomI7Kt7uOpTo7+5e2MX0iIze53gR9Sl4bavAVPM7FvABuCqcPsNwD1mdjXBL/8vEyzIIpJR1EYgkqKwjWCCu1dGHYtIZ1LVkIhIzKlEICIScyoRiIjEnBKBiEjMKRGIiMScEoGISMwpEYiIxNz/ByYvq+RbpF/kAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[[426  34]\n",
      " [131 421]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       0.76      0.93      0.84       460\n",
      "           1       0.93      0.76      0.84       552\n",
      "\n",
      "    accuracy                           0.84      1012\n",
      "   macro avg       0.85      0.84      0.84      1012\n",
      "weighted avg       0.85      0.84      0.84      1012\n",
      "\n",
      "Predictions of 5 medical and 5 alternative medical titles, respectively are [1 1 0 1 0 0 0 0 0 0]\n",
      "--- 53.76300501823425 seconds ---\n"
     ]
    }
   ],
   "source": [
    "from keras.models import Sequential\n",
    "from keras.utils import np_utils\n",
    "from keras.layers.core import Dense, Activation, Dropout\n",
    "from keras.utils import to_categorical\n",
    "from keras.layers import Dense, Dropout, BatchNormalization, Activation\n",
    "from keras.utils.np_utils import to_categorical\n",
    "from sklearn.metrics import classification_report,confusion_matrix\n",
    "from keras import optimizers\n",
    "\n",
    "import time\n",
    "start_time = time.time()\n",
    "\n",
    "\n",
    "def neuralnets(): \n",
    "    \n",
    "    X_Train, X_Test, Y_Train, Y_Test = train_test_split(X, y, test_size = 0.30, random_state = 101)\n",
    "    \n",
    "    Y_Train = to_categorical(Y_Train)\n",
    "\n",
    "    \n",
    "    #Y_Test = to_categorical(Y_Test)\n",
    "    \n",
    "\n",
    "\n",
    "    input_dim = X_Train.shape[1]\n",
    "    nb_classes = Y_Train.shape[1]\n",
    "\n",
    "    \n",
    "    model = Sequential()\n",
    "    model.add(Dense(512, input_dim=input_dim))\n",
    "    model.add(BatchNormalization())\n",
    "    model.add(Activation('relu'))\n",
    "    model.add(Dropout(0.15))\n",
    "    model.add(Dense(256))\n",
    "    model.add(BatchNormalization())\n",
    "    model.add(Activation('relu'))\n",
    "    model.add(Dropout(0.15))\n",
    "    #model.add(Dense(256))\n",
    "    #model.add(BatchNormalization())\n",
    "    #model.add(Activation('relu'))\n",
    "    #model.add(Dropout(0.15))\n",
    "    model.add(Dense(nb_classes))\n",
    "    model.add(BatchNormalization())\n",
    "    model.add(Activation('sigmoid'))\n",
    "\n",
    "  \n",
    "    model.compile(loss='categorical_crossentropy', optimizer='rmsprop', metrics=['accuracy'])\n",
    "\n",
    "\n",
    "    print(\"Training...\")\n",
    "\n",
    "    \n",
    "    history = model.fit(X_Train, Y_Train, validation_split=0.1, epochs=35, batch_size=100, verbose=2)\n",
    "\n",
    "    preds = model.predict_classes(X_Test, verbose=0)\n",
    "  \n",
    "    # plot metrics\n",
    "    import matplotlib.pyplot as plt\n",
    "    plt.plot(history.history['accuracy'])\n",
    "    plt.plot(history.history['val_accuracy'])\n",
    "    plt.title('Model accuracy')\n",
    "    plt.ylabel('Accuracy')\n",
    "    plt.xlabel('Epoch')\n",
    "    plt.legend(['Train', 'Test'], loc='upper left')\n",
    "    plt.show()\n",
    "    \n",
    "    print(confusion_matrix(Y_Test,preds))\n",
    "    print(classification_report(Y_Test,preds))\n",
    "    \n",
    "    med = \"Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study\"\n",
    "    med2 = \"Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial\"\n",
    "    med3 = \"Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer\"\n",
    "    med4 = \"PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma\"\n",
    "    med5 = \"Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone\"\n",
    "    altm = \"Prevalence, Patterns, and Predictors of T'ai Chi and Qigong Use in the United States: Results of a Nationally Representative Survey\"\n",
    "    altm2 = 'Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin'\n",
    "    altm3 = \"The American Coneflower: A Prophylactic Role Involving Nonspecific Immunity\"\n",
    "    altm4 = \"Effect of BEMER Magnetic Field Therapy on the Level of Fatigue in Patients with Multiple Sclerosis: A Randomized, Double-Blind Controlled Trial\"\n",
    "    altm5 = \"Improving Access to Integrative Oncology Through Group Medical Visits: A Pilot Implementation Project\"\n",
    "\n",
    "\n",
    "    newtitles = titles_word.transform([med, med2, med3, med4, med5, altm, altm2, altm3, altm4, altm5])\n",
    "    \n",
    "    print(\"Predictions of 5 medical and 5 alternative medical titles, respectively are {}\".format(np.argmax(model.predict(newtitles), axis=1)))\n",
    "\n",
    "\n",
    "neuralnets()\n",
    "print(\"--- %s seconds ---\" % (time.time() - start_time))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# ANN Fit to Abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Training...\n",
      "Train on 2127 samples, validate on 237 samples\n",
      "Epoch 1/30\n",
      " - 2s - loss: 0.6740 - accuracy: 0.5802 - val_loss: 0.6803 - val_accuracy: 0.5443\n",
      "Epoch 2/30\n",
      " - 1s - loss: 0.5946 - accuracy: 0.7005 - val_loss: 0.6581 - val_accuracy: 0.6667\n",
      "Epoch 3/30\n",
      " - 1s - loss: 0.5509 - accuracy: 0.7819 - val_loss: 0.6239 - val_accuracy: 0.8017\n",
      "Epoch 4/30\n",
      " - 1s - loss: 0.5118 - accuracy: 0.8246 - val_loss: 0.5815 - val_accuracy: 0.8734\n",
      "Epoch 5/30\n",
      " - 1s - loss: 0.4915 - accuracy: 0.8514 - val_loss: 0.5341 - val_accuracy: 0.8903\n",
      "Epoch 6/30\n",
      " - 1s - loss: 0.4622 - accuracy: 0.8843 - val_loss: 0.5032 - val_accuracy: 0.8903\n",
      "Epoch 7/30\n",
      " - 1s - loss: 0.4375 - accuracy: 0.9130 - val_loss: 0.4789 - val_accuracy: 0.9072\n",
      "Epoch 8/30\n",
      " - 1s - loss: 0.4247 - accuracy: 0.9267 - val_loss: 0.4557 - val_accuracy: 0.9072\n",
      "Epoch 9/30\n",
      " - 1s - loss: 0.4065 - accuracy: 0.9389 - val_loss: 0.4441 - val_accuracy: 0.9114\n",
      "Epoch 10/30\n",
      " - 1s - loss: 0.3894 - accuracy: 0.9539 - val_loss: 0.4279 - val_accuracy: 0.9198\n",
      "Epoch 11/30\n",
      " - 1s - loss: 0.3855 - accuracy: 0.9605 - val_loss: 0.4122 - val_accuracy: 0.9325\n",
      "Epoch 12/30\n",
      " - 1s - loss: 0.3716 - accuracy: 0.9704 - val_loss: 0.4069 - val_accuracy: 0.9325\n",
      "Epoch 13/30\n",
      " - 1s - loss: 0.3574 - accuracy: 0.9784 - val_loss: 0.3960 - val_accuracy: 0.9367\n",
      "Epoch 14/30\n",
      " - 1s - loss: 0.3514 - accuracy: 0.9779 - val_loss: 0.3962 - val_accuracy: 0.9409\n",
      "Epoch 15/30\n",
      " - 1s - loss: 0.3438 - accuracy: 0.9817 - val_loss: 0.3885 - val_accuracy: 0.9451\n",
      "Epoch 16/30\n",
      " - 1s - loss: 0.3391 - accuracy: 0.9817 - val_loss: 0.3770 - val_accuracy: 0.9536\n",
      "Epoch 17/30\n",
      " - 1s - loss: 0.3362 - accuracy: 0.9850 - val_loss: 0.3751 - val_accuracy: 0.9494\n",
      "Epoch 18/30\n",
      " - 1s - loss: 0.3285 - accuracy: 0.9854 - val_loss: 0.3681 - val_accuracy: 0.9578\n",
      "Epoch 19/30\n",
      " - 1s - loss: 0.3221 - accuracy: 0.9897 - val_loss: 0.3653 - val_accuracy: 0.9578\n",
      "Epoch 20/30\n",
      " - 1s - loss: 0.3181 - accuracy: 0.9901 - val_loss: 0.3682 - val_accuracy: 0.9578\n",
      "Epoch 21/30\n",
      " - 1s - loss: 0.3137 - accuracy: 0.9906 - val_loss: 0.3586 - val_accuracy: 0.9494\n",
      "Epoch 22/30\n",
      " - 1s - loss: 0.3142 - accuracy: 0.9840 - val_loss: 0.3556 - val_accuracy: 0.9536\n",
      "Epoch 23/30\n",
      " - 1s - loss: 0.3072 - accuracy: 0.9882 - val_loss: 0.3565 - val_accuracy: 0.9494\n",
      "Epoch 24/30\n",
      " - 1s - loss: 0.3075 - accuracy: 0.9878 - val_loss: 0.3596 - val_accuracy: 0.9494\n",
      "Epoch 25/30\n",
      " - 1s - loss: 0.2988 - accuracy: 0.9929 - val_loss: 0.3517 - val_accuracy: 0.9451\n",
      "Epoch 26/30\n",
      " - 1s - loss: 0.2964 - accuracy: 0.9878 - val_loss: 0.3469 - val_accuracy: 0.9536\n",
      "Epoch 27/30\n",
      " - 1s - loss: 0.2966 - accuracy: 0.9887 - val_loss: 0.3397 - val_accuracy: 0.9620\n",
      "Epoch 28/30\n",
      " - 1s - loss: 0.2888 - accuracy: 0.9953 - val_loss: 0.3415 - val_accuracy: 0.9578\n",
      "Epoch 29/30\n",
      " - 1s - loss: 0.2896 - accuracy: 0.9939 - val_loss: 0.3314 - val_accuracy: 0.9578\n",
      "Epoch 30/30\n",
      " - 1s - loss: 0.2826 - accuracy: 0.9948 - val_loss: 0.3316 - val_accuracy: 0.9578\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYMAAAEWCAYAAACEz/viAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAgAElEQVR4nO3deXxU9bn48c+TSUL2BLKxBEiAsARQRNQquOOGWm3Vqq23bq3Xe2trtfbW3mvV7ra/LtdWr16rWLVWrtaNWq27xaUKqFFIwi6EQMgGWcg+mef3xzkhQ0jIBDKZyczzfr3mlTlnzjnzHAfPc87zPef7FVXFGGNMdIsJdQDGGGNCz5KBMcYYSwbGGGMsGRhjjMGSgTHGGCwZGGOMwZKBiRIiki8iKiKxASx7lYi8MxxxGRMuLBmYsCMiW0WkQ0Syes0vdg/o+aGJzJjIZcnAhKvPgMu7J0RkLpAYunDCQyBXNsYcCksGJlw9BnzVb/pK4FH/BUQkXUQeFZEaEdkmIreJSIz7mUdEfiUitSKyBTi3j3UfEpFKEdkhIj8REU8ggYnIUyKyS0QaRGSFiMz2+yxRRH7txtMgIu+ISKL72SIReU9E6kVku4hc5c5/S0S+5reN/cpU7tXQN0RkI7DRnXe3u41GEflQRE70W94jIv8pIptFpMn9fKKI3Csiv+61L38VkW8Hst8mslkyMOHqfSBNRGa5B+lLgT/1Wub3QDowBTgZJ3lc7X72deA84ChgAXBxr3UfAbzANHeZM4GvEZiXgEIgB/gIeNzvs18BRwMnAGOA/wB8IjLJXe/3QDYwDygO8PsALgSOA4rc6VXuNsYAfwaeEpEE97Obca6qlgBpwDVAi7vPl/slzCzgdOCJQcRhIpWq2steYfUCtgKLgduAnwNnA68CsYAC+YAHaAeK/Nb7V+At9/0bwPV+n53prhsL5LrrJvp9fjnwpvv+KuCdAGPNcLebjnNy1Qoc2cdy3wee7WcbbwFf85ve7/vd7Z82QBx7ur8XWA9c0M9yZcAZ7vsbgBdD/XvbKzxeVn804ewxYAVQQK8SEZAFxAPb/OZtAya478cD23t91m0yEAdUikj3vJhey/fJvUr5KXAJzhm+zy+eUUACsLmPVSf2Mz9Q+8UmIt/BuZIZj5Ms0twYBvquR4ArcJLrFcDdhxGTiSBWJjJhS1W34TQkLwGe6fVxLdCJc2DvNgnY4b6vxDko+n/WbTvOlUGWqma4rzRVnc3AvgxcgHPlko5zlQIgbkxtwNQ+1tvez3yAZiDJb3psH8vs617YbR/4HvAlYLSqZgANbgwDfdefgAtE5EhgFvBcP8uZKGPJwIS7a3FKJM3+M1W1C3gS+KmIpIrIZJxaeXe7wpPAt0QkT0RGA7f6rVsJvAL8WkTSRCRGRKaKyMkBxJOKk0jqcA7gP/Pbrg9YCvxGRMa7DbnHi8gonHaFxSLyJRGJFZFMEZnnrloMfFFEkkRkmrvPA8XgBWqAWBG5HefKoNuDwI9FpFAcR4hIphtjBU57w2PA06raGsA+myhgycCENVXdrKqr+/n4mzhn1VuAd3AaUpe6n/0BeBn4BKeRt/eVxVdxykylOPX2vwDjAgjpUZyS0w533fd7fX4LsAbngLsb+AUQo6rlOFc433HnFwNHuuv8FugAqnDKOI9zcC/jNEZvcGNpY/8y0m9wkuErQCPwEPvflvsIMBcnIRgDgKja4DbGRBMROQnnCirfvZoxxq4MjIkmIhIH3Ag8aInA+LNkYEyUEJFZQD1OOey/QxyOCTNWJjLGGGNXBsYYYxh5D51lZWVpfn5+qMMwxpgR5cMPP6xV1ez+Ph9xySA/P5/Vq/u709AYY0xfRGTbwT63MpExxhhLBsYYYywZGGOMIYhtBiKyFKc/+WpVndPH54LTY+ISnL7Wr1LVjw7luzo7O6moqKCtre1wQh5REhISyMvLIy4uLtShGGMiQDAbkP8I3MOBXQ93OwdngJBCnEE77nP/DlpFRQWpqank5+fj1yVxxFJV6urqqKiooKCgINThGGMiQNDKRKq6AqdDrv5cADyqjveBDBEJpKOwA7S1tZGZmRkViQBARMjMzIyqKyFjTHCFss1gAvv3tFhBz8Ak+xGR60RktYisrqmp6XNj0ZIIukXb/hpjgiuUzxn0dTTrs28MVX0AeABgwYIF1n+GMSYsdfmUTyrqWfmZUxRJTYglNSGO1IRY0vzepybEkRzv2e+kTlXp7FJaO7to6+yitaOL1k7n1ea+n56bysQxSf19/WEJZTKoYP+RqPKAnSGK5bDU1dVx+umnA7Br1y48Hg/Z2c6DfitXriQ+Pn7AbVx99dXceuutzJgxI6ixGhPJVJXy3S0Ub6+nobWTI/IymDUulVGxnqB95476VlZsqOHtjTW8s7GWxjZvQOvFCKSMiiU+1uMc/Du76PId/Fz3xxfO4V8+N/mgyxyqUCaD5cANIrIMp+G4wR2BasTJzMykuLgYgDvvvJOUlBRuueWW/ZbpHnQ6JqbvytzDDz8c9DhNdFF1zjI7uxRvlw+vT+ns8uHtUrw+nztf6fS587p8dPrcv+4y3i53HXd+R5eSmhDLwmlZTMhIHDiIIGto7eTTino+Lq+neLvz2t3csd8y8Z4YisancdSkDOZNzOCoiaOZOCbxkEutze1ePvisjhUbalmxsYYtNc4gfGPTEjhr9lhOmp7NwmlZJMTF0NTmpamtk8Y2L01tXhpbO/fN6/7b0aUkxXtIjPOQGO8hIa77fQyJcf7THvJGB+eqAIJ7a+kTwClAlohUAHfgDEKOqt4PvIhzW+kmnFtLrw5WLKGyadMmLrzwQhYtWsQHH3zACy+8wA9/+EM++ugjWltbufTSS7n99tsBWLRoEffccw9z5swhKyuL66+/npdeeomkpCSef/55cnJyQrw3Jpw1t3tZX9XE+l3Oa92uRtbtaqK+pTNo3zklO5mTCrM5aXoWxxVkkjxqcIcTn0+p2NPKul2NVDW1ExsjxMYIcZ4YYj1CbEwMcR4h1hNDXIzzVwTW72qieHs9H5fvYXNNz2io03JSOG1mjnPAn5RBemIcn1Y0OEmivJ4nVpbz8LtbAchMjmfeRCc5HDkxg1GxMT3lmc4uWjqcMk33dGuHj9bOLrbWNrN62246u5SEuBiOK8jky8dO4uTp2UzLSTkgwSTFx5KblnDY/62HQ9CSgapePsDnCnxjqL/3h38toXRn45Bus2h8GnecH8hY6QcqLS3l4Ycf5v777wfgrrvuYsyYMXi9Xk499VQuvvhiioqK9lunoaGBk08+mbvuuoubb76ZpUuXcuutt/a1eRNhVNU9C+//jL3d28XW2hbW72qkzD34l+9u2beNpHgPM8amcs6csUwck0S8J2bfATYuxj3Q+h1g/efHuQdh5727nt8BOi4mhqqmNt7eWMuKDTUsW1XOH9/bSpxHWDB5DCdOz+KkwmyKxqURE9NzYKxv6WDdribWVTayvqqJdbua2LCrieaOrkP679R9ML9w3gTmTcrgiDzn4N9b3ugklsx1blLs7PLtSyTdyeT1ddUDfpcnRkiK85AQ7yEndRTXLCzgxMJsFuSPJiEueOWn4TbiOqobaaZOncoxxxyzb/qJJ57goYcewuv1snPnTkpLSw9IBomJiZxzzjkAHH300bz99tvDGrMJnobWTsrrWti2u5ltdS373pfXtVDd1I53gJqxvxiBgqxk5ualc8nRecwYm8rMsWnkjU7c70A81NKT4piem8q1iwpo6+ziw217WLGhhhUba/nl39fzy7+vJzM5ns9NzaSpzcv6XY1UNbbvWz8jKY4ZualcsmAiM8amMmNsKnkZiXSp7leW6quk1aVKQWbyIZV54jwxzJmQzpwJ6Vzh1t0bWjsp3dmIqpLQXaqJ85AU79k3HeeJjo4aIi4ZHOoZfLAkJyfve79x40buvvtuVq5cSUZGBldccUWfzwr4Nzh7PB683sAapEzwqCqVDW1srtnL5uq97PI7uAWy3rbdLZTXNbOnV9kmK2UUkzOT+NyUTHLTE5yzcfeMPc4jfZ7Rx3uEvNFJTMtJCfmZaUKch4XTslg4LYvvA9WNbbyzyblqWPnZbjKS4lk4NctJVOPSmDk2lZzUUWFza3R6YhzHT80MdRhhIeKSQThrbGwkNTWVtLQ0Kisrefnllzn77LNDHVZEU1X2tHTiEXEPps6Btb8z5+4STPdBf3PNXjbXNLO5Zi8tfiWNOI8EdEATICdtFJPHJHPO3HFMHpPE5MwkJo1JZlJmEimDrLOHu5y0BL44P48vzs8LdShmkCLrX2KYmz9/PkVFRcyZM4cpU6awcOHCUIcUkVSVj7fX87dPK3lpTSU7Gw68+ooR9qubx3mEGBFq97bjX6mZkJHI1JwULs2fyNTsFKblpDA1O4WslPiwObs1ZiiMuDGQFyxYoL0HtykrK2PWrFkhiih0onW/+9KdAF78tJIX3QQQ74nhxMIsjp/qdFXS+/bK3g20XV1KbnoCU7OTmZqdwpTsZJLi7XzJRAYR+VBVF/T3uf1LNyOWfwJ4ae0udtS37ksAt5w1g8VFuaQlWK+uxgTCkoEZcT6rbWbZynJe+LSSHfWtxHmEkwqzufmM6Swuyu3zFkNjzMFZMjAjgrfLx+vrqvnT+9t4e2MtsTHCSdMtARgzVCwZmLBW3djGslXbeWJlOZUNbYxLT+A7Z0zn0mMmkjNCnuw0ZiSwZGDCjqryzy11PP5+OS+X7MLrU04szOLOz8/m9Jk5xEbJQ0DGDCdLBiZs1DS187dPd/KnD8rZVL2X9MQ4rl6Yz5ePm0xBVvLAGzAmGFrroeyvsOYp2LMVsmdCbhHkzHb+ZhZC7MA9E4c7SwZDYCi6sAZYunQpS5YsYezYsUGLNZy0e7v4cOse/rGxhrc31FJa6fQpdeTEDH51yZGcd8S4kD9hG5Y6WsAbhFHuEkeDPTvh6GyDjS87CWDDK9DVDqMLYPxRULsBNr8OPrdngJg4yCqE3NmQU+T8zZ4Jo1KHPq64JIgLTnnUksEQCKQL60AsXbqU+fPnR2wyUFU21+xlxYZa3t5Yw/tbdtPa2UWcRzh68mi+e9YMTp2RQ9H4tFCHGn46WmD9i7DmL7DpNfAFoTfSrOkw9xKYcxFkTh367Ye7Li9sXeH8Ny77K7Q3QnIOLLjG+e8yYX5PsvR2QN1GqCqF6hLnb/n7TvIIpnN/A8dcG5RNWzIIskceeYR7772Xjo4OTjjhBO655x58Ph9XX301xcXFqCrXXXcdubm5FBcXc+mll5KYmDioK4pwpqq8sa6aV0qqeHtjzb6ngadkJfOlBXmcND2b46ZkRly3DACoQt0miE+B1LGDP+vu6oQtbzkHmLIXoLMZUsfDcf8KGZOGNtbOVtj4Krz5U+c14WiY+yWY/QVIzR389jpaYPdm52CakhO+VxyqsOMjWPMkrH0GmqshPhWKPg9zL4b8k8DTx7/N2HjnCiB3NnBJz/y2Bqgug5p14A2s/6pBmfS5od+mK/L+D3zpVti1Zmi3OXYunHPXoFdbu3Ytzz77LO+99x6xsbFcd911LFu2jKlTp1JbW8uaNU6c9fX1ZGRk8Pvf/5577rmHefPmDW38IbKtrpnbnlvL2xtrSU2IZdG0LG44LZsTC7OCNnRfWKjbDGufdg7itRuceYljekoI3fXmnD5KCaqwfaVzcCp5FlrqICHdOTDNvQQmnwAxQSqdLfo2NFT0xP7378HL34eCk53vnnWeE4s/Xxfs/qzn7Lj77+4t7BvFNimzZ9/3K6OkBGc/AlGzwdnHNU/Bns/AEw/Tz3L2s/BMiDvEgXsS0p0DdhAP2sESeckgjLz22musWrWKBQucJ8BbW1uZOHEiZ511FuvXr+fGG29kyZIlnHnmmSGOdGh1dvn4w9tbuPu1jcR5YvjRBbP58rGTIvsuoKYq5+C95knY8aEzb/JCOPY6UB9UlUB1KRQ/Dh17e9bLmNxzkPR5oeQZqC+H2ASYcY5zdj7tdIgdNTz7kZ4HC290XtXreg6Yz/87vHATzDgbxs93klxVCdSsB2+ru7LAmClOspt7CWRPh701PQnio8ecq5tuo/N7GmEzJoME8O9DxLkqyimCpDGD27fGnT2JrvITJ96Ck+DE78Cs8yExY3DbizCRlwwO4Qw+WFSVa665hh//+McHfPbpp5/y0ksv8bvf/Y6nn36aBx54IAQRDr2Pyvfwn8+sYd2uJs6ZM5Y7zp/N2PQIfR6grcEp36x5Cj77h3PQHzsXzviRU3dP76PnTp8PGsr9zqLdA+WGl53Pp54Kp/4XzDw3OA2Qg5EzE07/AZx2G1Ssdvaz5Bkofd4p/+QWOfX03CLn4Jw9E+IPcsXn80H9VnffS3sS5IaXnP92g5U6zu9qy02o2TP2T5yte6B0uRP71ncAhXHz4KyfwewvQtq4wX9vhIq8ZBBGFi9ezMUXX8yNN95IVlYWdXV1NDc3k5iYSEJCApdccgkFBQVcf/31AKSmptLU1BTiqA9NY1snv/z7Oh7/oJxxaQk8+NUFLC46hFpzOGut7zmIfbbCOYB3tTtntYtuds6Gc2YefBsxMc4Z8eh8mLmkZ7633blDqHcZJhyIwMRjnNdZP3MaVgd7Vg7Ovo+Z4rxmndczv7MN9lYFtg2f98Cy1AdvQ5c77rF4IHOak6C8HbDpVeezMVPhlFthzsWQNW3wsUcBSwZBNHfuXO644w4WL16Mz+cjLi6O+++/H4/Hw7XXXouqIiL84he/AODqq6/ma1/72ohqQFZVXlq7izuXl1C7t52rTyjg5jOnj+wGYW+HUwbxP3utKoXGip5lkrPh6KucBJC34PAbSGNHDV8p6HB4Yg8tERxMXAKMnhz48plToXBxz3RXp9NOsy9BlDqNwj4vHPN1p71l/FHh24gdJqwL6xEs1Pu9o76V259by+vrqpk9Po2ff3EuR+SNoLqrKjRs37/hs6rEuWVwv3vIp/eUQrrLEel5dnAxI4p1YW2GXFNbJw+/u5X7/7EZVbjt3FlcdUJ+eDcQt+45sFZdXeaUPLqlT3IO+jPO6TnoZ06LiKdLjRmIJQMTsOZ2L4/8cysPrNhCfUsnZxblcvv5ReSNDqPbRL3t7p0uvRpom3b2LJOQ7tzFcsSX3LP9OZAzCxLsYTcTvSImGXTX36PFcJb32jq7+NP727jvrc3UNXdw6oxsbjpjemhLQqrOLZjdZ/rdZ/t1m/Yv8WTPgPxFfn3JzIa08VbiMaaXiEgGCQkJ1NXVkZmZGRUJQVWpq6sjISG4t2y2dXaxbGU59761mZqmdhZNy+KmM6Zz9OTRQ/9l1WXwxk9g4yvOgX4g6gPtGaDeufd8tnNLZndtP3MaeGycA2MCERHJIC8vj4qKCmpqakIdyrBJSEggL6+P+9iHQIfXx5Ort3Pvm5uobGjjuIIx3HP5URw3JXPov2zPNnjr5/DJMue++qOvcrpvCETGRPdJXivxGHO4IiIZxMXFUVBQEOowRrwun/L0RxXc/dpGdtS3Mn+S03voCVODcMW1txpW/ApWL3W6VzjhBude/aG+bdEYE5CISAbm8L23uZYfv1BGWWUjR+Sl89MvzOHk6dlDnwTaGuC938M//8d5yOqoK+Dk70H6hKH9HmPMoFgyiHJba5v52YtlvFJaxYSMRO758lGcO3fc0CeBzlZY+QC881vnNs/ZX4BTb7OnQY0JE5YMolRjWyf3vLGJh9/9jDhPDN89awbXLioY+sFkWvc4/cO//Rvn9s5pi+G0H8D4yOiZ1ZhIYckgyni7fCxbtZ3fvrqB3S0dXHJ0HrecOWNoB5fvbIUNf3eSwMZXnL5h8o6Fi/7g3OZpjAk7lgyiyDsba/nxC6Wsr2ri2IIxPHJeEXMmDFHHaF1ep+fO7lGiOpogZaz1DWPMCGHJIApUNrTyg+fW8lpZNRPHJHLfV+Zz9pyxh98uoOr03f/pk07Xxs01MCodZl/g9MOfvyh4A7EYY4aUJYMI19TWyZVLV1Kxp5XvnT2TqxfmH3q7QHOtXy+eJU7/8Hs+A88oZ9CTuZfAtDOCNmC3MSZ4LBlEsC6f8q0nPmZzTTOPXnMsC6dlBbZiR4szhmt3183dPXo2V/csk5TllH5O+m7fwyEaY0YUSwYR7K6Xynh7fSXPzn6XI174XmDdPPi6YO+unpGnYhOcEawKz9h/DNuUnOAGb4wZVkFNBiJyNnA34AEeVNW7en0+GVgKZAO7gStUteKADZlB+79V5bz2znu8NeZB8jaXOeWbQA/g6RN7OnYbU2B1f2OiQNCSgYh4gHuBM4AKYJWILFfVUr/FfgU8qqqPiMhpwM+BfwlWTNHig821rHn+bv6e8BjxvkS45BGYfWGowzLGhLFgXhkcC2xS1S0AIrIMuADwTwZFwE3u+zeB54IYT1SoqCin9bGr+UnsajonnYxcdL/TZbMxxhxEMIemmgBs95uucOf5+wS4yH3/BSBVRA7oGlNErhOR1SKyOpp6Jh2slpIXSXroRE6gmLpFdxJ35XOWCIwxAQlmMujrJvbeLZi3ACeLyMfAycAOwHvASqoPqOoCVV2QnZ099JGOdB0t+P52C0lPXU5NVyql5y0nc/FNEBPGw1AaY8JKMMtEFcBEv+k8YKf/Aqq6E/gigIikABepakMQY4o8O4vhma8TU7uBB73nkLzkR1y+YHqoozLGjDDBTAargEIRKcA5478M+LL/AiKSBexWVR/wfZw7i6Jb3WYofQ58voGXbamDVQ/SEjear3d8n8LPnc+dJ1giMMYMXtCSgap6ReQG4GWcW0uXqmqJiPwIWK2qy4FTgJ+LiAIrgG8EK56wp+oM9PLyf4G3NeDVaicv4eyNF1I0rYDbzp0VxACNMZFMhnNg9aGwYMECXb16dajDGFp7a2D5DU5Pn1NOhQvuhZTcAVfbtruZC+77gKyUUTzz7yeQlmDj/Rpj+iYiH6rqgv4+tyeQQ23Dy/D8N6CtEc7+BRx7XUANvy0dXq59rBiAh65cYInAGHNYLBmESkcLvHIbrH4IcufAV5c7T/0G6M7lJWyu2cufrj2OyZnJQQzUGBMNLBmEws6P4emvQ91GOP4GOP12iB0V8OrLP9nJk6sruOHUaYF3PmeMMQdhyWA4+brg3f+GN38GyTnw1edhyimD2sT23S381zNrmD8pg28vLgxKmMaY6GPJYLjUl8Mz/wrl70HRhXDebyFpzKA20dnl45tPfAwCd192FLEee6jMGDM0LBkMB287PHgGdDTDhffDkZcd0hCQv311A8Xb67n3y/OZOCYpCIEaY6KVJYPhsPlNZ4yAy56AmUsOaRPvbqrlvn9s5rJjJnLuEeOGOEBjTLSzOsNwKH3OGRt42uJDWr1ubzs3/V8xU7NTuOP82UMcnDHGWDIIPm87rHsRZp4LsfGDXl1VueWpT6hv7eR3lx1FYrwNNGOMGXqWDIJt85vQ3gCzv3BIqz/87lbeXF/Dfy2ZRdH4tCEOzhhjHJYMgq30OWew+CmnDHrVtTsauOuldSyelctXj5885KEZY0w3SwbB5G2HdX+DmecNukTU3O7lW098zJjkeP7fxUcgh3D3kTHGBMruJgqmzW9Ce6PzXMEg3bm8hM/qmvnz1z7H6OTBtzUYY8xg2JVBMJU8e0gloueLd/DUhxV889RpHD/1gFFAjTFmyFkyCBZvO6x/cdAlovK6Fm57di1HTx7Nt0637iaMMcPDkkGwdJeIBnEX0Z7mDq7640pE4O7L5ll3E8aYYWNtBsHSXSIqODmgxds6u7j2kVVU7GnlT9ceR95o627CGDN87NQzGPaViM4PqETkdTug+3h7PXdfOo9jCwbXgZ0xxhwuSwbBsPkNt0Q08F1Eqsrty0t4tbSKO8+fzTlzrd8hY8zws2QQDCXPQUJGQCWi37+xiT9/UM6/nTKVK0/ID35sxhjTB0sGQ20QdxE9uWo7v3l1A1+cP4H/OGvGMAVojDEHsmQw1PaViA5+F9Eb66r4/rNrOGl6Nr+4yJ4wNsaEliWDodZdIprSf4moeHs933j8Y4rGpfE/X5lPnN1CaowJMTsKDaXuEtGs88AT1+ciW2r2cs0fV5GdOoqlVx1Dyii7u9cYE3qWDIZSd4moqO8SUXVTG1c+vBKAR645luzUUcMZnTHG9MuSwVAqebbfEtHedi/X/HEVtU0dLL3qGAqykkMQoDHG9M2SwVDpbIP1L/VZIlJVbvjzR5RVNvE/X5nPvIkZIQrSGGP6ZslgqBykRPS3NZW8tb6GH5w7i1Nn5oQgOGOMOThLBkOltO+7iNo6u7jrpXXMHJvKvxyfH5rYjDFmAJYMhsJBSkSPvLeVij2t3HZuEZ4Ye5bAGBOeLBkMhX4eNKvb2849b2zi1BnZLCrMClFwxhgzsAGTgYjcICKjhyOYEav0OUgcfUBfRHe/vpGWzi7+c8msEAVmjDGBCeTKYCywSkSeFJGzxfpN2F9nG6xz+yLyKxFtqt7L4x+Uc/mxEynMTQ1hgMYYM7ABk4Gq3gYUAg8BVwEbReRnIjI1yLGNDJvfgI6mA7qrvuulMhLjPHx78fQQBWaMMYELqM1AVRXY5b68wGjgLyLyyyDGNjKUPHtAiei9TbW8VlbNv586lawUe8rYGBP+Amkz+JaIfAj8EngXmKuq/wYcDVw0wLpni8h6EdkkIrf28fkkEXlTRD4WkU9FZMkh7kdodN9F5Fci6vIpP/lbGRMyErlmYUGIAzTGmMAE0ktaFvBFVd3mP1NVfSJyXn8riYgHuBc4A6jAaXdYrqqlfovdBjypqveJSBHwIpA/yH0InX0lop67iJ75qILSykbuvmweCXGeEAZnjDGBC6RM9CKwu3tCRFJF5DgAVS07yHrHAptUdYuqdgDLgAt6LaNAmvs+HdgZaOBhYdu7EJsABScB0NLh5VevrOfIiRl8/sjxIQ7OGGMCF0gyuA/Y6zfd7M4byARgu990hTvP353AFSJSgZN0vtnXhkTkOhFZLSKra2pqAvjqYVJVAtkz95WIHlixharGdn5w7iwbrMYYM6IEkgzEbUAGnPIQgZWX+joaaq/py4E/qmoesAR4TEQOiElVH1DVBaq6IHJTtf8AABLQSURBVDs7O4CvHiZVJZA7x3nb2Mb//mMLS+aOZUH+mBAHZowxgxNIMtjiNiLHua8bgS0BrFcBTPSbzuPAMtC1wJMAqvpPIAGnjSL8NddCczXkFgHw61fW4/X5+N7ZM0McmDHGDF4gyeB64ARgB84B/jjgugDWWwUUikiBiMQDlwHLey1TDpwOICKzcJJBGNWBDqKqxPmbU0TJzgae+rCCK4/PZ3KmjVNgjBl5Biz3qGo1zoF8UFTVKyI3AC8DHmCpqpaIyI+A1aq6HPgO8AcRuQmnhHSVf0kqrLnJQHNn87NlZaQnxvHN0wpDHJQxxhyaAZOBiCTglHNm45y5A6Cq1wy0rqq+iNMw7D/vdr/3pcDCQcQbPqpLIDmbNyuUdzfVccf5RaQn9T3usTHGhLtAykSP4fRPdBbwD5zaf1MwgxoRqkrw5RTx07+VUZCVzFeOmxzqiIwx5pAFkgymqeoPgGZVfQQ4F5gb3LDCnK8Lqtexkclsrmnm++fMJD7WegM3xoxcgRzBOt2/9SIyB+fhsPygRTQS7NkK3lbebsxmcmYSZxTlhjoiY4w5LIE8L/CAO57BbTh3A6UAPwhqVOGuai0AL1ZlctpxOfaAmTFmxDtoMnAfAGtU1T3ACmDKsEQV7qpKUYmhxDuem2yAe2NMBDhomch92viGYYpl5KhaS238BDzxiRxbYE8bG2NGvkDaDF4VkVtEZKKIjOl+BT2yMKbVpazpzOPEwixGxVrPpMaYkS+QNoPu5wm+4TdPidaSUUcz7P6M4s75nGYlImNMhAjkCWQbocVf9ToEZZ1O5IoZlgyMMZEhkCeQv9rXfFV9dOjDGQGq3W4ocmaTk5YwwMLGGDMyBFImOsbvfQJOx3IfAVGZDNoqPqVLRzGrKLqfuzPGRJZAykT7DTgjIuk4XVREpabyT6jQiZw+a2yoQzHGmCFzKH0otADR2T2nKol71rHVk8/cCemhjsYYY4ZMIG0Gf6VnhLIYoAh3QJpo422oJKWrEcbOJibGnjo2xkSOQNoMfuX33gtsU9WKIMUT1jatXclMYPz0+aEOxRhjhlQgyaAcqFTVNgARSRSRfFXdGtTIwtCODauZCRQddXyoQzHGmCEVSJvBU4DPb7rLnRd1uirXsjsmk9TR1kupMSayBJIMYlW1o3vCfR8fvJDC0/bdLUxo30JzxoxQh2KMMUMukGRQIyKf754QkQuA2uCFFJ7eKtvJNNlJ6uQjQx2KMcYMuUDaDK4HHheRe9zpCqDPp5IjWcnajxklnYzKnxfqUIwxZsgF8tDZZuBzIpICiKpG3fjHLR1e2io+BQ+QUxTqcIwxZsgNWCYSkZ+JSIaq7lXVJhEZLSI/GY7gwsV7m+qYquWoeCDb2gyMMZEnkDaDc1S1vnvCHfVsSfBCCj+vr6tmjmc7mlkIsaNCHY4xxgy5QJKBR0T2HQFFJBGImiOiqvLW+mrmxu0gJtdKRMaYyBRIA/KfgNdF5GF3+mrgkeCFFF7KKptoathNVsIuyJ0d6nCMMSYoAmlA/qWIfAosBgT4OzA52IGFizfWVTFd3N43LBkYYyJUoL2W7sJ5CvkinPEMyoIWUZh5Y101p49xH6uwZGCMiVD9XhmIyHTgMuByoA74P5xbS08dpthCbndzBx9vr+eO/F3gTYP0iaEOyRhjguJgZaJ1wNvA+aq6CUBEbhqWqMLEW+urUYWpWg45s0Cs22pjTGQ6WJnoIpzy0Jsi8gcROR2nzSBqvLGumuyUeJLr11uJyBgT0fpNBqr6rKpeCswE3gJuAnJF5D4ROXOY4guZzi4fKzbUcOEURdoa7MljY0xEG7ABWVWbVfVxVT0PyAOKgVuDHlmIfbhtD41tXs7K3u3MyJ0T2oCMMSaIBjUGsqruVtX/VdXTghVQuHhzXTVxHmFunHtbac6s0AZkjDFBNKhkEE3eWFfNcQWZjKpbB2l5kJgR6pCMMSZoLBn0YfvuFjZW7+W0mTlQVWqNx8aYiBfUZCAiZ4vIehHZJCIHtDOIyG9FpNh9bRCR+r62M9zeWFcNwGmFGVC7HqxPImNMhAukb6JDIiIe4F7gDJwBcVaJyHJVLe1eRlVv8lv+m8BRwYpnMN5YV82UrGTy2Qk+rzUeG2MiXjCvDI4FNqnqFnfc5GXABQdZ/nLgiSDGE5DOLh/vb6njlBk5UFXizLTbSo0xES6YyWACsN1vusKddwARmQwUAG/08/l1IrJaRFbX1NQMeaD+NlQ10e71cdSkDCcZxMRBVmFQv9MYY0ItmMmgr6eVtZ9lLwP+oqpdfX2oqg+o6gJVXZCdnT1kAfZl7Y4GAOZOSIfqUmdkM09cUL/TGGNCLZjJoALw79ktD9jZz7KXEQYlIoA1OxpIHRXLpDFJzpWBlYiMMVEgmMlgFVAoIgUiEo9zwF/eeyERmQGMBv4ZxFgCtmZHI7MnpBHTXg+NO+xOImNMVAhaMlBVL3AD8DLO+AdPqmqJiPxIRD7vt+jlwDJV7a+ENGw6u3yUVTY6JaIq96Ynu5PIGBMFgnZrKYCqvgi82Gve7b2m7wxmDIOxsWovHV4fcyakQ/W7zkwrExljooA9gexnv8bjqrWQkAFp40MclTHGBJ8lAz9rdjSQMiqW/Mzknm4obEAbY0wUsGTgZ82OBmaPTyMGheoyKxEZY6KGJQOX17/xuKEcOpqsgzpjTNSwZODaWL2Xdq+PuXn+dxJZMjDGRAdLBq7uxuM5E9L9+iSyAW2MMdHBkoFrrdt4XJCZDNUlkDEZRqWGOixjjBkWlgxca3Y0UDQ+jZgYsQFtjDFRx5IBTuNxaWUjc8anQ2cr1G2yZGCMiSqWDIDNNc20dfqYm5fmtBdoF4w7MtRhGWPMsLFkgFMiAvfJ48piZ+a4eSGMyBhjhpclA5zG46R4DwVZKVD5CSSOgfS8UIdljDHDxpIBPU8ee2IEdhY7JSLrhsIYE0WiPhl0+ZTSnY3O8wXedqcbCmsvMMZEmahPBptr9tLa2eUOc1kGvk5LBsaYqBP1yWBNhX/j8SfOTEsGxpgoY8nAbTyeku02Ho9Kg9EFoQ7LGGOGVdQng7U7Giga5zYeV34CY4+AmKj/z2KMiTJRfdTr8ikl3Y3HXV5ndDMrERljolBUJ4Mt/o3HtRvA22bJwBgTlaI6Gazx77a6u/F4vD15bIyJPlGfDBLiYpianewkg7gkyJwW6rCMMWbYRXUy6G48jvXEuI3HcyHGE+qwjDFm2EVtMvC5jcdzJ6SDzwe7PrX2AmNM1IraZLCltpmWji6nvWD3ZujYa8nAGBO1ojYZdI95PDfPnjw2xpioTQbdjcfTslOcMQw88ZA9M9RhGWNMSER1Mpjl33icOxs8caEOyxhjQiIqk4HP7bZ67oR0UHWSgZWIjDFRLCqTwWd1zext9zqNx/XboK3BkoExJqpFZTJYu8O6rTbGGH9RmQzWVDQwKjaGwhy32+qYWMiZHeqwjDEmZKIzGfRuPM6eBXEJoQ7LGGNCJuqSgW9ft9VpTuPxzmIrERljol5Qk4GInC0i60Vkk4jc2s8yXxKRUhEpEZE/BzMegK1u4/HcCenQuBNaai0ZGGOiXmywNiwiHuBe4AygAlglIstVtdRvmULg+8BCVd0jIjnBiqfb/t1Wv+vMtGRgjIlywbwyOBbYpKpbVLUDWAZc0GuZrwP3quoeAFWtDmI8gHMnUXxsDNNzU907iQTGzgn21xpjTFgLZjKYAGz3m65w5/mbDkwXkXdF5H0ROTuI8QBu4/HYVOK6G4+zpkN8crC/1hhjwlowk4H0MU97TccChcApwOXAgyKSccCGRK4TkdUisrqmpuaQA/L5lJId7pjHYE8eG2OMK5jJoAKY6DedB+zsY5nnVbVTVT8D1uMkh/2o6gOqukBVF2RnZx9yQNt2t9DU3Xi8txqadloyMMYYgpsMVgGFIlIgIvHAZcDyXss8B5wKICJZOGWjLcEKaP/G40+dmZYMjDEmeMlAVb3ADcDLQBnwpKqWiMiPROTz7mIvA3UiUgq8CXxXVeuCFdPaHQ3Ee7obj4udmeOOCNbXGWPMiBG0W0sBVPVF4MVe8273e6/Aze4r6NbuaGDmuFTiY93G4zFTICF9OL7aGGPCWtQ8gayqrN3RYI3HxhjTh6hJBuW7W2hscxuPW/c4XVdbMjDGGCCKksG+xuPx1m21Mcb0FjXJYFdDG0nxHqaPTelJBmMtGRhjDAS5ATmcfO3EKVx5Qn7Pk8fpEyE5M9RhGWNMWIiaKwPASQRgjcfGGNNLVCUDANoaoW6TJQNjjPETfcmgaq3z15KBMcbsE33JYN+dRPNCG4cxxoSR6EwGKWMhNTfUkRhjTNiIzmRgJSJjjNlPdCWDjhaoWWfJwBhjeomuZFBVAuqzZGCMMb1EVzLY1221JQNjjPEXZcngE0gcA+l5oY7EGGPCSvQlg3FHgvQ1PLMxxkSv6EkG3naoLrMSkTHG9CF6kkF1Gfg6LRkYY0wfoicZ2BgGxhjTr+hJBslZMONcGF0Q6kiMMSbsRM14Bsw813kZY4w5QPRcGRhjjOmXJQNjjDGWDIwxxlgyMMYYgyUDY4wxWDIwxhiDJQNjjDFYMjDGGAOIqoY6hkERkRpg2yGungXUDmE44SDS9inS9gcib58ibX8g8vapr/2ZrKrZ/a0w4pLB4RCR1aq6INRxDKVI26dI2x+IvH2KtP2ByNunQ9kfKxMZY4yxZGCMMSb6ksEDoQ4gCCJtnyJtfyDy9inS9gcib58GvT9R1WZgjDGmb9F2ZWCMMaYPlgyMMcZETzIQkbNFZL2IbBKRW0Mdz+ESka0iskZEikVkdajjORQislREqkVkrd+8MSLyqohsdP+ODmWMg9HP/twpIjvc36lYRJaEMsbBEpGJIvKmiJSJSImI3OjOH5G/00H2Z8T+TiKSICIrReQTd59+6M4vEJEP3N/o/0Qk/qDbiYY2AxHxABuAM4AKYBVwuaqWhjSwwyAiW4EFqjpiH5QRkZOAvcCjqjrHnfdLYLeq3uUm7dGq+r1QxhmofvbnTmCvqv4qlLEdKhEZB4xT1Y9EJBX4ELgQuIoR+DsdZH++xAj9nUREgGRV3SsiccA7wI3AzcAzqrpMRO4HPlHV+/rbTrRcGRwLbFLVLaraASwDLghxTFFPVVcAu3vNvgB4xH3/CM7/qCNCP/szoqlqpap+5L5vAsqACYzQ3+kg+zNiqWOvOxnnvhQ4DfiLO3/A3yhaksEEYLvfdAUj/B8Azo/9ioh8KCLXhTqYIZSrqpXg/I8L5IQ4nqFwg4h86paRRkQ5pS8ikg8cBXxABPxOvfYHRvDvJCIeESkGqoFXgc1Avap63UUGPOZFSzKQPuaN9PrYQlWdD5wDfMMtUZjwcx8wFZgHVAK/Dm04h0ZEUoCngW+ramOo4zlcfezPiP6dVLVLVecBeTiVkFl9LXawbURLMqgAJvpN5wE7QxTLkFDVne7fauBZnH8AkaDKret213erQxzPYVHVKvd/VB/wB0bg7+TWoZ8GHlfVZ9zZI/Z36mt/IuF3AlDVeuAt4HNAhojEuh8NeMyLlmSwCih0W9fjgcuA5SGO6ZCJSLLb+IWIJANnAmsPvtaIsRy40n1/JfB8CGM5bN0HTNcXGGG/k9s4+RBQpqq/8ftoRP5O/e3PSP6dRCRbRDLc94nAYpy2kDeBi93FBvyNouJuIgD3VrH/BjzAUlX9aYhDOmQiMgXnagAgFvjzSNwfEXkCOAWnu90q4A7gOeBJYBJQDlyiqiOiUbaf/TkFp/SgwFbgX7tr7SOBiCwC3gbWAD539n/i1NlH3O90kP25nBH6O4nIETgNxB6cE/wnVfVH7nFiGTAG+Bi4QlXb+91OtCQDY4wx/YuWMpExxpiDsGRgjDHGkoExxhhLBsYYY7BkYIwxBksGxhxARLr8eq8sHspebkUk379XU2PCRezAixgTdVrdR/uNiRp2ZWBMgNwxJH7h9h2/UkSmufMni8jrbidnr4vIJHd+rog86/Yz/4mInOBuyiMif3D7nn/FfWrUmJCyZGDMgRJ7lYku9fusUVWPBe7BeaId9/2jqnoE8DjwO3f+74B/qOqRwHygxJ1fCNyrqrOBeuCiIO+PMQOyJ5CN6UVE9qpqSh/ztwKnqeoWt7OzXaqaKSK1OAOmdLrzK1U1S0RqgDz/LgDcbpNfVdVCd/p7QJyq/iT4e2ZM/+zKwJjB0X7e97dMX/z7h+nC2u5MGLBkYMzgXOr395/u+/dwesIF+ArOsIMArwP/BvsGH0kbriCNGSw7IzHmQInuqFHd/q6q3beXjhKRD3BOpC53530LWCoi3wVqgKvd+TcCD4jItThXAP+GM3CKMWHH2gyMCZDbZrBAVWtDHYsxQ83KRMYYY+zKwBhjjF0ZGGOMwZKBMcYYLBkYY4zBkoExxhgsGRhjjAH+P5WPfeWZn6bZAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[[452  16]\n",
      " [ 29 517]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       0.94      0.97      0.95       468\n",
      "           1       0.97      0.95      0.96       546\n",
      "\n",
      "    accuracy                           0.96      1014\n",
      "   macro avg       0.95      0.96      0.96      1014\n",
      "weighted avg       0.96      0.96      0.96      1014\n",
      "\n",
      "Predictions of 5 medical and 5 alternative medical abstracts, respectively are [1 1 1 1 1 0 0 0 0 0]\n",
      "--- 27.63914704322815 seconds ---\n"
     ]
    }
   ],
   "source": [
    "# ATTEMPT WITH DECAYING LEARNING RATE\n",
    "import time\n",
    "start_time = time.time()\n",
    "\n",
    "\n",
    "def neuralnets_abs(): \n",
    "    \n",
    "    X_Train, X_Test, Y_Train, Y_Test = train_test_split(X_abstracts, y_abstracts, test_size = 0.30, random_state = 101)\n",
    "    \n",
    "    Y_Train = to_categorical(Y_Train)\n",
    "\n",
    "    \n",
    "    #Y_Test = to_categorical(Y_Test)\n",
    "    \n",
    "\n",
    "\n",
    "    input_dim = X_Train.shape[1]\n",
    "    nb_classes = Y_Train.shape[1]\n",
    "\n",
    "\n",
    "    model = Sequential()\n",
    "    model.add(Dense(30, input_dim=input_dim))\n",
    "    model.add(BatchNormalization())\n",
    "    model.add(Activation('relu'))\n",
    "    model.add(Dropout(0.15))\n",
    "    model.add(Dense(15))\n",
    "    model.add(BatchNormalization())\n",
    "    model.add(Activation('relu'))\n",
    "    model.add(Dropout(0.15))\n",
    "    model.add(Dense(20))\n",
    "    model.add(BatchNormalization())\n",
    "    model.add(Activation('relu'))\n",
    "    model.add(Dropout(0.15))\n",
    "    model.add(Dense(nb_classes))\n",
    "    model.add(BatchNormalization())\n",
    "    model.add(Activation('sigmoid'))\n",
    "    \n",
    "\n",
    "    RMSprop =optimizers.RMSprop(learning_rate=0.0001, rho=0.9)\n",
    "    model.compile(loss='categorical_crossentropy', optimizer= RMSprop, metrics=['accuracy'])\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "    print(\"Training...\")\n",
    "\n",
    "    #history = model.fit(X_Train, Y_Train, nb_epoch=15, batch_size=5, validation_split=0.1, verbose=2)\n",
    "    history = model.fit(X_Train, Y_Train, validation_split=0.1, epochs=30, batch_size=30, verbose=2)\n",
    "\n",
    "    predsabs = model.predict_classes(X_Test, verbose=0)\n",
    "    # history = model.fit(X_Train, Y_Train,validation_data = (X_Test,Y_Test), epochs=15, batch_size=5)\n",
    "\n",
    "    # plot metrics\n",
    "    import matplotlib.pyplot as plt\n",
    "    plt.plot(history.history['accuracy'])\n",
    "    plt.plot(history.history['val_accuracy'])\n",
    "    plt.title('Model accuracy')\n",
    "    plt.ylabel('Accuracy')\n",
    "    plt.xlabel('Epoch')\n",
    "    plt.legend(['Train', 'Test'], loc='upper left')\n",
    "    plt.show()\n",
    "    \n",
    "    print(confusion_matrix(Y_Test,predsabs))\n",
    "    print(classification_report(Y_Test,predsabs))\n",
    "    \n",
    "    medab = \"The National Institute of Mental Health (NIMH) ‘fast-fail’ approach seeks to improve too-often-misleading early-phase drug development methods by incorporating biomarker-based proof-of-mechanism (POM) testing in phase 2a. This first comprehensive application of the fast-fail approach evaluated the potential of κ-opioid receptor (KOR) antagonism for treating anhedonia with a POM study determining whether robust target engagement favorably impacts the brain circuitry hypothesized to mediate clinical effects. Here we report the results from a multicenter, 8-week, double-blind, placebo-controlled, randomized trial in patients with anhedonia and a mood or anxiety disorder (selective KOR antagonist (JNJ-67953964, 10 mg; n = 45) and placebo (n = 44)). JNJ-67953964 significantly increased functional magnetic resonance imaging (fMRI) ventral striatum activation during reward anticipation (primary outcome) as compared to placebo (baseline-adjusted mean: JNJ-67953964, 0.72 (s.d. = 0.67); placebo, 0.33 (s.d. = 0.68); F(1,86) = 5.58, P < 0.01; effect size = 0.58 (95% confidence interval, 0.13–0.99)). JNJ-67953964, generally well tolerated, was not associated with any serious adverse events. This study supports proceeding with assessment of the clinical impact of target engagement and serves as a model for implementing the ‘fast-fail’ approach.\"\n",
    "    medab2 = \"Neoadjuvant checkpoint inhibition, in which the therapy is administered before surgery, is a promising new approach to managing bulky but resectable melanoma, and is also being explored in other cancers. This strategy has a high pathologic response rate, which correlates with survival outcomes. The fact that biopsies are routinely available provides a unique opportunity for understanding the responses to therapy and carrying out reverse translation in which these data are used to select therapies in the clinic or in trials that are more likely to improve patient outcomes. In this Perspective, we discuss the rationale for neoadjuvant immunotherapy in resectable solid tumors based on preclinical and human translational data, summarize the results of recent clinical trials and ongoing research, and focus on future directions for enhancing reverse translation.\"\n",
    "    medab3 = \"Successful drug discovery is ultimately contingent on the availability of workable, relevant, predictive model systems. Conversely, for cardiac muscle, the lack of human preclinical models to inform target validation and compound development has likely contributed to the perennial problem of clinical trial failures, despite encouraging non-human results. By contrast, human cardiomyocytes produced from pluripotent stem cell models have recently been applied to safety pharmacology, phenotypic screening, target validation and high-throughput assays, facilitating cardiac drug discovery. Here, we review the impact of human pluripotent stem cell models in cardiac drug discovery, discussing the range of applications, readouts, and disease models employed, along with the challenges and prospects to advance this fruitful mode of research further.\"\n",
    "    medab4 = \"Epithelial-to-mesenchymal transition (EMT) plays an important role in invasion and metastasis of hepatocellular carcinoma (HCC). Our previous study found that atypical protein kinase C-ι (aPKC-ι) promoted the EMT process in HCC. However, how the aPKC-ι signaling pathway is regulated in HCC has not been elucidated. In this study, vector transfection was utilized to study the invasion of HCC cells, and the mechanism between P300 and aPKC-ι signaling pathways in regulating the EMT process of HCC was further elucidated in vitro and in vivo. We found both P300 and aPKC-ι were highly expressed in HCC and they were correlated with tumor progression and poor survival in HCC patients. P300 knockdown inhibited EMT, invasion and other malignant events of HCC cells but promoted cell apoptosis and cycle arrest. However, the effects mediated by P300 knockdown were abolished by aPKC-ι overexpression. Further studies showed that P300 upregulates aPKC-ι expression through increasing the transcription of Elk1, a transcriptional activator of aPKC-ι, and stabilizing Elk1 protein and its phosphorylation. In conclusion, our work uncovered the molecular mechanism by which oncogenic aPKC-ι is upregulated in HCC and suggests that P300, like aPKC-ι, may be used as a prognostic biomarker and therapeutic target in patients with HCC.\"\n",
    "    medab5 = \"An unmet clinical need remains for an effective tetravalent dengue vaccine suitable for all age groups, regardless of serostatus. We assessed the immunogenicity and safety of three different dose schedules of a tetravalent dengue vaccine (TAK-003) over a 48-month period in children living in dengue-endemic countries. We did a large, phase 2, double-blind, placebo-controlled trial at three sites in the Dominican Republic, Panama, and the Philippines. Healthy participants aged 2–17 years were randomly assigned 1:2:5:1 using an interactive web response system with stratification by age to receive either a two-dose primary series (days 1 and 91), one primary dose (day 1), one primary dose plus booster (days 1 and 365), or placebo. Participants and relevant study personnel were masked to the random assignment until completion of the study at month 48. To maintain masking, TAK-003 recipients were administered placebo doses when appropriate. The primary objective was assessment of neutralising geometric mean titres for each serotype to month 48 assessed in the per-protocol immunogenicity subset. Secondary safety endpoints included proportions of participants with serious adverse events and symptomatic virologically confirmed dengue. This study is registered with ClinicalTrials.gov, NCT02302066. Between Dec 5, 2014, and Feb 13, 2015, 1800 children were randomly assigned to the following groups: two-dose primary series (n=201), one primary dose (n=398), one primary dose plus 1-year booster (n=1002), and placebo (n=199). Of them, 1479 (82%) participants completed the 48-month study. Immunogenicity endpoints were assessed in 562 participants enrolled in the immunogenicity subset, of whom 509 were included in the per-protocol subset. At month 48, antibody titres remained elevated in all TAK-003 groups compared with placebo, irrespective of baseline serostatus. At month 48, geometric mean titres were 378 (95% CI 226–632) in two-dose, 421 (285–622) in one-dose, 719 (538–960) in one-dose plus 1-year booster, and 100 (50–201) in placebo recipients against DENV 1; 1052 (732–1511), 1319 (970–1794), 1200 (927–1553), and 208 (99–437) against DENV 2; 183 (113–298), 201 (135–298), 288 (211–392), and 71 (37–139) against DENV 3; and 152 (97–239), 164 (114–236), 219 (165–290), and 46 (26–82) against DENV 4; and tetravalent seropositivity rate was 89% (79–96), 86% (80–92), 97% (93–99), and 60% (47–72), respectively. Virologically confirmed dengue was recorded in 37 (2%) TAK-003 and 13 (7%) placebo participants, with a relative risk of 0·35 (0·19–0·65). No vaccine-related serious adverse events or severe dengue virus disease were reported. TAK-003 elicited antibody responses against all four serotypes, which persisted to 48 months post-vaccination, regardless of baseline serostatus. No important safety risks were identified. We observed a long-term reduction in risk of symptomatic dengue virus disease in vaccinees. Results from this study provide a long-term safety database and support assessment of the vaccine in the ongoing phase 3 efficacy study.\"\n",
    "    altmab = \"In order to meet the growing needs of the European Union medicinal and aromatic plants, Hungary is still one of the major exporters today, although earlier, until the 1980s, we were considered a great herb-growing nation. Therefore, the development of the national medicinal and aromatic herb growing sector is an essential requirement for maintaining and developing our market position. The natural conditions of Hungary favor the cultivation of medicinal and aromatic plants. There are more than 330 herbs in our country. About seventy percent of the drugs grown and harvested are exported. However, significant changes are needed in domestic sales and further processing in order to become a leading industrial sector. Hungary also possesses modern separation techniques and large instruments for analysis, which allow the proper analytical examination of drugs and the precise determination of their active substances. Our universities and research institutes are also prepared to study the active ingredients of herbs by molecular biological methods, which may allow the exact mechanism of action of bioactive substances to be determined and the herbs to be reassessed. Our accession to the European Union the palette of products made from former herbs has significantly changed. From 2013, the category of medicinal product was discontinued and the preparations were classified as either food or medicine. However, there are significant costs associated with qualifying as a drug, so drugs or extracts are largely added to dietary supplements. As a result, the strange situation is that dietary supplements are prohibited from making any health claims, even though the dietary supplement is actually not for the benefit of a healthy population, but for those who have a health problem or do not have suitable foods, which are rich in bioactive substances. The justification of phytotherapy must be demonstrated, depending on the state of the art. In the context of safe therapy, studies must follow the requirements of medicines and only then can they become herbal medicines. There is still much to be desired in this area in our country. Classification as a drug is based on expensive animal tests and clinical studies. A new problem arises here, as herbal cure is currently part of the arsenal of complementary medicine. With few exceptions, clinical doctors do not use herbal therapies. Patients usually ask the advice of pharmacists, naturalists, and more rarely, dietitians. At the Arteriosclerosis Research Group, at the II. Department of Medicine and Institute of Pharmacognosy several decades of biomedical research have served and serve the purpose of evaluating and reassessing the effects of plants used in folk medicine. Over the years, we have been searching for drugs, extracts, and medicines of natural origin that are useful in liver and intestinal diseases known in folk medicine, and are believed to have lipid lowering, antioxidant and immune stimulating effects. In the article, animal and human studies will be also presented.\"\n",
    "    altmab2 = \"This research was done to explore the role of fresh garlic homogenate (GH) on attenuation of myocardial damage when administered concurrently with atenolol (ATN) in experimental animals. At the end of treatment of male albino rats, hearts were excised from anesthetized animals and mounted on modified Langendorff setup. After initial perfusion with physiological solution, hearts were subjected to 15 min global no flow ischemia reperfusion injury (IRI) and perfused again. Significant recovery in developed tension and heart rate was exhibited by hearts of animals pretreated with ATN, GH-125 and GH-250. There was significant elevation of LDH and CK-MB in heart tissue homogenate and fall in perfusate of treated groups (ATN, GH-125 and GH-250). Additionally, simultaneous administration of GH-250 with ATN resulted in significant increase in endogenous antioxidant enzymes (SOD and catalase) activities. The augmented antioxidant activities could be due to the possible synergistic potential of ATN in GH mediated scavenging of oxidative free radicals produced during IRI. On the contrary, high dose of GH (500 mg/kg) failed to demonstrate similar potential even in presence of ATN. Hence, only moderate intake of garlic is good for cardioprotection when administered prophylactically and addition of ATN produces synergistic effect.\"\n",
    "    altmab3 = \"NMR proton relaxation is sensitive to the dynamics of the water molecule H2O, through the interaction of the spin of the proton (1H) with external magnetic and electromagnetic fields. We measured dilution and potentization processes through measurements of 1H spin-lattice T1 and spin–spin T2 relaxation times. In order to interpret the recorded fluctuations in T1- or T2-values, experimental data were linearized by investigating how the area under a fluctuating time = f(dilution) curve (dilution integral or DI) changes with dilution. Two kinds of fitting procedures were considered: chi-square fitting with a goodness-of-fit probability, and least absolute deviations criterion with Pearson's linear correlation coefficient. We showed that fluctuations are not attributable to random noise and/or experimental errors, evidencing a memory effect quantifiable by the slope of the DI = f(dilution) straight line. For all experiments, correlation coefficients were found to lie above 0.9999, against 0.999 for random noise. The discrimination between experimental slopes and slopes associated with random noise data was very good at a five-sigma level of confidence (i.e. probability 3 × 10−7). Discrimination between experimental slopes at a five-sigma level was possible in most cases, with three exceptions: gelsemium aqua pura v gelsemium dilution (four-sigma); copper aqua pura v gelsemium aqua pura (four-sigma) and copper simple dilution v gelsemium simple dilution (three-sigma). All potentized samples show very good discrimination (at least nine-sigma level) against aqua pura, lactose or simple dilution. It was possible to transform the associated relaxation times into a molecular rotational correlation time τc and an average spin–spin distance d. Our experiments thus point to a considerable slowing down of molecular movements (τc > 1300 ps or T = 224–225 K) around water molecules up to a distance of 3.7 Å, values. It was also possible to rule out other possible mechanisms of relaxation (diffusive motion, 17O-1H relaxation or coupling with the electronic spin, S = 1, of dissolved dioxygen molecules). There is clear evidence that homeopathic solutions cannot be considered as pure water as commonly assumed. Instead, we have evidenced a clear memory effect upon dilution/potentization of a substance (water, lactose, copper, gelsemium) reflected by different rotational correlation times and average H⋯H distances. A possible explanation for such a memory effect may lie in the formation of mesoscopic water structures around nanoparticles and/or nanobubbles mediated by zero-point fluctuations of the vacuum electromagnetic field as suggested by quantum field theories. The existence of an Avogadro's ‘wall’ for homeopathically-prepared medicines is not supported by our data. Rather it appears that all dilutions have a specific material configuration determined by the potentized substance, also by the chemical nature of the containers, and dissolved gases and the electromagnetic environment. This sensitivity of homeopathically-prepared medicines to electromagnetic fields may be amplified by the highly non-linear processing routinely applied in the preparation of homeopathic medicines. Future work is needed in such directions. The time is now ripe for a demystification of the preparation of homeopathic remedies.\"\n",
    "    altmab4 = \"This article describes the implementation of a group medical visit (GMV) model to increase access to integrative oncology (IO) care. The most challenging and critical time to access high-quality IO care is while patients are receiving conventional cancer therapy. Often demand for individual IO clinic consultations precludes this from occurring. A three-session GMV program was designed to alleviate barriers to receiving integrative care during active cancer treatment. Design: A consolidated framework was used for implementation research and focused ethnography methods to describe the IO GMV implementation process. Data sources included patient evaluations, participant observation, and brief provider and patient interviews. Setting: A pilot program was created to assess the feasibility and acceptability of implementing IO GMVs at a comprehensive cancer center. Intervention: Each three-session GMV consisted of a didactic session, followed by individual visits with the integrative oncologist. Results: The setting, intervention, and implementation process of the IO GMV program were described. Thirty-two patients participated in the first five cohorts of the program. Twenty-two were women; 24 were White. The median age of participants was 52. Patient evaluations demonstrate high levels of satisfaction with the program with all scored aspects rated >4.0 on a five-point Likert scale. For the medical center, group visits are a financially viable alternative to individual IO visits; revenue from group visits exceeded the revenue potential of 6 h of individual visits by an average of 38%. Conclusion: GMVs are a feasible and promising model for increasing access to IO. Patients in active cancer treatment were able to participate in the program. Future research and implementation efforts could examine health outcomes over time after participation in GMVs, as well as the feasibility of using this model with more diverse patient populations.\" \n",
    "    altmab5 = \"As rates of opiate misuse rise in the United States, so do significant associated health and financial consequences to afflicted individuals, their families, and society at large. Methadone maintenance therapy (MMT) is one evidence-based approach to treating opiate addiction, yet supplemental psychosocial treatment to support this approach is lacking. Mindfulness-based relapse prevention (MBRP) has shown to be efficacious in various substance use populations, but has yet to be assessed with MMT clients. Design: The current mixed methods study was designed to inform protocol adaptation for MMT clients and to evaluate the feasibility, acceptability, and preliminary efficacy of MBRP for this population. Subjects: The sample consisted of adults (N = 15) recruited from a methadone clinic to participate in a 6-week MBRP course. Outcome measures: Data from focus groups and course satisfaction surveys supported feasibility and acceptability of the intervention. Self-report outcome measures included depression, anxiety, craving, symptoms of post-traumatic stress, and experiential avoidance, and were assessed at baseline and postcourse. Results: Mean scores on all primary outcomes changed in the expected direction at postcourse, and baseline to postcourse changes in depression, craving, and trauma symptoms reached statistical significance. Conclusions: Results from this initial pilot trial support feasibility and acceptability, and provide preliminary data on outcomes for future trials of mindfulness-based approaches within the MMT community.\"\n",
    "\n",
    "    new_abs = word_bagger.transform([medab, medab2, medab3, medab4, medab5, altmab, altmab2, altmab3, altmab4, altmab5])\n",
    "    \n",
    "    print(\"Predictions of 5 medical and 5 alternative medical abstracts, respectively are {}\".format(np.argmax(model.predict(new_abs), axis=1)))\n",
    "\n",
    "\n",
    "    \n",
    "neuralnets_abs()\n",
    "\n",
    "print(\"--- %s seconds ---\" % (time.time() - start_time))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "scores = {'Titles Accuracy':{\"Naive-Bayes\":90, 'Decision Tree': 82.8, 'Random Forests': 85, \"Adaboost\": 80, 'SVM': 88, 'ANN':84},\n",
    "'Titles Time':{\"Naive-Bayes\":0.184, 'Decision Tree': 92.96, 'Random Forests': 87.724, \"Adaboost\": 241.16, 'SVM': 0.43, 'ANN':53.76},\n",
    "'Titles Predictions':{\"Naive-Bayes\":8/10, 'Decision Tree': 8/10, 'Random Forests': 9/10, \"Adaboost\": 9/10, 'SVM': 8/10, 'ANN':9/10},         \n",
    "'Titles Accuracy/Time':{\"Naive-Bayes\":90/0.184, 'Decision Tree': 82.8/92.96, 'Random Forests': 85/87.24, \"Adaboost\": 80/241.16, 'SVM': 88/0.43, 'ANN':84/53./76},\n",
    "'Abstracts Accuracy':{\"Naive-Bayes\":94, 'Decision Tree': 89, 'Random Forests': 94, \"Adaboost\": 95, 'SVM': 95, 'ANN':96},\n",
    "'Abstracts Time':{\"Naive-Bayes\":1.35, 'Decision Tree': 199, 'Random Forests': 162.4, \"Adaboost\": 1154, 'SVM': 2.88, 'ANN':27.64},\n",
    "'Abstracts Predictions':{\"Naive-Bayes\":9/10, 'Decision Tree': 8/10, 'Random Forests': 10/10, \"Adaboost\": 9/10, 'SVM': 10/10, 'ANN':10/10},\n",
    "'Abstracts Accuracy/Time':{\"Naive-Bayes\":94/1.35, 'Decision Tree': 89/199, 'Random Forests': 94/162.4, \"Adaboost\": 95/1154, 'SVM': 95/2.88, 'ANN':96/27.64}}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Titles Accuracy</th>\n",
       "      <th>Titles Time</th>\n",
       "      <th>Titles Predictions</th>\n",
       "      <th>Titles Accuracy/Time</th>\n",
       "      <th>Abstracts Accuracy</th>\n",
       "      <th>Abstracts Time</th>\n",
       "      <th>Abstracts Predictions</th>\n",
       "      <th>Abstracts Accuracy/Time</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Naive-Bayes</th>\n",
       "      <td>90.0</td>\n",
       "      <td>0.184</td>\n",
       "      <td>0.8</td>\n",
       "      <td>489.130435</td>\n",
       "      <td>94</td>\n",
       "      <td>1.35</td>\n",
       "      <td>0.9</td>\n",
       "      <td>69.629630</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decision Tree</th>\n",
       "      <td>82.8</td>\n",
       "      <td>92.960</td>\n",
       "      <td>0.8</td>\n",
       "      <td>0.890706</td>\n",
       "      <td>89</td>\n",
       "      <td>199.00</td>\n",
       "      <td>0.8</td>\n",
       "      <td>0.447236</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Random Forests</th>\n",
       "      <td>85.0</td>\n",
       "      <td>87.724</td>\n",
       "      <td>0.9</td>\n",
       "      <td>0.974324</td>\n",
       "      <td>94</td>\n",
       "      <td>162.40</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.578818</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Adaboost</th>\n",
       "      <td>80.0</td>\n",
       "      <td>241.160</td>\n",
       "      <td>0.9</td>\n",
       "      <td>0.331730</td>\n",
       "      <td>95</td>\n",
       "      <td>1154.00</td>\n",
       "      <td>0.9</td>\n",
       "      <td>0.082322</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SVM</th>\n",
       "      <td>88.0</td>\n",
       "      <td>0.430</td>\n",
       "      <td>0.8</td>\n",
       "      <td>204.651163</td>\n",
       "      <td>95</td>\n",
       "      <td>2.88</td>\n",
       "      <td>1.0</td>\n",
       "      <td>32.986111</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ANN</th>\n",
       "      <td>84.0</td>\n",
       "      <td>53.760</td>\n",
       "      <td>0.9</td>\n",
       "      <td>0.020854</td>\n",
       "      <td>96</td>\n",
       "      <td>27.64</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.473227</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                Titles Accuracy  Titles Time  Titles Predictions  \\\n",
       "Naive-Bayes                90.0        0.184                 0.8   \n",
       "Decision Tree              82.8       92.960                 0.8   \n",
       "Random Forests             85.0       87.724                 0.9   \n",
       "Adaboost                   80.0      241.160                 0.9   \n",
       "SVM                        88.0        0.430                 0.8   \n",
       "ANN                        84.0       53.760                 0.9   \n",
       "\n",
       "                Titles Accuracy/Time  Abstracts Accuracy  Abstracts Time  \\\n",
       "Naive-Bayes               489.130435                  94            1.35   \n",
       "Decision Tree               0.890706                  89          199.00   \n",
       "Random Forests              0.974324                  94          162.40   \n",
       "Adaboost                    0.331730                  95         1154.00   \n",
       "SVM                       204.651163                  95            2.88   \n",
       "ANN                         0.020854                  96           27.64   \n",
       "\n",
       "                Abstracts Predictions  Abstracts Accuracy/Time  \n",
       "Naive-Bayes                       0.9                69.629630  \n",
       "Decision Tree                     0.8                 0.447236  \n",
       "Random Forests                    1.0                 0.578818  \n",
       "Adaboost                          0.9                 0.082322  \n",
       "SVM                               1.0                32.986111  \n",
       "ANN                               1.0                 3.473227  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "summary =pd.DataFrame.from_dict(scores)\n",
    "summary"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "summary.to_csv('summary_')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
